foscarnet and ganciclovir

foscarnet has been researched along with ganciclovir in 606 studies

Research

Studies (606)

Timeframe	Studies, this research(%)	All Research%
pre-1990	20 (3.30)	18.7374
1990's	329 (54.29)	18.2507
2000's	147 (24.26)	29.6817
2010's	94 (15.51)	24.3611
2020's	16 (2.64)	2.80

Authors

Authors	Studies
Breitenbach, JM; Devivar, RV; Drach, JC; Kawashima, E; Kreske, ED; Revankar, GR; Townsend, LB	1
Drach, JC; Townsend, LB; Zou, R	2
Chamberlain, SD; Drach, JC; Girardet, JL; Koszalka, GW; Migawa, MT; Townsend, LB; Walker, JA	1
Chen, JJ; Drach, JC; Townsend, LB; Wei, Y	1
Choi, WJ; Chun, MW; Hong, JH; Jeong, LS; Kim, HO; Lee, CK; Moon, HR; Yoo, SJ	1
Andrei, G; Balzarini, J; De Clercq, E; McGuigan, C; Pathirana, RN; Snoeck, R	1
Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S	1
Brideau, RJ; Cudahy, MM; Homa, FL; Hopkins, TA; Knechtel, ML; Oien, NL; Pitts, TW; Poorman, RA; Schnute, ME; Wathen, MW; Wieber, JL	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Chou, S; Rawlinson, WD; Scott, GM; Weinberg, A	1
Anderson, DJ; Brideau, RJ; Ciske, FL; Collier, SA; Cudahy, MM; Eggen, M; Genin, MJ; Hopkins, TA; Judge, TM; Kim, EJ; Knechtel, ML; Nair, SK; Nieman, JA; Oien, NL; Schnute, ME; Scott, A; Tanis, SP; Vaillancourt, VA; Wathen, MW; Wieber, JL	1
Black, DH; Eberle, R; Focher, F; Gambino, JJ; Lossani, A; Maioli, A; Medveczky, M; Medveczky, P; Shugar, D; Spadari, S; Verri, A; Wright, GE	1
Brideau, RJ; DiPaolo, BA; Hageman, MJ; Hopkins, TA; Knechtel, ML; Larsen, SD; Manninen, PR; Oien, NL; Rohrer, DC; Rush, BD; Schwende, FJ; Stefanski, KJ; Wathen, MW; Wieber, JL; Wilkinson, KF; Zamora, KM; Zhang, Z	1
Chou, S; Li, S; Marousek, GI; Van Wechel, LC; Weinberg, A	1
Lombardo, F; Obach, RS; Waters, NJ	1
Brideau, RJ; Collier, SA; Cudahy, MM; Hopkins, TA; Knechtel, ML; Oien, NL; Sackett, RS; Schnute, ME; Scott, A; Stephan, ML; Wathen, MW; Wieber, JL	1
Andrei, G; Balzarini, J; Camarasa, MJ; de Castro, S; Naesens, L; Peromingo, MT; Snoeck, R; Velázquez, S	1
Hamprecht, K; Schott, H; Schott, S; Schott, TC; Schwendener, RA	1
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E	1
Andrei, G; Balzarini, J; Camarasa, MJ; De Castro, S; García-Aparicio, C; Snoeck, R; Velázquez, S	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Daily, SL; Frederick, SL; Harden, EA; Hartline, CB; Jefferson, G; Kern, ER; Maddry, JA; Prichard, MN; Quenelle, DC; Secrist, JA; Tiwari, KN; Whitley, RJ	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Hopkins, TA; Knechtel, ML; Moon, MW; Oien, NL; Parker, TT; Perrault, WR; Stephanski, KJ; Strohbach, JW; Tanis, SP; Thaisrivongs, S; Wathen, MW; Wieber, JL	1
Chen, K; Heasley, SE; Hopkins, TA; Knechtel, ML; Nair, SK; Nieman, JA; Nugent, RA; Oien, NL; Schultz, BL; Stephanski, KJ; Wathen, MW; Wieber, JL; Zerth, HM	1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Hirsch, MS	1
Heinemann, MH	1
Jacobson, MA	5
Jabs, DA	4
Butler, KM; De Smet, MD; Husson, RN; Jarosinski, P; Lovato, G; Manjunath, K; Montrella, K; Mueller, B; Nussenblatt, RB; Pizzo, PA	1
Salit, IE	1
Evans, JK; Miller, RF; Scoular, A	1
Drew, WL	4
Cerrina, J; Le Roy Ladurie, F	1
Wilson, RJ	1
Skolnik, PR	1
Deray, G; Jacobs, C; Katlama, C	1
Bachman, DM	1
Peters, M; Pohle, HD; Ruf, B; Schürmann, D; Timm, U	1
Polis, MA	1
Balfour, HH; Drew, WL; Hardy, WD; Heinemann, MH; Polsky, B	1
Jacobson, PA; Levinson, ML	1
Gazzard, BG; Harman, C; Mathalone, B; Mitchell, S; Moyle, G	1
Lurain, NS; Tatarowicz, WA; Thompson, KD	1
Reusser, P	3
Spratt, PM	1
Crapotta, J; Freeman, WR; Keefe, KS; Listhaus, AD; Peterson, TJ; Quiceno, JI; Wiley, CA	1
Bachman, DM; Bruni, LM; DiGioia, RA; Harris, PJ; McMackin, CM; Pistole, MC; Thomas, RM; Ward, DJ	1
Lauchart, W	1
Geier, SA; Goebel, FD; Klauss, V; Kronawitter, U; Matuschke, A	1
Dugel, PU; Klatt, EC; Lee, M; Morinelli, EN; Rao, NA	1
Fabricius, EM; Popescu, M; Schmitz, K	1
Morris, DJ	2
Wood, CA	1
de Gans, J; Enting, R; Jansen, C; Portegies, P; Reiss, P	1
Peters, M; Pohle, HD; Ruf, B; Schürmann, D; Timm, H	1
Crumpacker, CS	1
Cox, SW; Wahren, B	1
Leport, C; Longuet, P	1
Drew, WL; Feinberg, J; Jacobson, MA; Miner, RD; O'Donnell, JJ; Parenti, D; Whitmore, PV	1
Petersen, EA	1
Reed, EC	1
Charpentier, B	1
Ash, RC; Carrigan, DR; Drobyski, WR; Knox, KK	1
Marwick, C	1
Degré, M	1
Bruun, JN; Moeland, A	1
Borysiewicz, LK; Gray, JJ; Higenbottam, TW; Scott, JP; Sharples, LD; Smyth, RL; Stewart, S; Wallwork, J; Wreghitt, TG	1
Minor, JR	1
Anderson, S; Beck, EJ; Coker, R; Coleman, D; Harris, JR; Main, J; Migdal, C; Peters, BS; Pinching, AJ	1
Bacchetti, P; Harb, GE; Jacobson, MA	1
Gaballo, A; Gerna, G; Milanesi, G; Parea, M; Percivalle, E; Zavattoni, M; Zipeto, D	1
Gümbel, H; Helm, EB; Ohrloff, C; Schalnus, R	1
De Clercq, E; Himpens, B; Neyts, J; Schols, D; Snoeck, R	1
Jenkins, RE; Peters, BS; Pinching, AJ	1
Carrigan, DR; Drobyski, WR; Knox, KK	1
Barter, G; Gazzard, BG; Hawkins, D; Nelson, MR	1
Coker, RJ; Harris, JR; Horner, P; Migdal, C; Tomlinson, D	1
Griffiths, PD	1
Jacobson, MA; O'Donnell, JJ	2
Henderly, DE; Jampol, LM	1
Bakker-Woudenberg, IA; Lokerse, AF; ten Kate, M	1
Goldberg, DJ; Green, ST; Kennedy, DH; Mack, DJ; Nathwani, D	1
Leport, C; Salmon, D	1
Lane, HC; Manischewitz, JF; Quinnan, GV; Wittek, AE	1
Charles, SJ; Gray, JJ	1
Ellis, MN; Hackman, RC; Ljungman, P; Meyers, JD; Shepp, DH	1
Balzarini, J; Bron, D; De Clercq, E; Delforge, A; Lagneaux, L; Snoeck, R; Stryckmans, P; Van der Auwera, P	1
Meyers, JD; Reed, EC	1
Bryson, YJ	1
Azuma, M; Sakuma, T	1
Chiba, S	1
Pinching, AJ	1
Fraser-Smith, EB; Freitas, VR; Matthews, TR	1
Agut, H; Collandre, H; Huraux, JM; Montagnier, L	1
Acheson, JF; Bradbeer, C; Shah, SM; Spalton, DJ; Thin, RN	1
Brunette, EN; DeBruin, M; Debs, RJ; Montgomery, AB; Shanley, JD	1
Jacobson, MA; Mills, J	1
Meyers, JD	1
Gonzales, MF; Greco, C; Jacobson, MA; Miller, RG; Mills, J; O'Donnell, JJ; Rush, J	1
Bloom, JN; Palestine, AG	1
Girard, PM; Le Hoang, P; Michon, C; Ngovan, P; Simonpoli, AM	1
Ablashi, DV; Fullen, J; Hellman, K; Hung, CL; Salahuddin, SZ; Saxinger, C; Streicher, HZ	1
Coen, DM; Fleming, HE; Leslie, LK; Retondo, MJ	1
Clarke, JR; Davis, JM; Jeffries, DJ; Tyms, AS	1
Bombail, D; Cavazzana, M; De Castro, H; Gluckman, E; Huart, JJ; Jolivet, I; Keable, H; Meletis, J; Nebout, T	1
Cheriyan, UO; Galloway, KS; Ogilvie, KK; Smith, KO	1
Luckie, AP	1
Bryson, HM; Wagstaff, AJ	1
Arevalo, JF; Bergeron-Lynn, G; Capparelli, EV; Connor, JD; Freeman, WR; Gambertoglio, J; Garcia, RF; Gonzalez, C; Kirsch, LS; Quiceno, JI	1
Ai, E; Irvine, AR; Kuppermann, BD; Luckie, AP; Margolis, TP; McCann, JD; Schwartz, DM; Wong, MG	1
Holida, MD; Kook, H; Lee, NF; Peters, C; Rumelhart, SL; Trigg, ME	1
Benhamou, Y; Blanshard, C; Dohin, E; Gazzard, BG; Katlama, C; Lernestedt, JO	1
Costagliola, D; Mary-Krause, M	1
Fernandez-Viladrich, P; Ferrer, I; Gudiol, F; Perez, JL; Podzamczer, D; Reñe, R; Salazar, A; Santin, M	1
Engstrom, RE; Holland, GN	1
Thimons, JJ	1
Aweeka, FT; Emrick, L; Gambertoglio, JG; Jacobson, MA; Jayewardene, A; Kramer, F; Lizak, P; Polsky, B; Tong, W; van der Horst, C	1
Masur, H; Polis, MA	1
Apuzzo, L; Charache, P; Dunn, JP; Forman, MS; Jabs, DA; MacCumber, MW	1
Grob, R; Roedel, C; Ruef, C	1
Barnett, BB; Holy, A; Reist, EJ; Sidwell, RW; Smee, DF	1
Baldanti, F; Gerna, G; Percivalle, E; Revello, MG; Sarasini, A; Zavattoni, M	1
Raffi, F	1
el Amrani, M; Girard, PM; Gozlan, J; Jacomet, C; Lebrette, MG; Monfort, L; Rozenbaum, W	1
Cardineau, E; Freymuth, F; Hurault de Ligny, B; Le Goff, C; Lobbedez, T; Ryckelynck, JP	1
Gayowski, T; Singh, N	1
Decker, CF; Martin, GJ; Murray, DF; Tarver, JH	1
Balfour, HH	1
Irvine, AR	1
Schwartz, DA; Straub, RF; Wilcox, CM	1
Chu, SY; Hanson, DL; Jaffe, HW; Jones, JL; Ward, JW	1
Colucciello, M	1
Gazzard, BG; Moyle, G	1
Brincat, S; Catovsky, D; Iveson, T; Jameson, B; Mehta, J; Paul, B; Powles, R; Singhal, S; Treleaven, J; Zomas, A	1
Bacigalupo, A; Frassoni, F; Gualandi, F; Longren, M; Moro, F; Occhini, D; Sanna, MA; Tedone, E; Trespi, G; van Lint, MT	1
Hamprecht, K; Jahn, G	1
Nadler, PI; Nokta, M; Pollard, RB; Tolpin, MD	1
Assuerus, V; Baudrimont, M; Duvivier, C; el Amrani, M; Gonzales-Canali, G; Gozlan, J; Jacomet, C; Ropert, A; Roullet, E; Saïd, G	1
Boeckh, M; Bowden, R; Goodrich, JM	1
Bols, K; Colebunders, R; Fleerackers, Y; Lachenal, M; Van Damme, L; Van den Abbeele, K	1
Causey, D; Cheung, TW; Davis, R; Feinberg, JE; Heath-Chiozzi, ME; Jacobson, MA; Murphy, RL; Owens, S; Power, M; Wulfsohn, M	1
Bassiakos, Y; Geheb, H; Hooton, T; Jacobson, MA; Korvick, JA; Kramer, F; O'Donnell, JJ; Polsky, B; van der Horst, C; Walker, JD	1
Andersson, B; Deisseroth, AB; Giralt, S; Goodrich, J; Ippoliti, C; Luna, M; Mehra, R; Panina, A; Przepiorka, D; van Besien, K	1
Decazes, JM; Karmochkine, M; Lagrange, P; Modai, J; Molina, JM; Morinet, F; Schnell, L; Scieux, C; Welker, Y	1
Fujino, Y; Kimura, S; Mochizuki, M; Mouri, H; Nagata, Y; Oka, S; Ono, A; Shimada, K	1
Dieterich, DT; McMeeking, AA; Poles, MA; Scholes, JV	1
Mehta, J; Powles, R; Singhal, S	1
Freeman, WR	2
Charlebois, E; Harb, G; Jacobson, MA; Stanley, HD	1
Baudouin, C; Berthe, P; Garraffo, R; Hofmann, P; Lapalus, P; Taburet, AM	1
Bogner, JR; Geier, SA; Goebel, FD; Klauss, V; Sadri, I; Schmidt-Kittler, H	1
Alain, S; Mazeron, MC; Morinet, F; Pépin, JM; Raskine, L; Sanson-Le Pors, MJ	1
Dieterich, DT; Lew, EA; Poles, MA	1
Ahmed, T; Cook, P; Mittelman, A; Razis, E	1
Bergmann, F; Grünewald, T; Peters, M; Pohle, HD; Ruf, B; Schürmann, D; Timm, H	1
Berman, SM; Kim, RC	1
Murphy, R; Naughton, K; Weinberg, DV	1
Biron, P; Bosi, A; Cahn, JY; Goldstone, AH; Gorin, NC; Link, H; Ljungman, P; Messina, C; Michallet, M; Richard, C	1
Flores-Aguilar, M; Freeman, WR; Kuppermann, BD; Quiceno, JI; Rickman, LS	1
Brun-Vezinet, F; Leport, C; Levy, S; Pepin, JM; Perronne, C; Puget, S; Vildé, JL	1
Fisher, EJ; Nussbaum, JJ; Roarty, JD	1
Behette, M; Berry, C; Freeman, WR; Friedberg, DN; Fullerton, SC; Munguia, D; Quiceno, JI	1
Collins, P	1
Zaia, JA	2
Cohn, D; De Veranez, D; Kemmerly, S; Phan, LD; Plotkin, B; Safrin, S; Smith, T; Weissbach, N	1
Spaide, RF	1
Bogner, JR; Geier, SA; Goebel, FD; Sadri, I	1
Daon, F; Eugene-Ruelland, G; Freymuth, F; Galateau, F; Petitjean, J	1
Freifeld, AG	1
Cello, JP	1
Jansen, CL; Smit, WM; Surachno, JS; vd Horn, GJ; Wagemans, MA	1
Greenspan, D; Greenspan, JS; Heinic, GS	1
Rubin, RH; Snydman, DR; Werner, BG	1
Baird, BF; Davey, RT; deSmet, MD; Falloon, J; Kovacs, JA; Masur, H; Mellow, S; Nussenblatt, RB; Palestine, AG; Polis, MA	1
Sacks, SL; Sasadeusz, JJ	1
Ash, RC; Burd, EM; Carrigan, DR; Drobyski, WR; Dunne, WM; Flomenberg, N; Horowitz, MM; Knox, KK	1
Dicker, M; Dieterich, DT; Lew, E; Poles, MA; Tepper, R	1
Addessi, A; Dieterich, DT; Friedberg, DN; Holbrook, JT; Lew, EA; Mendez, PE; Murphy, R; Naughton, K; Poles, MA	1
Beijnen, JH; Burger, DM; Keijer, WJ; Koks, CH; Meenhorst, PL; Neuteboom, GH; Vrooland, JL	1
Brockmeyer, NH; Gooss, M; Hengge, UR; Malessa, R; Mertins, L; Steinmetz, R	1
Krom, RA; Marin, E; Paya, CV; Porayko, MK; Steers, JL; Wiesner, RH	1
Capparelli, EV; Connor, JD; Dankner, WM; Flores-Aguilar, M; Fullerton, S; Gambertoglio, JG; Kuppermann, BD; Quiceno, JI; Sherwood, CH; Wolf, DG	1
Cheng, YC; Egan, W; Grill, S; Yao, GQ	1
Young, LH	1
Chenot, JF; Cinatl, J; Doerr, HW; Encke, A; Gümbel, HO; Rabenau, H; Scholz, M; Weber, B	1
Baldanti, F; Barbi, M; Brerra, R; Furione, M; Gerna, G; Percivalle, E; Sarasini, A	1
Flury, R; Giezendanner, S; Meyenberger, C; Weber, R; Wirth, HP; Zala, G	1
Anderson, KP; Azad, RF; Brown-Driver, V; Buckheit, RW	1
Huengsberg, M; Stevenson, M	1
Cohen, BA	1
Baldanti, F; Biron, KK; Chou, S; Gerna, G; Sarasini, A; Silini, E; Stanat, SC; Underwood, MR	1
Detels, R; Glesby, MJ; Graham, NM; Ho, M; Hoover, DR; Phair, JP; Saah, AJ; Weng, S	1
Desatnik, HR; Foster, RE; Lowder, CY	1
Bressler, N; Charache, P; Dunn, JP; Enger, C; Forman, M; Jabs, DA	1
Detels, RR; Hoover, DR; Peng, Y; Phair, JP; Rinaldo, CR; Saah, A; Semba, R	1
Coleson, LC; Holbrook, J; Jabs, DA; Wu, AW	1
Avery, RK; Dodds, EM; Foster, RE; Lowder, CY; Prayson, RA	1
Ljungman, P	1
Mahmood, W; Sacks, SL	1
Baldanti, F; Barbi, M; Biron, KK; Gerna, G; Lazzarin, A; Sarasini, A; Silini, E	1
Balzarini, J; De Clercq, E; Dvoráková, H; Holý, A; Naesens, L; Reymen, D	1
López-Cortés, LF; Pachón-Díaz, J	1
Goedert, JJ; Humphrey, RW; Newcomb, FM; Nishihara, H; O'Brien, TR; Ramos, GA; Saville, MW; Straus, SE; Wyvill, KM; Yarchoan, R	1
Pollard, RB	1
Aschan, J; Ehrnst, A; Klaesson, S; Lewensohn-Fuchs, I; Ljungman, P; Lönnqvist, B; Loré, K; Ringdén, O; Winiarski, J	1
Civitico, G; Locarnini, S; Shaw, T	1
Flaherty, JF	1
Hardy, D	1
Cordonnier, C; Einsele, H; Engelhard, D; Link, D; Ljungman, P; Locasciulli, A; Reusser, P	1
Ai, E; Luckie, AP	1
Danner, SA	1
Bacigalupo, A; Bregante, S; Gualandi, F; Isaza, A; Lamparelli, T; Marmont, AM; Occhini, D; Tedone, E; Trespi, G; Van Lint, MT	1
Chatterjee, S; Lakeman, F; Nii, S; Whitley, RJ; Yamada, M; Yoshida, M	1
Alain, S; Mazeron, MC	1
Larkin, M	1
Bate, K; Brown, G; Colman, P; Conn, J; Street, A	1
Chong, LP; Marx, JL; Patel, SS; Rao, NA; Rutzen, AR; Thach, AB	1
Chin, SY; Khoobehi, B; Peyman, GA; Rahimy, MH; Yang, D	1
Gazzard, B; Halai, R; Mocroft, A; Morcinek, J; Phillips, AN; Youle, M	1
Craigen, JL; Grundy, JE	1
Epps, CH; Rana, SN; Sanders, RJ; Sastry, SM; Walton, RC	1
Bacigalupo, A; Bregante, S; Gualandi, F; Isaza, A; Lamparelli, T; Marmont, AM; Moro, F; Occhini, D; Tedone, E; Trespi, G; Van Lint, MT	1
Eddleston, M; Juniper, M; Peacock, S; Warrell, DA	1
Baruzzo, S; Gotti, E; Moioli, F; Perani, V; Remuzzi, G; Suter, F	1
Courpotin, C; Dollfus, C; Khouri, J; Lasfargues, G; Leverger, G; Maout, F; Quartier, P; Tabone, MD	1
Katz, A; Martin, DF; Spaide, RF; Teich, SA; Toth, I	1
Itin, PH; Lautenschlager, S	1
Breton, G; Crémieux, AC	1
Grose, C	1
Bright, DC	1
Benner, KG; Chou, S; Flora, KD; Olyaei, A; Orloff, SL; Rabkin, JM; Rosen, HR	1
Lyon, AT; Weinberg, DV	1
Friedberg, DN	1
Hardy, WD	1
Kuppermann, BD	1
Fujisaki, T; Gondo, H; Matsuo, I; Minamishima, Y; Minematsu, T; Niho, Y; Otsuka, T; Takenaka, K; Tanimoto, K; Uchida, N	1
Lewis, LL; Mueller, BU; Nussenblatt, RB; Pizzo, PA; Walton, RC; Whitcup, SM	1
Adán, A; Alecrim-Andrade, J; Buira, E; Gatell, JM; Gómez-Sirvent, JL; Guelar, A; Lonća, M; Mallolas, J; Miró, JM; Morales, M; Soriano, E; Zamora, L	1
Baldanti, F; Gerna, G; Percivalle, E; Revello, MG; Sarasini, A; Zella, D	1
Cunningham, ET	1
Gazzard, BG; Moore, DA; Nelson, MR	1
Chiodo, F; Coronado, OV; Manfredi, R; Mastroianni, A	1
Balfour, HH; Boivin, G; Chou, S; Erice, A; Gil-Roda, C; Hanson, MN; Pérez, JL; Sannerud, KJ	1
Berger, BB; Fowell, SM; Jampol, LM; Kumar, S; Loose, IA; Minturn, JT; Moorthy, RS; Rao, NA; Teich, SA; Weinberg, DV	1
Gabriel, V; Herbort, CP; Hirschel, B; Olmari, M; Opravil, M; Sansonetti, A; Stalder, N; Sudre, P; von Overbeck, J	1
Chuang, EL; Freeman, WR; Friedberg, DN; Haidt, SJ; Heinemann, MH; Hurwitz, S; Jabs, DA; Jacobson, MA; Kaplan, HJ; Mueller, AJ	1
Ganem, D; Kedes, DH	1
Gane, EJ; Macartney, M; Portmann, B; Williams, R	1
Drew, WL; Flood, J; Follansbee, S; Garvey, J; Jekic-McMullen, D; Kolberg, J; Miner, R; Poscher, M; Shen, LP	1
Fischer, H; Kapelari, K; McIntosh, K; Sailer, M; Zaknun, D; Zangerle, R	1
Speyrer, MP	1
Chou, S; Drew, WL; Follansbee, SE; Guentzel, S; Lalezari, JP; Marousek, G; Miner, RC; Poscher, ME	1
Biondo, FX; Kaplan, MH; Lipson, SM; Shepp, DH; Soni, M; Sun, T	1
Cline, JJ; Garrett, AD	1
Chiodo, F; Coronado, OV; Dal Monte, P; Lazzarotto, T; Manfredi, R; Mastroianni, A; Spezzacatena, P	1
Horvath, E; Lund, T; Medveczky, MM; Medveczky, PG	1
Katlama, C	1
Andersson, B; Champlin, R; Gajewski, J; Giralt, S; Ippoliti, C; Khouri, I; Mehra, R; Morgan, A; Przepiorka, D; van Besien, K; Warkentin, D	1
Pérez, JL	1
Ericzon, BG; Hägglund, H; Ringdén, O; Sparrelid, E; Winiarski, J	1
Fujimori, Y; Kakishita, E; Kanamaru, A; Mori, A; Okada, M; Okamoto, T; Saheki, K; Takatsuka, H; Takemoto, Y; Tamura, A; Wada, H	1
Hampl, W; Hartmann, A; Mertens, T; Michel, D; Pavić, I; Schleyer, I; Zimmermann, A	1
Méndez Marín, I; Montero, M; Pérez-Blázquez, E; Traspas, R	1
Lalezari, JP	1
Einsele, H; Hebart, H; Jahn, G; Kanz, L	1
Takahashi, K	1
Usui, M; Usui, N	1
Okada, S; Tanaka-Taya, K	1
Cinatl, J; Guembel, HO; Hofmann, F; Makabe, R; van Even, G	1
Smith, CL	1
Baldanti, F; Biron, KK; Gerna, G	1
Pau, AK	1
Cunningham, ET; Jones, MR; Schwartz, D; Silverstein, BE; Smith, JH; Sykes, SO	1
Anders, HJ; Bogner, JR; Goebel, FD; Weiss, N	1
Goodgame, RW	1
Bianchi Porro, G; Parente, F	1
Cinque, P; Cleator, GM; Gerna, G; Klapper, PE; Monteyne, P; Sindic, C; van Loon, AM; Weber, T	1
Andreu, D; Arnó, A; Bonjoch, A; Clotet, B; Conejero, M; Jou, A; Romeu, J; Ruiz, L; Ruiz, S; Sirera, G; Tural, C	1
Ciulla, TA; Duker, JS; Morley, MG; Rutledge, BK	1
Behnsch, M; Bergmann, F; Grobusch, MP; Liekfeld, A; Schürmann, D	1
Chevallier, M; Dumortier, J; Durupt, S; Trépo, C; Zoulim, F	1
Benson, CA; Deutsch, TA; Dieterich, DT; Drew, WL; Feinberg, J; Friedberg, DN; Griffiths, PD; Hardy, WD; Holland, GN; Jabs, DA; Jacobson, MA; Kessler, HA; Polis, MA; Powderly, WG; Spector, SA; Walmsley, S; Whitley, RJ	1
Althaus, C; Hudde, T; Loeffler, KU; Schimkat, M; Sundmacher, R	1
Cherrington, JM; Cihlar, T; Fuller, MD	1
Agut, H; Challine-Lehmann, D; Gautheret-Dejean, A; Kirch, C; Rieux, C; Vernant, JP	1
Font, RL; Girard, B; Hauw, JJ; Park, SS; Young, LH	1
Derbolav, A; Krepler, K; Mühlbauer, B; Rieger, A; Ries, E; Ruhswurm, I; Svolba, G; Wedrich, A	1
Cinatl, J; Scholz, M; Vogel, JU	1
Chou, S; Drew, WL; Gordon, SM; LaVoy, AG; Marousek, G; Miner, RC; Parenti, DM; Ross, JG	1
Baldanti, F; Furione, M; Gerna, G; Percivalle, E; Revello, MG; Sarasini, A; Torsellini, M; Zavattoni, M	1
Cassetti, LI; Espinoza, L; Hansman-Whiteman, ML; Jayaweera, DT; Lopardo, GD; Scerpella, EG	1
Bacigalupo, A; Berisso, G; Bregante, S; Bruno, B; Gualandi, F; Lamparelli, T; Mordini, N; Moretti, S; Occhini, D; Tedone, E; Van Lint, MT; Zikos, P	1
Dunn, JP; Enger, C; Forman, M; Hubbard, L; Jabs, DA	1
Hamprecht, K; Jahn, G; Maierl, J; Prix, L	1
Baldanti, F; Gerna, G; Percivalle, E; Revello, MG	1
Freeman, WR; Garcia, CR; Torriani, FJ	1
Cherrington, JM; Drew, WL; Fuller, MD; Lalezari, JP; Lamy, PD; Miner, R; Nuessle, S	1
Kijlstra, A; Paydafar, D; ten Kate, FJ; van den Horn, GJ; van der Meer, JT; Verbraak, FD; Wertheim-van Dillen, PM	1
Bergeron, MG; Boivin, G; Gaudreau, A; Handfield, J; Lalonde, R; Murray, G; Routy, JP; Toma, E	1
Gee, L; Jacobson, MA; Lugo, D; Robles, R	1
Fuchs, AV; Jäger, H; Kampik, A; Scheider, A; Wolf, E	1
Apperley, JF; Baccarani, M; Fanin, R; Stocchi, R; Ward, KN	1
Cheung, TW; Teich, SA	1
Flores-Aguilar, M	1
Bergeron, MG; Boivin, G; Handfield, J; Lalonde, R; Toma, E	1
Champlin, R; Giralt, S; Hecht, D; Ippoliti, C; Jacobson, K; Luna, M; Nguyen, Q; Raad, I; Rolston, K; Tarrand, J; Whimbey, E	1
Skiest, DJ	1
Cai, GY; Chou, S; Crumpacker, CS; Lurain, NS; Sharma, PL; Weinberg, A	1
Huang, J; Rabkin, CS; Testa, MA; Von Roenn, JH	1
Drew, WL; Lalezari, JP	1
Tseng, A; Walmsley, S	1
de la Iglesia, JL; Iglesias, J; Lambert, JL; Manso, JV; Oña, M	1
Hoy, J	1
Clark, AD; Geretti, AM; Griffiths, PD; Johnston, RE; Potter, M; Prentice, HG; Wheeler, AC	1
Keating, MR	1
Au Eong, KG; Beatty, S; Charles, SJ	1
Aversa, F; Ballanti, S; Barozzi, P; Gurdo, G; Luppi, M; Tabilio, A; Tiacci, E; Torelli, G	1
Blaheta, RA; Cinatl, J; Doerr, HW; Gümbel, HO; Kotchetkov, R; Scholz, M; Vogel, JU; Weimer, E	1
Biron, K; Brambilla, D; Britt, W; Chou, S; Crumpacker, C; Drew, WL; Erice, A; Gilliam, B; Jokela, J; Landry, ML; Lurain, N; Manischewitz, J; Miner, R; Nokta, M; Reichelderfer, P; Spector, S; Stanat, S; Weinberg, A; Yen-Lieberman, B	1
Emery, VC	2
Bareta, J; Hidalgo, J; Rhee, W; Steidl, S; Wutoh, AK	1
Delfraissy, JF; Frau, E; Furlan, V; Goujard, C; Labetoulle, M; Lantz, O; Lecointe, D; Niessen, F; Offret, H; Rogier, H	1
Andrei, G; De Clercq, E; Myhren, F; Neyts, J; Sandvold, ML; Snoeck, R	1
Durand, H; Gisselbrecht, M; Haas, C; Lowenstein, W; Marteau, P; Roudière, L	1
Anduze-Faris, BM; Boukli, N; Caumes, E; Costagliola, D; Fillet, AM; Gasnault, J; Gozlan, J; Katlama, C; Lancar, R; Leport, C; Livartowsky, J; Matheron, S; Salmon, D	1
Agut, H; Debré, P; Gautheret-Dejean, A; Grenot, P; Huraux, JM; Manichanh, C	1
Fong, IW; Fong, MW; Ho, J; Lo, B; Toy, C	1
Bini, EJ; Gorelick, SM; Weinshel, EH	1
Einsele, H; Hebart, H	1
Bacigalupo, A; Benvenuto, F; Berisso, G; Bertilson, S; Bregante, S; Figari, O; Gualandi, F; Lamparelli, T; Mordini, N; Raiola, AM; Tedone, E; Trespi, G; Van Lint, MT	1
Boeckh, M; Corey, L; Davis, CL; Koelle, DM; Limaye, AP	1
Dworkin, MS; Hanson, DL; Jaffe, HW; Jones, JL	1
Davis, MD; Gilpin, AK; Holbrook, JT; Holland, GN; Hubbard, LD; Jabs, DA; Martin, BK; Meinert, C; Reshef, DS	1
Althaus, C; Best, J; Gantke, B; Kersten, A; Theisen, A	1
Brytting, M; Linde, A; Mousavi-Jazi, M; Sundqvist, VA; Wahren, B	1
Eckle, T; Hamprecht, K; Handgretinger, R; Jahn, G; Klingebiel, T; Prix, L; Selle, B	1
Hoffman, VF; Skiest, DJ	1
Chou, S; Drew, WL; Miner, RC	1
Distler, A; Ketteler, M; Mertz, A; Offermann, G; Preuschof, L; Schäfer, H; Stöffler-Meilicke, M	1
Boeckh, M; Corey, L; Davis, C; Drew, WL; Gooley, T; Huang, M; Miner, R; Nichols, WG	1
Bolaños-Meade, J; Buddharaju, LN; Chen, T; Cottler-Fox, M; Cross, A; Fassas, AB; Lovchik, JC; Rapoport, A; Tricot, G	1
Boeckh, M; Chuang, EL; Corey, L; Crippa, F; Sale, G	1
Feinberg, J; Wilkin, A	1
Castagnola, E; Cristina, E; Dallorso, S; Giacchino, R; Lanino, E	1
Fine, HF; Murante, BL; Nussenblatt, RB; Robinson, MR; Smith, JA	1
Chan, CC; Robinson, MR; Roy, CE; Velez, G; Whitcup, SM	1
Claro-Cala, CM; Cordero, E; López-Cortés, LF; Lucero-Muñoz, MJ; Pastor-Ramos, MT; Ruiz-Valderas, R; Uceda-Montañés, A	1
Brugger, W; Einsele, H; Grigoleit, U; Gscheidle, B; Hebart, H; Kanz, L; Loeffler, J; Schäfer, H; Sinzger, C	1
Amjad, M; Carlson, RM; Gillespie, MA; Karim, MR	1
Blanchet, KD	1
Cheng, B	2
Woodward, J	1
Baker, R	1
Bowers, M	1
Smart, T	2
Palestine, AG	1
Mascolini, M	1
Spector, SA	1
Highleyman, L	1
Foster, RE; Neuss, MN; Osher, RH; Petersen, MR	1
Adriaanse, HM; Dekkers, CA; Greijer, AE; Middeldorp, JM; The, TH; van der Bij, W; Verschuuren, EA	1
Lee, TA; Malinverni, R; Pleil, AM; Ramsey, SD; Steger, PJ; Sullivan, SD; Veenstra, DL; Williamson, T	1
Basara, N; Kiehl, MG	1
Castagnola, E; Chierici, M; Cristina, E; Lanino, E; Miano, M; Morreale, G	1
Amo, K; Aono, T; Hara, J; Kim, JY; Matsuda, Y; Miyagawa, H; Ohta, H; Okada, S; Sashihara, J; Sawada, A; Tanaka-Taya, K; Tano, Y; Tokimasa, S; Yamamoto, S; Yamanishi, K	1
Boulad, F; Cihlar, T; George, D; Kiehn, TE; Lin, DC; Polsky, B; Prasad, VK; Regan, A; Seo, SK	1
Brytting, M; Drew, WL; Harmenberg, J; Linde, A; Miner, RC; Mousavi-Jazi, M; Schloss, L; Wahren, B	1
Herrero, M; Labeaga, R; Margall, R; Muñoz, JM; Otegui, M; Prats, G; Rabella, N	1
Battmer, K; Dammann, E; Eder, M; Ganser, A; Hambach, L; Heil, G; Hertenstein, B; Stucki, A	1
Salmon-Ceron, D	1
Numazaki, K	1
Knight, DA; LeClaire, JD; Waldman, WJ	1
Cordonnier, C; Einsele, H; Engelhard, D; Finke, J; Lee, J; Link, H; Ljungman, P; Reusser, P; Rovira, M; Volin, L	1
Brytting, M; Grillner, L; Hökeberg, I; Linde, A; Mousavi-Jazi, M; Schloss, L; Zweygberg-Wirgart, B	1
Cañizares, MA; Casado, JL; González, J; Guerrero, A; Losada, I; Pérez-Elías, MJ; Rubio, R	1
De Clercq, E; Naesens, L	1
Cañete, A; Carvajal, E; Castel, V; Fernández, JM; Verdeguer, A	1
Chou, SW	1
Assi, AC; Lightman, S	1
Fishman, JA; Kallas, WM; Mylonakis, E	1
Williams, IG	1
Davis, JL; Scott, IU; Verm, AM	1
Kimberlin, DW	1
Carrington, D; Cornish, JM; Foot, AB; Goulden, N; Marks, DI; Oakhill, A; Ronghe, MD; Steward, CG	1
Davis, JL; Luu, KM; Scott, IU	1
Baldanti, F; Drach, JC; Gerna, G; Sarasini, A; Zemlicka, J	1
Mitchell, SM; Obi, AA; Zambarakji, HJ	1
Emery, VC; Leśnikowski, ZJ; Olejniczak, A; Paradowska, E; Przepiórkiewicz, M	1
Davis, MD; Friedberg, D; Holbrook, JT; Jabs, DA; Lewis, RA; Weinberg, DV	1
Avery, RK; Braun, W; Flechner, SM; Goldman, M; Gordon, SM; Haug, M; Isada, CM; Kohn, D; Long, J; Longworth, DL; Lurain, NS; Maurer, J; Mawhorter, SD; Mossad, SB; Schilz, R; Schmitt, SK; Taege, AJ; Yen-Lieberman, B	1
Balfour, HH; Clark, HB; Holman, CJ; Julin, JE; Krivit, W; van Burik, JH; Webb, C	1
Brytting, M; Mousavi-Jazi, M; Schloss, L; Wahren, B	1
Benz, MS; Davis, JL; Glaser, JS	1
Bidanset, DJ; Kern, ER; Kushner, NL; Long, MC; Williams, SL	1
Bakker, HI; De Boer, FM; Harmsen, MC; Meijer, DK; Molema, G; van der Strate, BW	1
Dickson, J; Gaspar, A; Machado, D; Valdez, O; Weigert, A	1
Boeckh, M; Nichols, WG; Papanicolaou, G; Rubin, R; Wingard, JR; Zaia, J	1
Bodaghi, B; Cassoux, N; Chau Tran, TH; Lehoang, P	1
Andrei, G; Bousseau, A; De Bolle, L; De Clercq, E; Naesens, L; Otto, M; Roy, C; Snoeck, R; Van Lommel, A; Zhang, Y	1
Blanc, C; Gillet, M; Halkic, N; Kovacsovics, T; Ksontini, R; Meylan, P; Mosimann, F; Muheim, C; Scholl, B	1
Eksborg, S	1
Alain, S; Belloc, S; Brouet, JC; Ducancelle, A; Malphettes, M; Mazeron, MC; Petit, F; Sanson Le Pors, MJ; Scieux, C	1
Amooty, G; Brown, VS; Burroughs, AK; Emery, VC; Geretti, AM; Grace, SC; Griffiths, PD; Hainsworth, EG; Hassan-Walker, AF; Mattes, FM; Nebbia, G; Okwuadi, S; Potter, M; Prentice, G; Sabin, C; Sweny, P	1
Clarke, HE; Maggs, DJ	1
Clark, DA; Emery, VC; Fryer, JF; Griffiths, PD	1
Bodaghi, B; Caspers-Velu, L; Gaudric, A; Lehoang, P; Liesnard, C; Rozenberg, F; Stanescu, D; Tran, TH	1
Baldanti, F; Gerna, G; Lurain, N	1
Dewhurst, S	1
Ceci, G; Francavilla, A; Ierardi, E; Luzzi, I; Monno, R; Rendina, M; Rizzo, C; Rizzo, G	1
Alston, B; Asmuth, DM; Aweeka, F; Borucki, MJ; Caliendo, A; Gnann, J; Hirsch, MS; Hubbard, L; Nadler, PI; Nevin, TT; Nokta, M; Owens, S; Pollard, RB; Sattler, F; Spritzler, J; Waterman, K	1
Chou, S; Giller, RH; Li, S; Quinones, R; Shira, JE; Springer, KL; Weinberg, A	1
Klass, CM; Krug, LT; Offermann, MK; Pozharskaya, VP	1
Tanaka-Taya, K	2
Dediulescu, DF; Dediulescu, L	1
Buonfrate, D; Cesaro, S; Cusinato, R; Manzardo, C; Mengoli, C; Messina, C; Palù, G; Tridello, G; Zhou, X	1
Bando, T; Chen, F; Fukuse, T; Hanaoka, N; Hasegawa, S; Wada, H	1
Carmichael, T; Choonara, YE; Danckwerts, MP; Pillay, V	2
Bellaiche, M; Berrebi, D; Cezard, JP; Ghidini, B; Hugot, JP; Mougenot, JF; Munck, A; Peuchmaur, M; Viala, J	1
Bodaghi, B; Cassoux, N; Davis, JL; de Schryver, I; Kestelyn, P; Lehoang, P; Michelson, S; Rozenberg, F	1
Kitajima, N	1
Moriuchi, H; Moriuchi, M	1
Murayama, T	1
Baldelli, F; Belfiori, B; Canovari, B; Francisci, D; Marroni, M; Morosi, S; Stagni, G	1
Chou, S; Drew, WL; Marousek, GI; Miner, RC	1
Cairo, MS; Cooney, E; Della-Lotta, P; Shereck, EB; van de Ven, C	1
Asano, S; Iseki, T; Konuma, T; Ooi, J; Takahashi, S; Takasugi, K; Tojo, A; Tomonari, A; Tsukada, N	1
Kaiser, PK; Lowder, CY; Singh, RP; Ufret-Vincenty, RL	1
Croubels, S; De Backer, P; Garré, B; Nauwynck, H; Neyts, J; Nugent, J; van der Meulen, K	1
Hori, A; Kami, M; Kato, D; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Morinaga, S; Murashige, N; Narimatsu, H; Shibata, T; Taniguchi, S; Wake, A; Yuji, K	1
Grossman, ME; Hinds, G; Husain, S; Hutt, C; Pol-Rodriguez, M; Wanner, M	1
Hori, A; Kami, M; Kanda, Y; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Narimatsu, H; Tanaka, Y; Taniguchi, S; Wake, A; Yuji, K	1
Eizuru, Y	1
Carbonnel, F	1
Bakri, SJ; Eid, AJ; Kijpittayarit, S; Razonable, RR	1
Cervera, C; Cofan, F; Fica, A; Linares, L; Marcos, MA; Moreno, A; Navasa, M; Pérez, N; Pérez-Villa, F; Pumarola, T; Ramírez, J; Ricart, MJ; Soto, G	1
Michaels, MG	1
Iwasenko, JM; Rawlinson, WD; Scott, GM; Ziegler, JB	1
Casper, K; Fasola, C; Heffron, T; Lehneman, J; Rodriguez, J; Smallwood, G; Stieber, A	1
Chou, S; Marousek, GI	1
Hanson, KE; Palmer, SM; Reddy, AJ; Zaas, AK	1
Chamberlain, MC; Chowdhary, S	1
Angarone, M; Ison, MG	1
Chou, S; Li, S; Marousek, G; Weinberg, A	1
de Vries, RD; Duan, R; Osterhaus, AD; Remeijer, L; Verjans, GM	1
Boucher, HW; Torres-Madriz, G	1
Asano-Mori, Y; Chiba, S; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Shiraki, K; Watanabe, T	1
Bhangoo, MS; Blackburn, BG; Caulfield, AK; Montoya, JG; Troy, SB; Yeom, K	1
Járay, J; Péter, A; Telkes, G; Varga, M	1
Kneen, R; Mallewa, M; Riordan, A; Sohal, A; Solomon, T	1
Bunjes, D; Härter, G; Mertens, T; Michel, D; Schreiber, A; Schubert, A	1
de Weerdt, O; Rothova, A	1
Burgos, D; Cabello, M; González Molina, M; Gutiérrez, C; López, V; Siles, J; Sola, E; Vega, E	1
Boeckh, MJ; Pergam, SA; Travi, G; Xie, H	1
Forman, MS; Jabs, DA; Martin, BK	1
Chiou, SH; Liu, SJ; Peng, YJ; Wen, CW	1
Chan-Kai, BT; Chew, EY; Faia, LJ; Forooghian, F; Lauer, AK; Nussenblatt, RB; Sen, HN; Weichel, ED; Witherspoon, SR; Wong, WT; Yeh, S	1
Goldstein, DA; Kesen, MR; Meghpara, B; Sulkowski, G; Tessler, HH	1
Opozda, A; Pietrzyk, JJ; Tomasik, T	1
Azzi, A; Boivin, G; Lin, SX; Martin, M	1
Asakura, M; Atsuta, Y; Etoh, T; Fukuda, T; Hatanaka, K; Ikegame, K; Kanamori, H; Mori, T; Ogawa, H; Sakamaki, H; Suzuki, R; Takami, A; Taniguchi, S; Yoshida, T; Yoshihara, S; Yujiri, T	1
Yoshikawa, T	1
Xia, CS; Zhang, Z	1
Chou, S; Lurain, NS	1
De Keyzer, K; Peeters, P; Van Laecke, S; Vanholder, R	1
Kern, ER; Prichard, MN	1
Baldwin, K	1
Chou, S	2
Chronister, CL; Kaiser, H; Pagani, JM	1
Asberg, A; Hartmann, A; Haug Dorenberg, D; Kristiansen, KI; Leivestad, T; Myhre, HA; Rollag, H	1
Azzi, A; Boivin, G; Gilbert, C; Goyette, N; Lin, SX	1
Agut, H	1
Capobianchi, A; Foà, R; Gentile, G; Girmenia, C; Iori, AP; Mauro, FR; Micozzi, A; Torelli, GF	1
Razonable, RR	2
Bowlin, TL; Chou, S; Marousek, G	1
Fahle, G; Faia, LJ; Flaxel, CJ; Forooghian, F; Lauer, AK; Nussenblatt, RB; Sen, HN; Stout, JT; Weichel, ED; Yeh, S	1
Blaschke, D; Boldt, LH; Haverkamp, W; Huemer, M; Parwani, A; Rolf, S; Wutzler, A	1
Chavala, S; Miller, MB; Moss, HB; Say, E	1
Carmichael, A; Goldsmith, PM; Husain, MM; Middleton, SJ; Zhang, H	1
Bian, JM; Chen, HR; Chen, P; Guo, Z; He, XP; Liu, D; Liu, XD; Lou, JX; Yang, K; Zhang, Y	1
Nakamura, K	1
Dickson, M; Eliadou, E; Ferguson, P; Goossens, L; Stace, NH; Weinkove, R	1
Bacigalupo, A; Boyd, A; Clissold, S; Curtis, J; Slipper, J	1
Cunha-Bang, Cd; Frederiksen, CM; Gustafsson, F; Iversen, M; Kirkby, N; Kjaer, J; Lepri, AC; Lundgren, JD; Rasmussen, A; Sengeløv, H; Sønderholm, M; Sørensen, SS	1
Brichová, M; Dvořák, J; Heissigerová, J; Kalvodová, B; Ríhová, E; Svozílková, P	1
Albini, TA; Flaxel, CJ; Gupta, S; Mandelcorn, E; Suhler, EB; Vemulakonda, GA; Yeh, S	1
Eliott, D; Elner, SG; Goldberg, N; Johnson, MW; Lieberman, RM; Schneider, EW; van Kuijk, FJ	1
Hartline, CB; James, SH; Lanier, ER; Price, NB; Prichard, MN	1
Goumenos, DS; Kalliakmani, P; Koukoulaki, M; Marangos, M; Papachristou, E; Papasotiriou, M; Savvidaki, E	1
Ablashi, DV; Arbuckle, JH; Hu, J; Luka, J; Medveczky, MM; Medveczky, PG; Montoya, JG; Pantry, SN; Peterson, D; Pritchett, JC; Renne, R	1
Ashizawa, M; Ishihara, Y; Kako, S; Kanda, J; Kanda, Y; Kawamura, K; Kikuchi, M; Kimura, S; Machishima, T; Nakasone, H; Nishida, J; Sakamoto, K; Sato, M; Tanihara, A; Terasako-Saito, K; Wada, H; Yamasaki, R; Yamazaki, R	1
Fischer, L; Göhring, K; Hamprecht, K; Jahn, G; Laib Sampaio, K	1
Abdel-Massih, R; Bermudez, C; Bhama, JK; Clancy, CJ; Crespo, MM; Kwak, EJ; Minces, LR; Mitsani, D; Nguyen, MH; Pilewski, JM; Shields, RK; Silveira, FP; Toyoda, Y	1
Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A	1
Arav-Boger, R; Cai, H; Forman, M; He, R; Kapoor, A; Posner, GH; Venkatadri, R	1
Beersma, MF; Boucher, CA; Falkenburg, F; Hoek, RA; Hoogsteden, HC; Jedema, I; Murk, JL; Pas, SD; Schipper, ME; van Bergeijk, H; van den Blink, B; van Hal, PT; Verkaik, NJ	1
Bowlin, TL; Chou, S; Komazin-Meredith, G; Williams, JD	1
Baumal, CR; Tawse, KL	1
Boivin, G; Piret, J	1
Gregg, K; Hakki, M; Kaul, DR	1
Cavanna, L; Immovilli, P; Mordenti, P; Nobili, E; Zaffignani, E	1
Chou, S; Ercolani, RJ; Lefterova, MI; Pinsky, BA; Sahoo, MK; Strasfeld, LM	1
Agut, H; Aït-Arkoub, Z; Autran, B; Boutolleau, D; Burrel, S; Carcelain, G; Conan, F; Deback, C; Gandjbakhch, I; Varnous, S	1
Behr, J; Giessen, C; Jäger, G; Kneidinger, N; Milger, K; Neurohr, C; Nitschko, H; Schramm, R; Striebinger, H; von Wulffen, W	1
Andrei, G; Coen, N; Duraffour, S; Snoeck, R; Topalis, D	1
Moisseiev, J; Rahav, G; Shapira, Y; Shimoni, A; Somech, R; Vishnevskia-Dai, V	1
Boivin, G; Drouot, E; Eckenroth, BE; Götte, M; Goyette, N; Piret, J	1
Biousse, V; Del Rio, C; Schechter, MC; Weissman, HM; Yeh, S	1
Albini, TA; Churgin, D; Davis, JL; Relhan, N	1
Iapadre, G; Lasorella, S; Mareri, A; Maresca, M; Nigro, G; Tambucci, R	1
Akkoç, G; Atıcı, S; Bakır, M; Çeliker, H; Demir, SÖ; Kadayifci, EK; Karaaslan, A; Kazokoğlu, H; Koç, A; Şenay, E; Soysal, A; Yakut, N	1
Alain, S; Andouard, D; Cahen, R; Couvreux, A; Deering, M; Hantz, S; Ligat, G; Mazeron, MC; Pouteil-Noble, C; Viget, N; Yasdanpanah, Y	1
Fujita, H; Hatanaka, K; Higuchi, H; Iwami, D; Morita, K; Ogawa, Y; Oishi, Y; Sasaki, H; Shinohara, N	1
Angarone, M; Flaherty, J; Ison, MG; Penugonda, S; Rubin, J; Stosor, V; Young, PG	1
Chou, S; Ercolani, RJ; Lanier, ER	1
Fischer, L; Göhring, K; Hamprecht, K; Hofmann, J; Imrich, E; Jahn, G; Sampaio, KL	1
Ambrose, T; Butler, A; Carmichael, A; Duncan, S; English, S; Gkrania-Klotsas, E; Louis-Auguste, J; Massey, D; Middleton, S; Russell, N; Rutter, CS; Sharkey, LM; Woodward, JM	1
Alain, S; Delacour, ML; Essig, M; Fleury, H; Garrigue, I; Kaminski, H; Merville, P; Moulinas, R; Recordon-Pinson, P; Rerolle, JP	1
Ahn, KS; Choi, DL; Hong, HL; Kang, GW; Kim, JD; Lee, IH	1
Agut, H; Bonnafous, P; Gautheret-Dejean, A	1
Dirks, J; Fliser, D; Leyking, S; Mihm, J; Rissland, J; Sester, M; Sester, U; Smola, S; Wilkens, H	1
Ambinder, R; Arav-Boger, R; Avery, RK; Forman, M; Kraus, E; Lees, L; Marr, KA; Neofytos, D; Ostrander, D; Shah, P; Shoham, S; Trollinger, B; Valsamakis, A	1
Ablashi, DV; Ogata, M; Ongrádi, J; Stercz, B; Yoshikawa, T	1
Ariza-Heredia, E; Chemaly, RF; Doan, V; El Chaer, F; Jan, A; Mori, N; Oliver, N; Shah, D; Tayar, J; Tverdek, F; Wang, E	1
Boss, JD; Rosenberg, K; Shah, R	1
Bruminhent, J; Rotjanapan, P; Watcharananan, SP	1
Atsuta, Y; Eto, T; Fukuda, T; Hashimoto, H; Ichinohe, T; Ikebe, T; Kanamori, H; Kondo, T; Miyamoto, T; Mori, T; Ogata, M; Ogawa, H; Oshima, K; Takano, K; Ueda, Y; Ueki, T	1
Agrawal, N; Beltran, D; Echenique, IA; Najafian, N; Ramirez-Ruiz, L	1
Fukuda, T; Hiroshima, Y; Hoshi, K; Ichikawa, N; Kobayashi, H; Ogata, M; Satou, T; Sumi, M; Ueki, T	1
Allen, A; Ison, MG; Lacloche, L; Pierce, B; Richardson, CL	1
Corral, Í; Galán, JC; Kawiorski, MM; López-Martínez, MJ; Rodríguez, M; Sainz de la Maza, S	1
Bernal-Blanco, G; Cintra-Cabrera, M; Fernández-Cuenca, F; Gentil-Govantes, MÁ; González-Roncero, FM; Pérez-Valdivia, MÁ; Rocha-Castilla, JL; Suárez-Benjumea, A; Súñer-Poblet, M; Toapanta-Gaibor, NG	1
Baghban, A; Malinis, M	1
Brothers, AW; Englund, JA; Vora, SB; Waghmare, A	1
Meesing, A; Razonable, RR	1
Fukuda, T; Ogata, M; Phan, TL	1
DeVita, AV; Gentry, BG; Markovich, KC; O'Brien, MS; Selleseth, D; Sethna, P	1
Daikoku, T; Hattori, M; Hisano, M; Miura, K; Nawashiro, Y; Sasada, Y; Shiraki, K; Suehiro, M; Takizawa, K; Yamamoto, S	1
Czarnecka, K; Czarnecka, P; Durlik, M; Tronina, O	1
Zerr, DM	1
Sinkó, J	1
Boibieux, A; Burillon, C; Charleux, B; Denis, P; Frobert, E; Hafidi, M; Janin-Manificat, H; Kodjikian, L; Rabilloud, M	1
Al-Aloul, M; Fu, L; Jones, NP; Santhanakrishnan, K; Steeples, LR	1
Abella Ross, J; Al Malki, MM; Chen, J; Dadwal, SS; Dickter, JK; Ito, JI; Kriengkauykiat, J; Mokhtari, S; Nakamura, R; Tegtmeier, B; Yang, D; Zaia, JA	1
Hakki, M	1
Iida, H; Ino, K; Kajiguchi, T; Kasahara, S; Kasai, M; Kohno, A; Kurahashi, S; Kusumoto, S; Miyao, K; Morishita, T; Murata, M; Nishida, T; Ozawa, Y; Sawa, M; Takami, A; Terakura, S	1
Brown, JW; Domingo, W; Johnsrud, JJ; Nguyen, IT	1
Müller, TF; Näf, B; Rho, E; Schachter, T; von Moos, S; Wüthrich, RP	1
Alain, S; Alexander, BD; Avery, RK; Blumberg, EA; Chemaly, RF; Cordonnier, C; Duarte, RF; Florescu, DF; Fournier, M; Kamar, N; Kumar, D; Maertens, J; Marty, FM; Papanicolaou, GA; Silveira, FP; Sundberg, AK; Witzke, O; Wu, J	1
Kuo, PH; Lin, CC; Liu, WD; Wu, UI; Yu, HC	1
Cho, SY; Choi, SM; Jung, JY; Kim, HJ; Kim, M; Lee, DG; Nho, D; Oh, EJ	1
Chen, S; Huang, X; Li, Q; Li, S; Lin, Y; Qin, A; Shen, A; Xia, L; Xiang, AP; Zhang, L	1
Blumberg, EA; Halpern-Cohen, V	1
Lee, HJ; Woo, SJ	1
Demin, MV; Filatov, FP; Tikhomirov, DS; Tupoleva, TA	1
He, Y; Huang, XJ; Liu, KY; Ma, R; Sun, YQ; Wang, Y; Xu, LP; Zhang, XH	1
Kleiboeker, SB	1

Reviews

150 review(s) available for foscarnet and ganciclovir

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Characteristics of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. The American journal of medicine, 1992, Feb-14, Volume: 92, Issue:2A Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retina; Retinitis	1992
Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet. The American journal of medicine, 1992, Feb-14, Volume: 92, Issue:2A Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis	1992
Cytomegalovirus infection in patients with AIDS. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 14, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Chorioretinitis; Cytomegalovirus Infections; Encephalitis; Foscarnet; Ganciclovir; Gastroenteritis; Humans; Phosphonoacetic Acid; Pneumonia, Viral	1992
[Cytomegalovirus infection in patients after lung transplantation]. Presse medicale (Paris, France : 1983), 1992, Mar-21, Volume: 21, Issue:11 Topics: Acyclovir; Antiviral Agents; Blood Transfusion; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immune Tolerance; Incidence; Lung Transplantation; Phosphonoacetic Acid; Prevalence; Viral Vaccines	1992
Cytomegalovirus retinitis in AIDS. Journal of the American Optometric Association, 1992, Volume: 63, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis	1992
Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature. The Clinical investigator, 1992, Volume: 70, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Meningitis, Viral; Phosphonoacetic Acid	1992
Foscarnet and ganciclovir in the treatment of cytomegalovirus retinitis. Journal of acquired immune deficiency syndromes, 1992, Volume: 5 Suppl 1 Topics: Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis	1992
Foscarnet therapy for AIDS-related opportunistic herpesvirus infections. AIDS clinical review, 1992 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpesviridae Infections; HIV Infections; Humans; Opportunistic Infections; Phosphonoacetic Acid	1992
Treatment and prophylaxis of cytomegalovirus disease. Pharmacotherapy, 1992, Volume: 12, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Gastroenteritis; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Phosphonoacetic Acid; Pneumonia, Viral; Retinitis	1992
[Clinical aspects and therapy of infection with cytomegalovirus]. Der Internist, 1992, Volume: 33, Issue:9 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Opportunistic Infections; Transplantation Immunology	1992
[Incidence, prevention and therapy of cytomegalovirus and pneumocystis carinii pneumonia after liver transplantation]. Medizinische Klinik (Munich, Germany : 1983), 1992, Volume: 87 Suppl 1 Topics: Acyclovir; Combined Modality Therapy; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Liver Transplantation; Opportunistic Infections; Pentamidine; Pneumonia, Pneumocystis; Pneumonia, Viral; Trimethoprim, Sulfamethoxazole Drug Combination	1992
Mechanism of action of foscarnet against viral polymerases. The American journal of medicine, 1992, Feb-14, Volume: 92, Issue:2A Topics: Antiviral Agents; DNA-Directed RNA Polymerases; Drug Interactions; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae; HIV; HIV Reverse Transcriptase; Humans; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Simplexvirus	1992
[Prophylactic treatments of opportunistic infections in acquired immunodeficiency syndrome]. Annales de medecine interne, 1992, Volume: 143, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Opportunistic Infections; Pentamidine; Phosphonoacetic Acid; Pneumonia, Pneumocystis; Sulfadiazine; Trimethoprim, Sulfamethoxazole Drug Combination	1992
Extrapulmonary cytomegalovirus disease in transplant patients. Transplantation proceedings, 1991, Volume: 23, Issue:2 Suppl 1 Topics: Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Heart Transplantation; Heart-Lung Transplantation; Humans; Immunotherapy; Kidney Transplantation; Liver Transplantation; Organ Transplantation; Phosphonoacetic Acid	1991
Treatment of cytomegalovirus pneumonia in transplant patients. Transplantation proceedings, 1991, Volume: 23, Issue:2 Suppl 1 Topics: Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Organ Transplantation; Phosphonoacetic Acid; Pneumonia, Viral	1991
[Cytomegalovirus infections in transplant patients]. Presse medicale (Paris, France : 1983), 1991, Jun-22, Volume: 20, Issue:24 Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immune Tolerance; Incidence; Organ Transplantation; Phosphonoacetic Acid	1991
[Antiviral agents for the systemic treatment of herpesvirus infections]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1991, Sep-10, Volume: 111, Issue:21 Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Phosphonoacetic Acid	1991
[Treatment of herpesvirus infections]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1991, Sep-20, Volume: 111, Issue:22 Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Phosphonoacetic Acid	1991
Advances in the prevention and treatment of cytomegalovirus infection in hospital patients. The Journal of hospital infection, 1991, Volume: 18 Suppl A Topics: Antibodies, Monoclonal; Antiviral Agents; Bronchoalveolar Lavage Fluid; Cross Infection; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Prognosis	1991
Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet. Journal of acquired immune deficiency syndromes, 1991, Volume: 4 Suppl 1 Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Eye Infections, Viral; Foscarnet; Ganciclovir; HIV Infections; Humans; Opportunistic Infections; Phosphonoacetic Acid; Retinitis	1991
Diagnosis and treatment of cytomegalovirus retinitis. Journal of acquired immune deficiency syndromes, 1991, Volume: 4 Suppl 1 Topics: Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Eye Infections, Viral; Foscarnet; Ganciclovir; HIV Infections; Humans; Opportunistic Infections; Phosphonoacetic Acid; Retinitis	1991
Treatment of cytomegalovirus infection. Clinics in laboratory medicine, 1987, Volume: 7, Issue:4 Topics: Acyclovir; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Interferons; Nucleosides; Phosphonoacetic Acid	1987
Promising new antiviral drugs. Journal of the American Academy of Dermatology, 1988, Volume: 18, Issue:1 Pt 2 Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster; Humans; Interferons; Phosphonoacetic Acid; Ribavirin; Thymidine; Zidovudine	1988
Cotton-wool spots and cytomegalovirus retinitis in AIDS. International ophthalmology clinics, 1989,Summer, Volume: 29, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Cytomegalovirus Infections; Diabetic Retinopathy; Diagnosis, Differential; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Pneumonia, Pneumocystis; Prognosis; Retinal Diseases; Retinitis; Zidovudine	1989
Cytomegalovirus infection in the acquired immune deficiency syndrome. The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl E Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Addison Disease; Antiviral Agents; Colitis; Cytomegalovirus Infections; Encephalitis; Esophageal Diseases; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Pneumonia, Viral; Retinitis	1989
Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Annals of internal medicine, 1988, Volume: 108, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Gastroenteritis; Humans; Opportunistic Infections; Phosphonoacetic Acid; Pneumonia, Viral; Retinitis	1988
Management of cytomegalovirus infection. The American journal of medicine, 1988, Aug-29, Volume: 85, Issue:2A Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Phosphonoacetic Acid; Pneumonia, Viral	1988
The diagnosis of cytomegalovirus retinitis. Annals of internal medicine, 1988, Dec-15, Volume: 109, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Opportunistic Infections; Phosphonoacetic Acid; Retinitis; Vision Disorders	1988
[Treatment of cytomegalovirus infections in immunosuppressed patients]. Annales de medecine interne, 1988, Volume: 139, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunologic Deficiency Syndromes; Organophosphorus Compounds; Phosphonoacetic Acid	1988
Cytomegalovirus retinitis in patients with AIDS: current status. The Medical journal of Australia, 1995, Nov-06, Volume: 163, Issue:9 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans	1995
Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections. Drugs, 1994, Volume: 48, Issue:2 Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpesviridae; HIV; Humans; Immunocompromised Host; Virus Diseases; Virus Replication	1994
Local therapy for cytomegalovirus retinopathy. American journal of ophthalmology, 1995, Volume: 120, Issue:3 Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents, Local; Cytomegalovirus Retinitis; Delayed-Action Preparations; Drug Delivery Systems; Drug Implants; Foscarnet; Ganciclovir; Humans; Injections; Vitreous Body	1995
CMV retinitis treatment. Optometry and vision science : official publication of the American Academy of Optometry, 1995, Volume: 72, Issue:5 Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans	1995
Promising new treatments for cytomegalovirus retinitis. JAMA, 1995, May-10, Volume: 273, Issue:18 Topics: AIDS-Related Opportunistic Infections; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Injections, Intralesional; Organophosphonates; Organophosphorus Compounds	1995
[Cytomegalovirus infections in AIDS]. La Revue du praticien, 1995, Mar-15, Volume: 45, Issue:6 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans	1995
Current management of cytomegalovirus disease in patients with AIDS. AIDS research and human retroviruses, 1994, Volume: 10, Issue:8 Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Randomized Controlled Trials as Topic	1994
Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease. Postgraduate medicine, 1995, Volume: 97, Issue:1 Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Recurrence	1995
Strategies for the prevention of cytomegalovirus disease after marrow transplantation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 19, Issue:2 Topics: Bone Marrow Transplantation; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans	1994
Adverse effects and drug interactions of clinical importance with antiviral drugs. Drug safety, 1994, Volume: 10, Issue:4 Topics: Acyclovir; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Didanosine; Drug Interactions; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Vidarabine; Zalcitabine; Zidovudine	1994
Retinal disease associated with AIDS. Australian and New Zealand journal of ophthalmology, 1993, Volume: 21, Issue:2 Topics: AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocytes; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Fundus Oculi; Ganciclovir; HIV Infections; Humans; Retinitis	1993
Mechanisms of herpes virus resistance. Annals of medicine, 1993, Volume: 25, Issue:5 Topics: Acyclovir; Animals; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae; Herpesviridae Infections; Humans	1993
Prevention and treatment of cytomegalovirus pneumonia in transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17 Suppl 2 Topics: Acyclovir; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Lung Diseases, Interstitial; Organ Transplantation; Pneumonia; Transplantation	1993
[Cytomegalovirus infection after transplantation. Virological diagnosis, antiviral treatment]. Pathologie-biologie, 1993, Volume: 41, Issue:8 Topics: Antibodies, Viral; Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Foscarnet; Ganciclovir; Humans; Organ Transplantation; Polymerase Chain Reaction; Postoperative Complications	1993
Infectious complications in the immunocompromised host. The antimicrobial armamentarium. Hematology/oncology clinics of North America, 1993, Volume: 7, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin	1993
Oral CMV lesions and the HIV infected. Early recognition can help prevent morbidity. Journal of the American Dental Association (1939), 1993, Volume: 124, Issue:2 Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Mouth Diseases; Ulcer	1993
New developments in cytomegalovirus prevention and management. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1993, Volume: 21, Issue:2 Topics: Antibodies, Viral; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Immunoglobulins, Intravenous; Immunosuppression Therapy; Kidney Transplantation; Prevalence	1993
Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet). The American journal of medicine, 1993, Volume: 94, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Cohort Studies; Cytomegalovirus Infections; Didanosine; Drug Tolerance; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Injections, Intravenous; Retinitis; Survival Rate; Time Factors; Zidovudine	1993
Systemic antivirals in herpesvirus infections. Dermatologic clinics, 1993, Volume: 11, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Animals; Antiviral Agents; Clinical Trials as Topic; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Vidarabine	1993
Ocular complications of the acquired immunodeficiency syndrome. Focus on the treatment of cytomegalovirus retinitis with ganciclovir and foscarnet. Pharmacy world & science : PWS, 1993, Apr-23, Volume: 15, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Cytomegalovirus Infections; Eye Diseases; Foscarnet; Ganciclovir; Humans; Retinitis	1993
Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation. Gastroenterology clinics of North America, 1993, Volume: 22, Issue:2 Topics: Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Incidence; Liver Transplantation; Risk Factors; Time Factors; Vaccination	1993
Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir. Infectious agents and disease, 1995, Volume: 4, Issue:3 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Randomized Controlled Trials as Topic; United States; Vision, Ocular	1995
Cytomegalovirus pneumonia: presentation, diagnosis, and treatment. Seminars in respiratory infections, 1995, Volume: 10, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Infant, Newborn; Neoplasms; Opportunistic Infections; Organ Transplantation; Pneumonia, Viral	1995
Anti-infective therapy for viral pneumonia. Seminars in respiratory infections, 1995, Volume: 10, Issue:4 Topics: Acyclovir; Amantadine; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Neuraminidase; Pneumonia, Viral; Ribavirin; Rimantadine	1995
A foveal-sparing pattern of cytomegalovirus retinitis in the acquired immunodeficiency syndrome. Australian and New Zealand journal of ophthalmology, 1996, Volume: 24, Issue:1 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Foscarnet; Fovea Centralis; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Visual Acuity	1996
Management of cytomegalovirus disease. AIDS (London, England), 1995, Volume: 9 Suppl 2 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Foscarnet; Ganciclovir; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds	1995
[Active antiviral agents against human cytomegalovirus and their use in pediatrics]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1996, Volume: 3 Suppl 1 Topics: Antiviral Agents; Child; Child, Preschool; Cytomegalovirus; Foscarnet; Ganciclovir; Humans; Infant	1996
Current management of cytomegalovirus retinitis in AIDS update on ganciclovir and foscarnet for CMV infections. Advances in experimental medicine and biology, 1996, Volume: 394 Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans	1996
Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options. The Journal of hospital infection, 1996, Volume: 33, Issue:4 Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae; Herpesviridae Infections; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine	1996
Severe cytomegalovirus infection in immunocompetent patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:1 Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Cytomegalovirus Infections; Diagnosis, Differential; Fatal Outcome; Female; Foscarnet; Ganciclovir; Humans; Immunocompetence; Liver; Lung; Male; Middle Aged	1997
Viral lesions of the mouth in HIV-infected patients. Dermatology (Basel, Switzerland), 1997, Volume: 194, Issue:1 Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cytomegalovirus Infections; Disease Progression; Famciclovir; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; Leukoplakia, Hairy; Lymphoma, B-Cell; Lymphoma, T-Cell; Molluscum Contagiosum; Mouth Diseases; Mouth Neoplasms; Oral Ulcer; Prodrugs; Sarcoma, Kaposi; Stomatitis, Herpetic; Tumor Virus Infections; Valacyclovir; Valine; Virus Diseases; Warts	1997
[Treatment of cytomegalovirus infections in HIV infection]. Presse medicale (Paris, France : 1983), 1996, Dec-14, Volume: 25, Issue:39 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans	1996
Childhood infections with human herpesviruses types 6, 7, and 8. Advances in pediatric infectious diseases, 1996, Volume: 12 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Antiviral Agents; Burkitt Lymphoma; Central Nervous System; Child; Child, Preschool; Exanthema Subitum; Foscarnet; Ganciclovir; Genome, Viral; Herpesviridae Infections; Herpesvirus 6, Human; Herpesvirus 7, Human; Herpesvirus 8, Human; Humans; Sarcoma, Kaposi; Transplantation	1996
Pharmacologic management of cytomegalovirus retinitis: review of current and future therapeutic modalities. Journal of the American Optometric Association, 1997, Volume: 68, Issue:1 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Male; Visual Acuity	1997
Cytomegalovirus retinitis: diagnosis and status of systemic therapy. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, Volume: 14 Suppl 1 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Diagnosis, Differential; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Ophthalmoscopy	1997
Management strategies for patients with cytomegalovirus retinitis. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, Volume: 14 Suppl 1 Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Interactions; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds	1997
Therapeutic options for resistant cytomegalovirus retinitis. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, Volume: 14 Suppl 1 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds; Recurrence; Thionucleotides	1997
Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. The New England journal of medicine, 1997, Jul-10, Volume: 337, Issue:2 Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds	1997
Combination antiviral therapy for cytomegalovirus disease in patients with AIDS. The Annals of pharmacotherapy, 1997, Volume: 31, Issue:9 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans	1997
Management of CMV retinitis in HIV infected patients. Genitourinary medicine, 1997, Volume: 73, Issue:3 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Organophosphorus Compounds; Prodrugs; Prospective Studies; Recurrence	1997
Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance. Microbiologia (Madrid, Spain), 1997, Volume: 13, Issue:3 Topics: Antiviral Agents; Cidofovir; Codon; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genes, Viral; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins; Viral Structural Proteins	1997
New treatment options for CMV retinitis in AIDS. Advance for nurse practitioners, 1997, Volume: 5, Issue:4 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Retinitis	1997
Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects. Drugs, 1998, Volume: 55, Issue:1 Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Guidelines as Topic; Hematopoietic Stem Cell Transplantation; Humans; Organ Transplantation	1998
[Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7]. Nihon rinsho. Japanese journal of clinical medicine, 1998, Volume: 56, Issue:1 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Purines; Thymidine Kinase	1998
[Cytomegalovirus retinitis]. Nihon rinsho. Japanese journal of clinical medicine, 1998, Volume: 56, Issue:1 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Diagnosis, Differential; Foscarnet; Ganciclovir; HIV-1; Humans; Prognosis; Retina	1998
[Human herpesvirus-6 and -7 infection and bone marrow transplantation (BMT)]. Nihon rinsho. Japanese journal of clinical medicine, 1998, Volume: 56, Issue:1 Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Bone Marrow Transplantation; Foscarnet; gamma-Globulins; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunocompromised Host; Polymerase Chain Reaction	1998
Local therapy for cytomegalovirus retinitis. The Annals of pharmacotherapy, 1998, Volume: 32, Issue:2 Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Vitreous Body	1998
Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy. The Journal of infection, 1998, Volume: 36, Issue:1 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Male; Peripheral Nervous System Diseases; Spinal Nerve Roots; Treatment Outcome	1998
Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis. Journal of neurovirology, 1998, Volume: 4, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Diagnostic Techniques, Neurological; DNA, Viral; Encephalitis, Viral; Foscarnet; Ganciclovir; Humans; Polymerase Chain Reaction; Polyradiculopathy	1998
Treatment of cytomegalovirus diseases. Intervirology, 1997, Volume: 40, Issue:5-6 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds	1997
Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 1998, Jul-24, Volume: 11, Issue:1 Topics: Antigens, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Transplantation; Treatment Failure; Viral Load; Viremia	1998
Cidofovir in the treatment of cytomegalovirus (CMV) retinitis. Ocular immunology and inflammation, 1998, Volume: 6, Issue:3 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Injections; Organophosphonates; Organophosphorus Compounds	1998
Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. Haematologica, 1999, Volume: 84, Issue:1 Topics: Acyclovir; Adolescent; Adult; Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Hematopoietic Stem Cells; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunotherapy, Adoptive; Infant; Pneumonia, Viral; Risk Factors; Sensitivity and Specificity; T-Lymphocytes, Cytotoxic; Transplantation Conditioning; Transplantation, Homologous; Viral Vaccines; Viremia; Virus Activation	1999
Cytomegalovirus infection in patients with HIV infection. The Mount Sinai journal of medicine, New York, 1999, Volume: 66, Issue:2 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds	1999
Clinically resistant cytomegalovirus retinitis. Seminars in ophthalmology, 1995, Volume: 10, Issue:2 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Fundus Oculi; Ganciclovir; Humans	1995
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART). The American journal of the medical sciences, 1999, Volume: 317, Issue:5 Topics: Antiviral Agents; Biomarkers; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Diagnosis, Differential; Foscarnet; Ganciclovir; Herpesviridae; Humans; Incidence; Organophosphonates; Organophosphorus Compounds; Risk Factors	1999
Cytomegalovirus: disease syndromes and treatment. Current clinical topics in infectious diseases, 1999, Volume: 19 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Central Nervous System Diseases; Chorioretinitis; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds; Pneumonia; Sexually Transmitted Diseases, Viral	1999
Comparative tolerability of therapies for cytomegalovirus retinitis. Drug safety, 1999, Volume: 21, Issue:3 Topics: Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; HIV Infections; Humans	1999
Management of CMV infections in HIV-infected patients. Advances in experimental medicine and biology, 1999, Volume: 458 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds	1999
Antiviral agents for non-human immunodeficiency virus infections. Mayo Clinic proceedings, 1999, Volume: 74, Issue:12 Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir	1999
Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Postgraduate medical journal, 1999, Volume: 75, Issue:888 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Retinal Detachment	1999
Cytomegalovirus drug resistance. Antiviral therapy, 1998, Volume: 3, Issue:4 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Organophosphorus Compounds	1998
Cytomegalovirus infection following stem cell transplantation. Haematologica, 1999, Volume: 84 Suppl EHA-4 Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Blood Donors; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunocompromised Host; Immunotherapy, Adoptive; Leukocyte Transfusion; Organophosphonates; Organophosphorus Compounds; Premedication; Risk Factors; Tissue Donors; Transfusion Reaction; Virus Latency	1999
Therapeutic developments in cytomegalovirus retinitis. Expert opinion on investigational drugs, 2000, Volume: 9, Issue:2 Topics: Adenine; Antibodies, Monoclonal; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drugs, Investigational; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides; Valganciclovir	2000
Prophylaxis against fungal infections and cytomegalovirus disease after bone marrow transplantation. Oncology (Williston Park, N.Y.), 2000, Volume: 14, Issue:12 Topics: Antifungal Agents; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Mycoses; Opportunistic Infections; Prognosis; Retrospective Studies; Surgical Wound Infection	2000
Progress in understanding cytomegalovirus drug resistance. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2001, Volume: 21, Issue:3 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Forecasting; Foscarnet; Ganciclovir; Humans; Incidence; Organophosphonates; Organophosphorus Compounds	2001
Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS. PharmacoEconomics, 2001, Volume: 19, Issue:5 Pt 2 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Economics, Pharmaceutical; Foscarnet; Ganciclovir; Humans; Models, Economic; Organophosphonates; Organophosphorus Compounds; Switzerland; Treatment Failure	2001
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia. Bone marrow transplantation, 2001, Volume: 28, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Cystitis; Cytarabine; Cytomegalovirus Infections; DNA, Neoplasm; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility; Humans; Hydroxyurea; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Mitoxantrone; Neoplasms, Second Primary; Prednisolone; Prostaglandins; Remission Induction; Topotecan; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation	2001
Cytomegalovirus infection: the point in 2001. HIV medicine, 2001, Volume: 2, Issue:4 Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Monitoring; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Population Surveillance; Predictive Value of Tests; Prevalence; Risk Factors; Valganciclovir	2001
[Cytomegalovirus infection]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 7 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Disease Transmission, Infectious; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prognosis	2001
Recent developments in herpesvirus therapy. Herpes : the journal of the IHMF, 2001, Volume: 8, Issue:1 Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cidofovir; Clinical Trials as Topic; Cytosine; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides; Valacyclovir; Valine	2001
Cytomegalovirus drug resistance and clinical implications. Transplant infectious disease : an official journal of the Transplantation Society, 2001, Volume: 3 Suppl 2 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Incidence; Organ Transplantation; Organophosphonates; Organophosphorus Compounds; Risk Factors	2001
Management of CMV disease in HIV infection. International journal of STD & AIDS, 1999, Volume: 10, Issue:4 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Encephalitis, Viral; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds	1999
Prevention and management of CMV-related problems after hematopoietic stem cell transplantation. Bone marrow transplantation, 2002, Volume: 29, Issue:8 Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Organophosphonates; Organophosphorus Compounds; Risk Factors	2002
[Drugs against human cytomegalovirus]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002, Volume: 13, Issue:75 Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drugs, Investigational; Female; Foscarnet; Ganciclovir; Global Health; Humans; Infectious Disease Transmission, Vertical; Naphthalenesulfonates; Organophosphonates; Organophosphorus Compounds; Pregnancy; Pregnancy Complications, Infectious; Thionucleotides; Valacyclovir; Valganciclovir; Valine	2002
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2003, Volume: 9, Issue:9 Topics: Acyclovir; Antigens, CD34; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunotherapy; Lymphocyte Depletion; Organophosphonates; Organophosphorus Compounds; Transplantation Conditioning	2003
The pharmacokinetics of antiviral therapy in paediatric patients. Herpes : the journal of the IHMF, 2003, Volume: 10, Issue:3 Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Child; Child, Hospitalized; Cidofovir; Cytosine; Famciclovir; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Virus Diseases	2003
Clinical characteristics of acute HSV-2 retinal necrosis. American journal of ophthalmology, 2004, Volume: 137, Issue:5 Topics: Acyclovir; Adult; Antiviral Agents; Aqueous Humor; Child; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Female; Foscarnet; Ganciclovir; Herpes Simplex; Herpesvirus 2, Human; Humans; Interferons; Male; Middle Aged; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Virus Activation; Visual Acuity; Vitreous Body	2004
Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs. Human immunology, 2004, Volume: 65, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins; Virus Replication	2004
Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes : the journal of the IHMF, 2004, Volume: 11 Suppl 2 Topics: Antiviral Agents; Central Nervous System Viral Diseases; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Practice Guidelines as Topic; Roseolovirus Infections	2004
Campylobacter fetus bacteremia in an immunocompromised patient: case report and review of the literature. The new microbiologica, 2004, Volume: 27, Issue:3 Topics: Adult; Bacteremia; Campylobacter fetus; Campylobacter Infections; Ciprofloxacin; Cytomegalovirus; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Splenectomy; Steroids	2004
[Human cytomegalovirus infection]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 4 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; gamma-Globulins; Ganciclovir; HIV Infections; Humans; Immunotherapy, Adoptive; Opportunistic Infections; Reverse Transcriptase Inhibitors; Transplantation; Viral Vaccines	2005
[Antiherpetic therapy]. Oftalmologia (Bucharest, Romania : 1990), 2005, Volume: 49, Issue:1 Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Bromodeoxyuridine; Cidofovir; Cytosine; Drug Combinations; Famciclovir; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Herpetic; Oligonucleotides; Ophthalmic Solutions; Organophosphonates; Treatment Outcome; Valacyclovir; Valine; Vidarabine	2005
Is combination antiviral therapy for CMV superior to monotherapy? Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2006, Volume: 35, Issue:4 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Synergism; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic; Treatment Outcome	2006
[Therapy for cytomegalovirus infection]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 3 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Immunotherapy; Transplantation	2006
[Treatment of HHV-6 and HHV-7 infections]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 3 Topics: Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunoglobulins; Lymphocyte Transfusion; Organophosphonates; Roseolovirus Infections	2006
[Development of drug-resistant human cytomegalovirus]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 3 Topics: Antiviral Agents; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins; Virus Replication	2006
[Human cytomegalovirus infection]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Feb-28, Volume: 65 Suppl 2 Pt. 1 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Globins; Humans; Immunotherapy, Adoptive; Viral Vaccines	2007
[Mechanism of drug-resistance in human cytomegalovirus]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Feb-28, Volume: 65 Suppl 2 Pt. 1 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins	2007
[Management of severe or corticosteroid resistant ulcerative colitis]. Gastroenterologie clinique et biologique, 2007, Volume: 31, Issue:4 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antiviral Agents; Colectomy; Colitis, Ulcerative; Cyclosporine; Cytomegalovirus Infections; Drug Resistance; Foscarnet; Ganciclovir; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Multicenter Studies as Topic; Prospective Studies; Radionuclide Imaging; Randomized Controlled Trials as Topic; Time Factors	2007
Treatment of congenital cytomegalovirus: where are we now? Expert review of anti-infective therapy, 2007, Volume: 5, Issue:3 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Female; Foscarnet; Ganciclovir; Humans; Infant, Newborn; Organophosphonates; Pregnancy; Valganciclovir	2007
Prevention and early treatment of opportunistic viral infections in patients with leukemia and allogeneic stem cell transplantation recipients. Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:2 Topics: Antiviral Agents; Benzimidazoles; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Herpes Zoster; Humans; Immune Sera; Immunization, Passive; Immunocompromised Host; Leukemia; Opportunistic Infections; Ribonucleosides; Stem Cell Transplantation; Virus Diseases	2008
Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Sep-01, Volume: 47, Issue:5 Topics: Antiviral Agents; Chemoprevention; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Organ Transplantation; Organophosphonates; Transplantation; Valganciclovir	2008
[Gastrointestinal cytomegalovirus infections in organ transplant patients]. Orvosi hetilap, 2008, Dec-21, Volume: 149, Issue:52 Topics: Acyclovir; Antiviral Agents; Biopsy; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Endoscopy, Gastrointestinal; Foscarnet; Ganciclovir; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Immunocompromised Host; Immunoglobulins; Immunotherapy, Adoptive; Intestinal Mucosa; Organ Transplantation; Organophosphonates; Primary Prevention; Valganciclovir	2008
Antiviral treatment of cytomegalovirus infection and resistant strains. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:2 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Thionucleotides; Valganciclovir	2009
[Human herpesvirus 6 encephalitis]. Brain and nerve = Shinkei kenkyu no shinpo, 2010, Volume: 62, Issue:8 Topics: Antiviral Agents; Double-Blind Method; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Hippocampus; Humans; Immunocompromised Host; Infant; Randomized Controlled Trials as Topic; Roseolovirus Infections; Virus Replication	2010
Antiviral drug resistance of human cytomegalovirus. Clinical microbiology reviews, 2010, Volume: 23, Issue:4 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genome, Viral; Humans; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Sequence Analysis, DNA	2010
The search for new therapies for human cytomegalovirus infections. Virus research, 2011, Volume: 157, Issue:2 Topics: Antiviral Agents; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Valganciclovir; Virus Replication	2011
Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 52, Issue:3 Topics: Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Immunity, Cellular; Infant; Organophosphonates; Roseolovirus Infections; Viral Load; Virus Latency	2011
Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clinic proceedings, 2011, Volume: 86, Issue:10 Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir	2011
Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients. Expert review of anti-infective therapy, 2012, Volume: 10, Issue:11 Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host	2012
[Non-antibiotic anti-infectious treatments in urology]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2013, Volume: 23, Issue:15 Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir	2013
Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature. Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:6 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Isoxazoles; Leflunomide; Lung Transplantation; Middle Aged; Viral Load	2013
Antiviral drug resistance in herpesviruses other than cytomegalovirus. Reviews in medical virology, 2014, Volume: 24, Issue:3 Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 3, Human; Herpesvirus 6, Human; Humans; Immunocompromised Host; Organophosphonates	2014
Management of multidrug-resistant CMV infection in immunocompromised patients: case report of a heart-transplant recipient and review of the literature. Antiviral therapy, 2015, Volume: 20, Issue:2 Topics: Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Disease Management; Drug Resistance, Viral; Everolimus; Female; Foscarnet; Ganciclovir; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Infant; Male; Middle Aged; Valganciclovir; Viral Load	2015
Bilateral central retinal artery occlusion associated with herpes simplex virus-associated acute retinal necrosis and meningitis: case report and literature review. Ophthalmic surgery, lasers & imaging retina, 2015, Volume: 46, Issue:2 Topics: Antibodies, Viral; Antiviral Agents; Aqueous Humor; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Female; Fluorescein Angiography; Foscarnet; Ganciclovir; Herpes Simplex; Herpesvirus 2, Human; Humans; Magnetic Resonance Imaging; Meningitis, Viral; Middle Aged; Polymerase Chain Reaction; Retinal Artery Occlusion; Retinal Necrosis Syndrome, Acute	2015
Anti-viral therapy for congenital cytomegalovirus infection: pharmacokinetics, efficacy and side effects. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016, Volume: 29, Issue:10 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Immunocompetence; Organophosphonates; Treatment Outcome	2016
Cytomegalovirus Retinitis in Three Pediatric Cases with Acute Lymphoblastic Leukemia: Case Series and Review of the Literature. Japanese journal of infectious diseases, 2016, Nov-22, Volume: 69, Issue:6 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus Retinitis; DNA, Viral; Eye; Foscarnet; Ganciclovir; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Valganciclovir; Viremia; Vitreous Body	2016
Human Herpesviruses 6A, 6B, and 7. Microbiology spectrum, 2016, Volume: 4, Issue:3 Topics: Antiviral Agents; Cidofovir; Cytosine; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunocompromised Host; Organophosphonates; Roseolovirus Infections; Transplant Recipients; Virus Latency	2016
Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals. Journal of neurovirology, 2017, Volume: 23, Issue:1 Topics: Adult; Antiviral Agents; Child; Cord Blood Stem Cell Transplantation; Cytokines; Encephalitis, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; Immunocompetence; Immunocompromised Host; Limbic Encephalitis; Neuroglia; Risk Factors; Roseolovirus Infections	2017
Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review. Transplantation proceedings, 2018, Volume: 50, Issue:2 Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Antiviral Agents; Basiliximab; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Humans; Induction Chemotherapy; Kidney Transplantation; Male; Middle Aged; Mutation; Postoperative Complications; Recombinant Fusion Proteins; Tacrolimus; Valganciclovir; Virus Replication	2018
Ganciclovir and foscarnet dual-therapy for cytomegalovirus encephalitis: A case report and review of the literature. Journal of the neurological sciences, 2018, 05-15, Volume: 388 Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Encephalitis, Viral; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Middle Aged; Transplantation, Homologous	2018
New Developments in the Management of Cytomegalovirus Infection After Transplantation. Drugs, 2018, Volume: 78, Issue:11 Topics: Acetates; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Organ Transplantation; Quinazolines; Valganciclovir	2018
Cytomegalovirus Disease After Liver Transplant-A Description of a Treatment-Resistant Case: A Case Report and Literature Review. Transplantation proceedings, 2018, Volume: 50, Issue:10 Topics: Adult; Antilymphocyte Serum; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Foscarnet; Ganciclovir; Graft Rejection; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Risk Factors	2018
Human Herpesvirus 6B in the Transplant Recipient: When to Worry, When to Act. Journal of the Pediatric Infectious Diseases Society, 2018, Dec-26, Volume: 7, Issue:suppl_2 Topics: Antiviral Agents; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Roseolovirus Infections; Transplant Recipients; Virus Activation	2018
[Current treatment modalities of immunocompromised patients with cytomegalovirus infection. II. Therapeutic options and management strategies]. Orvosi hetilap, 2019, Volume: 160, Issue:10 Topics: Acetates; Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Quinazolines; Stem Cell Transplantation	2019
Management of Ganciclovir Resistant Cytomegalovirus Retinitis in a Solid Organ Transplant Recipient: A Review of Current Evidence and Treatment Approaches. Ocular immunology and inflammation, 2020, Oct-02, Volume: 28, Issue:7 Topics: Antiviral Agents; Cytomegalovirus Retinitis; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leflunomide; Lung Transplantation; Male; Middle Aged; Transplant Recipients	2020
Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy. Current hematologic malignancy reports, 2020, Volume: 15, Issue:2 Topics: Animals; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Vaccines; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Immunotherapy; Immunotherapy, Adoptive; Molecular Targeted Therapy; Opportunistic Infections; Risk Factors; T-Lymphocytes; Treatment Outcome	2020
New Perspectives on Antimicrobial Agents: Maribavir. Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9 Topics: Adult; Anti-Infective Agents; Antiviral Agents; Benzimidazoles; Child; Cidofovir; Cytomegalovirus Infections; Dichlororibofuranosylbenzimidazole; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Valganciclovir	2022
Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:9 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Transplant Recipients; Valganciclovir	2023

Trials

51 trial(s) available for foscarnet and ganciclovir

Article	Year
The treatment of cytomegalovirus in AIDS--more than meets the eye. The New England journal of medicine, 1992, Jan-23, Volume: 326, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Drug Tolerance; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis	1992
Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG). Controlled clinical trials, 1992, Volume: 13, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infections; Drug Administration Schedule; Fluorescein Angiography; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Multicenter Studies as Topic; Opportunistic Infections; Phosphonoacetic Acid; Randomized Controlled Trials as Topic; Retinitis	1992
Foscarnet and Ganciclovir in the treatment of CMV retinitis in AIDS patients: a randomised comparison. The Journal of infection, 1992, Volume: 25, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Male; Phosphonoacetic Acid; Retinitis	1992
Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. The New England journal of medicine, 1992, 01-23, Volume: 326, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Cytomegalovirus Infections; Drug Therapy, Combination; Drug Tolerance; Foscarnet; Ganciclovir; Humans; Leukocyte Count; Phosphonoacetic Acid; Random Allocation; Retinitis; Zidovudine	1992
AIDS file. The American journal of nursing, 1991, Volume: 91, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis	1991
Foscarnet versus ganciclovir in the management of cytomegalovirus disease in patients with AIDS. American journal of hospital pharmacy, 1991, Volume: 48, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid	1991
Treatment of cytomegalovirus infection. Clinics in laboratory medicine, 1987, Volume: 7, Issue:4 Topics: Acyclovir; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Interferons; Nucleosides; Phosphonoacetic Acid	1987
Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections. Drugs, 1994, Volume: 48, Issue:2 Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpesviridae; HIV; Humans; Immunocompromised Host; Virus Diseases; Virus Replication	1994
Antiviral effects of foscarnet and ganciclovir therapy on human immunodeficiency virus p24 antigen in patients with AIDS and cytomegalovirus retinitis. Studies of Ocular Complications of AIDS Research Group in collaboration with AIDS Clinical Trials Group The Journal of infectious diseases, 1995, Volume: 172, Issue:3 Topics: AIDS-Related Opportunistic Infections; Antigen-Antibody Complex; Cytomegalovirus Retinitis; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Antibodies; HIV Core Protein p24; Homosexuality, Male; Humans; Male; Probability; Risk Factors; Survival Rate; Time Factors	1995
Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison. The Journal of infectious diseases, 1995, Volume: 172, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; Follow-Up Studies; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Intestinal Mucosa; Middle Aged; Survival Rate; Time Factors	1995
Foscarnet and ganciclovir pharmacokinetics during concomitant or alternating maintenance therapy for AIDS-related cytomegalovirus retinitis. Clinical pharmacology and therapeutics, 1995, Volume: 57, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Drug Administration Schedule; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans	1995
Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Archives of internal medicine, 1995, Jan-09, Volume: 155, Issue:1 Topics: Acute Kidney Injury; Adolescent; Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Male; Neutropenia; Odds Ratio; Seizures; Water-Electrolyte Imbalance	1995
Foscarnet or ganciclovir for treatment of AIDS and CMV retinitis. The American journal of medicine, 1995, Volume: 98, Issue:3 Topics: AIDS-Related Opportunistic Infections; Clinical Trials as Topic; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Treatment Outcome	1995
Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir. Bone marrow transplantation, 1994, Volume: 13, Issue:6 Topics: Adult; Anemia, Aplastic; Antigens, Viral; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulin M; Leukemia; Male; Transplantation, Homologous	1994
Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. AIDS (London, England), 1994, Volume: 8, Issue:4 Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Salvage Therapy	1994
Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151. The Journal of infectious diseases, 1994, Volume: 170, Issue:1 Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Cells, Cultured; Clinical Protocols; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Male; Retinitis	1994
Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Ophthalmology, 1994, Volume: 101, Issue:7 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Female; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Lymphocyte Subsets; Male; Middle Aged; Photography; Treatment Outcome; Visual Acuity; Visual Fields	1994
Safety of alternating ganciclovir and foscarnet maintenance therapy in human immunodeficiency virus (HIV)-related cytomegalovirus infections. An open-labeled pilot study. Scandinavian journal of infectious diseases, 1994, Volume: 26, Issue:1 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Pilot Projects	1994
Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet). The American journal of medicine, 1993, Volume: 94, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Cohort Studies; Cytomegalovirus Infections; Didanosine; Drug Tolerance; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Injections, Intravenous; Retinitis; Survival Rate; Time Factors; Zidovudine	1993
Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction. The American journal of gastroenterology, 1993, Volume: 88, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Drug Resistance; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Male; Middle Aged	1993
Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:1 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Female; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Infusions, Intravenous; Male; Morbidity; Quality of Life; Recurrence; Retinitis; Survival Rate; Visual Acuity; Visual Fields	1996
Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir. Infectious agents and disease, 1995, Volume: 4, Issue:3 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Randomized Controlled Trials as Topic; United States; Vision, Ocular	1995
Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. The Journal of infectious diseases, 1996, Volume: 173, Issue:6 Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bisexuality; Case-Control Studies; Foscarnet; Ganciclovir; Herpesviridae Infections; Homosexuality, Male; Humans; Longitudinal Studies; Male; Risk; Sarcoma, Kaposi	1996
Assessment of cytomegalovirus retinitis. Clinical evaluation vs centralized grading of fundus photographs. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:7 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Follow-Up Studies; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Infusions, Intravenous; Photography; Reproducibility of Results	1996
Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Development of a questionnaire. Studies of Ocular Complication of AIDS Research Group. Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:7 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cross-Sectional Studies; Cytomegalovirus Retinitis; Female; Foscarnet; Ganciclovir; Humans; Male; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Vision, Ocular; Visual Acuity	1996
Clinical vs photographic assessment of treatment of cytomegalovirus retinitis. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial Report 8. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:7 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Male; Photography; Retina; Treatment Outcome	1996
Design of clinical trials for drug combinations: cytomegalovirus retinitis--foscarnet and ganciclovir. The CMV retinitis retreatment trial. Antiviral research, 1996, Volume: 29, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Research Design	1996
CMV retinitis: ganciclovir/monoclonal antibody. Antiviral research, 1996, Volume: 29, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antibodies, Monoclonal; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Viral Envelope Proteins	1996
Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients. Bone marrow transplantation, 1996, Volume: 17, Issue:4 Topics: Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Incidence; Leukocytes; Polymerase Chain Reaction; Prospective Studies; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Viremia; Virus Activation	1996
Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. AIDS (London, England), 1996, Volume: 10, Issue:10 Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Disease Progression; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Middle Aged; Proportional Hazards Models; Sarcoma, Kaposi	1996
[Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week]. Enfermedades infecciosas y microbiologia clinica, 1997, Volume: 15, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Administration Schedule; Female; Foscarnet; Ganciclovir; HIV Infections; HIV-1; Humans; Male; Middle Aged; Prospective Studies; Survival Rate	1997
Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group. The Journal of infectious diseases, 1997, Volume: 176, Issue:1 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance; Foscarnet; Ganciclovir; Humans; Prospective Studies; Retinitis; Treatment Outcome	1997
Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group American journal of ophthalmology, 1997, Volume: 124, Issue:1 Topics: Adolescent; Adult; Age Factors; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Incidence; Infusions, Intravenous; Prospective Studies; Retinal Detachment; Risk Factors; Treatment Outcome; Visual Acuity	1997
Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. American journal of ophthalmology, 1997, Volume: 124, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Diseases; Female; Foscarnet; Ganciclovir; Humans; Male; Retinitis; Vision Disorders; Visual Acuity; Visual Fields	1997
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir. Bone marrow transplantation, 1997, Volume: 20, Issue:6 Topics: Actuarial Analysis; Adolescent; Adult; Bone Marrow Transplantation; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Graft Survival; Humans; Kidney; Male; Middle Aged; Nausea; Transplantation, Homologous; Vomiting	1997
Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group. The American journal of gastroenterology, 1998, Volume: 93, Issue:3 Topics: AIDS-Related Opportunistic Infections; Biopsy; Cytomegalovirus Infections; Esophagitis; Foscarnet; Ganciclovir; Humans; Prospective Studies; Treatment Outcome	1998
[Cytomegalovirus polyradiculomyelopathy in AIDS]. Medicina, 1998, Volume: 58, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Electromyography; Female; Foscarnet; Ganciclovir; Humans; Male; Muscle Tonus; Polyradiculopathy; Spinal Cord Diseases; Treatment Outcome; Urinary Retention	1998
Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study. Bone marrow transplantation, 1998, Volume: 22, Issue:2 Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Male; Middle Aged; Transplantation, Homologous; Treatment Outcome	1998
Cytomegalovirus retinitis in advanced HIV-infected patients treated with protease inhibitors: incidence and outcome over 2 years. Journal of acquired immune deficiency syndromes (1999), 1999, Nov-01, Volume: 22, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; HIV Protease Inhibitors; Humans; Incidence; Indinavir; Nelfinavir; Outcome Assessment, Health Care; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir	1999
Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS (London, England), 2000, Mar-31, Volume: 14, Issue:5 Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Drug Tolerance; Encephalitis, Viral; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Survival Rate	2000
Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study. Bone marrow transplantation, 2000, Volume: 26, Issue:1 Topics: Adult; Antiviral Agents; Blood Pressure; Body Weight; Bone Marrow Transplantation; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Foscarnet; Ganciclovir; Humans; Lymphocyte Depletion; Prospective Studies; Survival Rate; Transplantation, Homologous	2000
Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group. Archives of ophthalmology (Chicago, Ill. : 1960), 2000, Volume: 118, Issue:9 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD8-Positive T-Lymphocytes; Cytomegalovirus Retinitis; Disease Progression; Foscarnet; Ganciclovir; Humans; Lymphocyte Count; Risk Factors; Virus Cultivation	2000
New trial for CMV retinitis. Treatment review, 1995, Issue:no 20 Topics: Antibodies; Antiviral Agents; Combined Modality Therapy; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Placebos	1995
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients. Blood, 2001, Sep-01, Volume: 98, Issue:5 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Myelodysplastic Syndromes; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Transplantation, Homologous; Treatment Failure; Viremia; Virus Activation	2001
Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood, 2002, Feb-15, Volume: 99, Issue:4 Topics: Adolescent; Adult; Antiviral Agents; Child; Cytomegalovirus Infections; Disease-Free Survival; Drug Administration Schedule; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Thrombocytopenia; Transplantation, Homologous	2002
Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Archives of ophthalmology (Chicago, Ill. : 1960), 2003, Volume: 121, Issue:1 Topics: Adult; AIDS-Related Opportunistic Infections; Antibodies, Monoclonal; Antiretroviral Therapy, Highly Active; Antiviral Agents; Blindness; Cytomegalovirus Retinitis; Female; Foscarnet; Ganciclovir; Humans; Male; Meta-Analysis as Topic; United States; Visual Acuity	2003
A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. The Journal of infectious diseases, 2004, Apr-15, Volume: 189, Issue:8 Topics: Adolescent; Adult; Aged; Antiviral Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Viral Load	2004
A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus re Antiviral research, 2004, Volume: 64, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Antibodies, Monoclonal; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Double-Blind Method; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Male; Treatment Outcome; Viral Envelope Proteins	2004
A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients. Pediatric blood & cancer, 2007, Volume: 49, Issue:3 Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Humans; Infant; Male; Pilot Projects; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous	2007
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 09-10, Volume: 75, Issue:4 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Dichlororibofuranosylbenzimidazole; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Valganciclovir; Viremia	2022
[Clinical analysis of the efficacies of ganciclovir plus foscarnet and a single antiviral drug for the treatment of cytomegalovirus infection after haploidentical stem cell transplantation]. Zhonghua nei ke za zhi, 2023, Jan-01, Volume: 62, Issue:1 Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Retrospective Studies	2023

Other Studies

409 other study(ies) available for foscarnet and ganciclovir

Article	Year
Benzimidazole ribonucleosides: design, synthesis, and antiviral activity of certain 2-(alkylthio)- and 2-(benzylthio)-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazoles. Journal of medicinal chemistry, 1994, Sep-02, Volume: 37, Issue:18 Topics: Antiviral Agents; Cell Line; Cell Survival; Cytomegalovirus; Dichlororibofuranosylbenzimidazole; Drug Design; Fibroblasts; Herpesvirus 1, Human; Humans; KB Cells; Structure-Activity Relationship	1994
Design, synthesis, and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections. Journal of medicinal chemistry, 1997, Feb-28, Volume: 40, Issue:5 Topics: Antiviral Agents; Benzimidazoles; Cell Division; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Drug Design; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Ribonucleosides; Simplexvirus	1997
Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections. Journal of medicinal chemistry, 1997, Feb-28, Volume: 40, Issue:5 Topics: Antiviral Agents; Benzimidazoles; Cell Division; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Drug Design; Humans; KB Cells; Magnetic Resonance Spectroscopy; Molecular Structure; Ribonucleosides; Simplexvirus	1997
Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles. Journal of medicinal chemistry, 1998, Apr-09, Volume: 41, Issue:8 Topics: Antiviral Agents; Benzimidazoles; Cell Division; Cell Survival; Cytomegalovirus; Drug Design; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Herpesvirus 1, Human; Humans; KB Cells; Microbial Sensitivity Tests; Nucleosides; Pentoses; Skin; Stereoisomerism; Structure-Activity Relationship; Viral Plaque Assay	1998
Synthesis and antiviral evaluation of trisubstituted indole N-nucleosides as analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole (TCRB). Journal of medicinal chemistry, 2000, Jun-15, Volume: 43, Issue:12 Topics: Antiviral Agents; Benzimidazoles; Cell Division; Cell Line; Cytomegalovirus; Enzyme-Linked Immunosorbent Assay; Herpesvirus 1, Human; Herpesvirus 6, Human; Humans; Indoles; Ribonucleosides; Structure-Activity Relationship; Viral Plaque Assay	2000
Syntheses and structure--activity relationships of novel apio and thioapio dideoxydidehydronucleosides as anti-HCMV agents. Journal of medicinal chemistry, 2001, Mar-01, Volume: 44, Issue:5 Topics: Antiviral Agents; Cell Line; Cytomegalovirus; Dideoxynucleosides; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV-1; Humans; Structure-Activity Relationship	2001
Discovery of a new family of inhibitors of human cytomegalovirus (HCMV) based upon lipophilic alkyl furano pyrimidine dideoxy nucleosides: action via a novel non-nucleosidic mechanism. Journal of medicinal chemistry, 2004, Mar-25, Volume: 47, Issue:7 Topics: Antiviral Agents; Cell Line; Cytomegalovirus; Furans; Humans; Pyrimidine Nucleosides; Structure-Activity Relationship; Virus Replication	2004
Exploring the role of different drug transport routes in permeability screening. Journal of medicinal chemistry, 2005, Jan-27, Volume: 48, Issue:2 Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics	2005
4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases. Journal of medicinal chemistry, 2005, Sep-08, Volume: 48, Issue:18 Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Herpesvirus 1, Human; Herpesvirus 3, Human; Humans; Nucleic Acid Synthesis Inhibitors; Point Mutation; Pyridines; Pyridones; Structure-Activity Relationship; Thiophenes; Viral Plaque Assay; Viral Proteins	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA Replication; DNA-Directed DNA Polymerase; Drug Resistance, Multiple; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genotype; Humans; Immunocompromised Host; Mutation; Organophosphonates; Phenotype; Viral Proteins; Virus Replication	2007
2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases. Bioorganic & medicinal chemistry letters, 2007, Jun-15, Volume: 17, Issue:12 Topics: Antiviral Agents; Binding, Competitive; Cytomegalovirus; DNA-Directed DNA Polymerase; Enzyme Inhibitors; Ethylamines; Exodeoxyribonucleases; Herpes Zoster; Herpesviridae; Herpesvirus 1, Human; Herpesvirus 4, Human; Humans; Models, Chemical; Nucleic Acid Synthesis Inhibitors; Pyridines; Structure-Activity Relationship; Viral Proteins	2007
Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Acyclovir; Amino Acid Sequence; Animals; Antiviral Agents; Chlorocebus aethiops; Deoxyuridine; Enzyme Inhibitors; Guanine; Herpesvirus 1, Cercopithecine; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleosides; Phosphorylation; Substrate Specificity; Thymidine; Thymidine Kinase; Vero Cells	2007
7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase. Bioorganic & medicinal chemistry letters, 2007, Jul-15, Volume: 17, Issue:14 Topics: Cytomegalovirus; Enzyme Inhibitors; Nucleic Acid Synthesis Inhibitors; Pyridines; Structure-Activity Relationship	2007
Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genotype; Humans; Mutation; Phenotype	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition. Bioorganic & medicinal chemistry letters, 2008, Jul-15, Volume: 18, Issue:14 Topics: Antiviral Agents; Chemistry, Pharmaceutical; Cytomegalovirus; Drug Design; Enzyme Inhibitors; Esters; Furans; Herpesviridae; Herpesvirus 3, Human; Herpesvirus 4, Human; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Nucleic Acid Synthesis Inhibitors; Pyridones; Simplexvirus	2008
4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action. Journal of medicinal chemistry, 2008, Sep-25, Volume: 51, Issue:18 Topics: Antiviral Agents; Cell Line; Cytomegalovirus; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Thymidine; Urea	2008
Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue. Bioorganic & medicinal chemistry, 2009, Jan-01, Volume: 17, Issue:1 Topics: Antiviral Agents; Cross-Linking Reagents; Cytomegalovirus; Drug Interactions; Foscarnet; Glyceryl Ethers; HIV; Humans; Inhibitory Concentration 50; Simplexvirus; Zidovudine	2009
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2 Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship	2009
4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cytomegalovirus; Herpesvirus 3, Human; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Naphthalenesulfonates; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Virus Replication	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Animals; Antiviral Agents; Cell Line; Cell Proliferation; Cells, Cultured; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Fluorescent Antibody Technique, Indirect; Herpesviridae; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 6, Human; Herpesvirus 8, Human; Humans; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Molecular Structure; Pyrimidine Nucleosides; Viral Proteins; Virus Replication	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase. Bioorganic & medicinal chemistry letters, 2010, Mar-15, Volume: 20, Issue:6 Topics: Antiviral Agents; Drug Design; Protease Inhibitors; Quinoxalines; Serine Endopeptidases	2010
Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubility. Bioorganic & medicinal chemistry letters, 2010, May-15, Volume: 20, Issue:10 Topics: Antiviral Agents; Cytomegalovirus; DNA-Directed DNA Polymerase; Herpesviridae; Herpesvirus 1, Human; Herpesvirus 3, Human; Humans; Nucleic Acid Synthesis Inhibitors; Pyrroles; Quinolines; Solubility; Structure-Activity Relationship	2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR. European journal of medicinal chemistry, 2011, Volume: 46, Issue:1 Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics	2011
Treatment of cytomegalovirus retinitis--1992. Archives of ophthalmology (Chicago, Ill. : 1960), 1992, Volume: 110, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Recurrence; Retinitis	1992
Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus. The Journal of pediatrics, 1992, Volume: 120, Issue:3 Topics: Antiviral Agents; Child, Preschool; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Infections; Humans; Phosphonoacetic Acid; Retinitis	1992
Why was treatment of cytomegalovirus retinitis randomized? Annals of internal medicine, 1992, Apr-01, Volume: 116, Issue:7 Topics: Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Randomized Controlled Trials as Topic; Retinitis	1992
Cytomegalovirus and AIDS. Genitourinary medicine, 1992, Volume: 68, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis; Retrospective Studies	1992
Treatment of CMV retinitis. The New England journal of medicine, 1992, Jun-18, Volume: 326, Issue:25 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis; Zidovudine	1992
Treatment of CMV retinitis. The New England journal of medicine, 1992, Jun-18, Volume: 326, Issue:25 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney; Phosphonoacetic Acid; Retinitis	1992
Treatment of CMV retinitis. The New England journal of medicine, 1992, Jun-18, Volume: 326, Issue:25 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis	1992
Therapeutic algorithm for treatment of cytomegalovirus retinitis in persons with AIDS. A roundtable summary. Journal of acquired immune deficiency syndromes, 1992, Volume: 5 Suppl 1 Topics: Acquired Immunodeficiency Syndrome; Adult; Algorithms; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Male; Phosphonoacetic Acid; Retinitis	1992
A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors. The Journal of infectious diseases, 1992, Volume: 166, Issue:4 Topics: Antiviral Agents; Chromatography, High Pressure Liquid; Cytomegalovirus; Drug Resistance, Microbial; Enzyme-Linked Immunosorbent Assay; Foscarnet; Ganciclovir; Humans; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Viral Plaque Assay	1992
Transplantation of the heart and lung. The Medical journal of Australia, 1992, Oct-05, Volume: 157, Issue:7 Topics: Australia; Coronary Artery Disease; Costs and Cost Analysis; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Heart Transplantation; Heart-Lung Transplantation; Humans; Immunosuppression Therapy; Lung Transplantation; Postoperative Complications; Survival Rate; Tissue Donors; Transplantation, Heterotopic	1992
Atypical healing of cytomegalovirus retinitis. Significance of persistent border opacification. Ophthalmology, 1992, Volume: 99, Issue:9 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Eye Infections, Viral; Female; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Prospective Studies; Retina; Retinitis; Virus Replication; Wound Healing	1992
Visual field testing in the management of cytomegalovirus retinitis. Ophthalmology, 1992, Volume: 99, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Follow-Up Studies; Foscarnet; Fundus Oculi; Ganciclovir; HIV Seropositivity; Humans; Male; Ophthalmoscopy; Photography; Retinitis; Vision Disorders; Visual Field Tests; Visual Fields	1992
2.5 years survival with sequential ganciclovir/foscarnet treatment in a patient with acquired immune deficiency syndrome and cytomegalovirus retinitis. German journal of ophthalmology, 1992, Volume: 1, Issue:2 Topics: AIDS-Related Opportunistic Infections; Cataract Extraction; Cytomegalovirus Infections; Drug Administration Schedule; Drug Tolerance; Eye Infections, Viral; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Recurrence; Retinitis; Survival Rate; Visual Acuity	1992
Opportunistic intraocular infections in AIDS. Transactions of the American Ophthalmological Society, 1992, Volume: 90 Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Choroiditis; Cytomegalovirus Infections; Eye Infections, Viral; Female; Foscarnet; Ganciclovir; HIV-1; Humans; Infant; Male; Middle Aged; Retinitis	1992
[Cytomegalovirus retinitis in AIDS. Effectiveness and complications of long-term therapy]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1992, Volume: 89, Issue:5 Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Long-Term Care; Recurrence; Retinitis; Retrospective Studies; Visual Acuity; Visual Fields	1992
Treatment of CMV retinitis. Lancet (London, England), 1992, Jan-25, Volume: 339, Issue:8787 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis; Zidovudine	1992
Foscarnet for CMV retinitis. Lancet (London, England), 1992, Feb-22, Volume: 339, Issue:8791 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Function Tests; Phosphonoacetic Acid; Retinitis	1992
Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS. Lancet (London, England), 1992, Aug-29, Volume: 340, Issue:8818 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Meningoencephalitis; Phosphonoacetic Acid	1992
Combined and alternating ganciclovir/foscarnet in HIV-related cytomegalovirus encephalitis. Lancet (London, England), 1992, Oct-17, Volume: 340, Issue:8825 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Homosexuality; Humans; Male	1992
Treatment of CMV retinitis. The New England journal of medicine, 1992, Jun-18, Volume: 326, Issue:25 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Zidovudine	1992
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. The Journal of infectious diseases, 1991, Volume: 163, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Male; Ophthalmoscopy; Phosphonoacetic Acid; Retinitis	1991
Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation. Transplantation, 1991, Volume: 52, Issue:1 Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Phosphonoacetic Acid; Pneumonia, Viral	1991
National Eye Institute issues clinical alert about CMV retinitis in AIDS. JAMA, 1991, Nov-20, Volume: 266, Issue:19 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Male; Phosphonoacetic Acid; Retinitis	1991
Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment. The Journal of infectious diseases, 1991, Volume: 164, Issue:6 Topics: Adolescent; Adult; Antibodies, Viral; Bacterial Infections; Child; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Heart-Lung Transplantation; Humans; Immunization, Passive; Immunosuppression Therapy; Male; Middle Aged; Phosphonoacetic Acid; Pneumonia, Viral; Retrospective Studies; Risk Factors; Tissue Donors; Transfusion Reaction; Virus Diseases	1991
Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival. The Journal of infection, 1991, Volume: 23, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Colitis; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; London; Male; Neutropenia; Opportunistic Infections; Phosphonoacetic Acid; Prevalence; Recurrence; Retinitis; Retrospective Studies; Survival Rate; Thrombocytopenia; Zidovudine	1991
Survival of patients with AIDS and cytomegalovirus disease treated with ganciclovir or foscarnet. AIDS (London, England), 1991, Volume: 5, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Opportunistic Infections; Phosphonoacetic Acid; Retinitis; Survival Rate	1991
Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia. Molecular and cellular probes, 1991, Volume: 5, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Antigens, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Humans; Neutrophils; Phosphonoacetic Acid; Polymerase Chain Reaction; Retinitis; Viral Proteins	1991
[Therapeutic alternative or 2d choice drug. Trisodium phosphonoformate in cytomegalovirus retinitis]. Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1991, Volume: 88, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Chorioretinitis; Cytomegalovirus Infections; Drug Therapy, Combination; Fluorescein Angiography; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Opportunistic Infections; Phosphonoacetic Acid	1991
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents. Journal of virological methods, 1991, Volume: 35, Issue:1 Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Esterases; Flow Cytometry; Fluoresceins; Fluorometry; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Polyethylene Glycols; Suramin	1991
Thromboembolic disease in AIDS is associated with cytomegalovirus disease. AIDS (London, England), 1991, Volume: 5, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Phosphonoacetic Acid; Thromboembolism	1991
Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient. Lancet (London, England), 1991, May-25, Volume: 337, Issue:8752 Topics: Adult; Antiviral Agents; Bone Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance; Female; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid	1991
Simultaneous treatment of cytomegalovirus retinitis with ganciclovir and foscarnet. Lancet (London, England), 1991, Jul-27, Volume: 338, Issue:8761 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Male; Phosphonoacetic Acid; Retinitis	1991
Treatment of cytomegalovirus retinitis with ganciclovir and foscarnet. Lancet (London, England), 1991, Aug-31, Volume: 338, Issue:8766 Topics: Adult; Cytomegalovirus Infections; Drug Combinations; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Male; Middle Aged; Phosphonoacetic Acid; Recurrence; Retinitis	1991
Seeing the way forward for treatment of CMV retinitis. Lancet (London, England), 1991, Dec-14, Volume: 338, Issue:8781 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis	1991
Increased efficacy of ganciclovir and foscarnet inhibition of cytomegalovirus replication in vitro by encapsulation in liposomes. Scandinavian journal of infectious diseases. Supplementum, 1990, Volume: 74 Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Drug Carriers; Fibroblasts; Foscarnet; Ganciclovir; Humans; Liposomes; Phosphonoacetic Acid; Viral Plaque Assay; Virus Replication	1990
Generalised cutaneous rash associated with foscarnet usage in AIDS. The Journal of infection, 1990, Volume: 21, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Drug Eruptions; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Male; Phosphonoacetic Acid	1990
[Treatment of Cytomegalovirus infection]. La Revue du praticien, 1990, Feb-21, Volume: 40, Issue:6 Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immune Tolerance; Phosphonoacetic Acid	1990
Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:2 Topics: Cytomegalovirus; DNA, Viral; Drug Synergism; Foscarnet; Ganciclovir; Phosphonoacetic Acid; Virus Replication	1990
Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease. The British journal of ophthalmology, 1990, Volume: 74, Issue:5 Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Dendritic; Microbial Sensitivity Tests; Phosphonoacetic Acid; Simplexvirus; Vidarabine	1990
Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation. The Journal of infectious diseases, 1990, Volume: 162, Issue:1 Topics: Acyclovir; Adult; Animals; Antiviral Agents; Bone Marrow Transplantation; Cells, Cultured; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Herpes Simplex; Humans; Male; Middle Aged; Phosphonoacetic Acid; Pneumonia, Viral; Simplexvirus; Thymidine Kinase; Vero Cells; Vidarabine	1990
Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990, Volume: 9, Issue:8 Topics: Adenine; Adult; Antiviral Agents; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Foscarnet; Ganciclovir; Granulocytes; Hematopoietic Stem Cells; HIV; Humans; Macrophages; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Zidovudine	1990
[Chemotherapy of cytomegalovirus infections]. Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 47, Issue:2 Topics: Acyclovir; Adenine; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid	1989
[Diagnosis and treatment of cytomegalovirus infections]. Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 47, Issue:2 Topics: Acyclovir; Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Foscarnet; Ganciclovir; Humans; Infant, Newborn; Phosphonoacetic Acid; Pregnancy; Serologic Tests	1989
Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo. Antiviral research, 1989, Volume: 12, Issue:4 Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Cytomegalovirus; Dose-Response Relationship, Drug; Drug Synergism; Female; Foscarnet; Ganciclovir; Humans; Mice; Phosphonoacetic Acid; Rats; Simplexvirus; Viral Plaque Assay	1989
Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir. Lancet (London, England), 1989, Sep-09, Volume: 2, Issue:8663 Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Herpesviridae; Humans; Microbial Sensitivity Tests; Phosphonoacetic Acid	1989
Treatment of CMV retinitis in an AIDS patient. The British journal of ophthalmology, 1987, Volume: 71, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Phosphonoacetic Acid; Retina; Retinitis; Visual Acuity	1987
Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus. The Journal of infectious diseases, 1988, Volume: 157, Issue:2 Topics: Acyclovir; Administration, Oral; Aerosols; Animals; Antiviral Agents; Cytomegalovirus Infections; Disease Models, Animal; Female; Foscarnet; Ganciclovir; Mice; Mice, Inbred BALB C; Phosphonoacetic Acid; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Ribavirin	1988
Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis. Archives of neurology, 1988, Volume: 45, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Encephalomyelitis; Foscarnet; Ganciclovir; Humans; Male; Organophosphorus Compounds; Phosphonoacetic Acid	1988
In vitro inhibition of human herpesvirus-6 by phosphonoformate. Journal of virological methods, 1988, Volume: 21, Issue:1-4 Topics: Acyclovir; Antiviral Agents; Cell Line; Foscarnet; Ganciclovir; Herpesviridae; Humans; Organophosphorus Compounds; Phosphonoacetic Acid	1988
Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus. Journal of virology, 1985, Volume: 53, Issue:2 Topics: Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Arabinonucleosides; Bromodeoxyuridine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genes, Viral; Idoxuridine; Mutation; Phosphonoacetic Acid; Simplexvirus; Thymidine; Vidarabine	1985
Synthesis of cytomegalovirus DNA is an antiviral target late in virus growth. The Journal of general virology, 1987, Volume: 68 ( Pt 6) Topics: Acyclovir; Antiviral Agents; Cell Line; Cytomegalovirus; DNA, Viral; Floxuridine; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Spermidine; Spermine; Viral Proteins	1987
[Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow]. Nouvelle revue francaise d'hematologie, 1987, Volume: 29, Issue:1 Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Phosphonoacetic Acid; Postoperative Complications	1987
Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds. Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:6 Topics: Acyclovir; Antiviral Agents; Cells, Cultured; Drug Synergism; Foscarnet; Ganciclovir; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Viral Plaque Assay	1982
Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis. The Journal of infectious diseases, 1995, Volume: 172, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus Retinitis; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Retinal Detachment; Vitreous Body	1995
A sensitive and specific polymerase chain reaction-based assay for the diagnosis of cytomegalovirus retinitis. American journal of ophthalmology, 1995, Volume: 120, Issue:2 Topics: AIDS-Related Opportunistic Infections; Base Sequence; Cytomegalovirus; Cytomegalovirus Retinitis; DNA Primers; DNA, Viral; Drug Therapy, Combination; Eye Diseases; False Positive Reactions; Foscarnet; Ganciclovir; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Sensitivity and Specificity; Vitreous Body; Vitreous Hemorrhage	1995
Cytomegalovirus encephalitis resistant to anti-cytomegalovirus therapy. AIDS (London, England), 1995, Volume: 9, Issue:5 Topics: Bone Marrow Transplantation; Child, Preschool; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Drug Resistance; Encephalitis, Viral; Fatal Outcome; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Male; Opportunistic Infections	1995
Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine. Lancet (London, England), 1995, Aug-26, Volume: 346, Issue:8974 Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bias; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Information Systems; Male; Proportional Hazards Models; Risk Factors; Sarcoma, Kaposi	1995
Cytomegalovirus ventriculoencephalitis in AIDS patients. Scandinavian journal of infectious diseases, 1995, Volume: 27, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Autopsy; Brain; Cerebral Ventricles; Cerebrospinal Fluid; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Encephalitis, Viral; Foscarnet; Ganciclovir; Humans; Magnetic Resonance Imaging; Male; Tomography, X-Ray Computed; Viremia	1995
Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir. American journal of ophthalmology, 1995, Volume: 119, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus; Cytomegalovirus Retinitis; Disease Progression; DNA, Viral; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Viremia	1995
[Clinical value of a polymerase chain reaction on cytomegalovirus DNA in cerebrospinal fluid in HIV patients with neurological symptoms]. Schweizerische medizinische Wochenschrift, 1995, Apr-29, Volume: 125, Issue:17 Topics: Adult; AIDS Dementia Complex; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Encephalitis, Viral; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polyradiculoneuropathy	1995
Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus. Antiviral research, 1995, Volume: 26, Issue:1 Topics: Acyclovir; Animals; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Mice; Mice, SCID; Microbial Sensitivity Tests; Muromegalovirus; Nucleosides; Nucleotides; Organophosphonates; Organophosphorus Compounds	1995
Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples. Journal of clinical microbiology, 1995, Volume: 33, Issue:3 Topics: Antigens, Viral; Blood; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Viral Plaque Assay	1995
[Lesions of the conus medullaris and the cauda equina caused by cytomegalovirus in HIV infection. 7 cases]. Presse medicale (Paris, France : 1983), 1995, Mar-18, Volume: 24, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Cauda Equina; Cytomegalovirus Infections; Drug Therapy, Combination; Fatal Outcome; Female; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Middle Aged; Nerve Compression Syndromes; Retrospective Studies; Spinal Nerve Roots	1995
[Quantitative cytomegaloviral leukocytic antigenemia. Clinical aspects]. Presse medicale (Paris, France : 1983), 1995, Mar-18, Volume: 24, Issue:11 Topics: Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Leukocytes; Male; Middle Aged; Postoperative Complications	1995
Lack of sustained efficacy of combination ganciclovir and foscarnet for hepatitis B virus recurrence after liver transplantation. Transplantation, 1995, Jun-15, Volume: 59, Issue:11 Topics: Drug Therapy, Combination; Foscarnet; Ganciclovir; Hepatitis B; Humans; Liver Transplantation; Male; Middle Aged; Recurrence	1995
Prolonged concurrent use of ganciclovir and foscarnet in the treatment of polyradiculopathy due to cytomegalovirus in a patient with AIDS. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 19, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Peripheral Nervous System Diseases; Spinal Nerve Roots; Time Factors	1994
Intraocular sustained drug release devices. Archives of ophthalmology (Chicago, Ill. : 1960), 1995, Volume: 113, Issue:1 Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Delayed-Action Preparations; Drug Delivery Systems; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans	1995
Cytomegalovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome. The American journal of medicine, 1995, Volume: 98, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Drug Administration Schedule; Esophagitis; Female; Foscarnet; Ganciclovir; Humans; Male; Probability; Prospective Studies; Recurrence; Survival Analysis; Treatment Outcome	1995
AIDS-associated Kaposi's sarcoma. Science (New York, N.Y.), 1995, Feb-24, Volume: 267, Issue:5201 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; AIDS-Related Opportunistic Infections; Female; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Male; Retrospective Studies; Risk Factors; Sarcoma, Kaposi	1995
Phosphonoformate for CMV retinitis in AIDS. The American journal of medicine, 1995, Volume: 98, Issue:3 Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Drug Administration Schedule; Foscarnet; Ganciclovir; Humans	1995
Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia. Bone marrow transplantation, 1994, Volume: 14, Issue:5 Topics: Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hepatitis, Viral, Human; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Meningitis, Listeria; Middle Aged; Opportunistic Infections; Transplantation, Homologous; Viremia	1994
[Cytomegaloviruses--clinical aspects and therapy]. Therapeutische Umschau. Revue therapeutique, 1994, Volume: 51, Issue:8 Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans	1994
Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replication. Antiviral research, 1994, Volume: 24, Issue:1 Topics: Antibodies, Monoclonal; Antibodies, Viral; Cytomegalovirus; Drug Synergism; Foscarnet; Ganciclovir; Humans; Viral Envelope Proteins; Virus Replication	1994
Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases. Neurology, 1994, Volume: 44, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Nervous System Diseases	1994
Two AIDS patients with life-threatening pancreatitis successfully treated, one with ganciclovir the other with foscarnet. Acta clinica Belgica, 1994, Volume: 49, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; Male; Pancreatitis; Recurrence	1994
Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation. Bone marrow transplantation, 1994, Volume: 13, Issue:4 Topics: Adolescent; Adult; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Drug Administration Schedule; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Life Tables; Lymphocyte Depletion; Male; Middle Aged; Neutropenia; Premedication; Proportional Hazards Models; Retrospective Studies; T-Lymphocytes; Treatment Failure; Virus Activation	1994
Combined therapy with ganciclovir and foscarnet for cytomegalovirus polyradiculomyelitis in patients with AIDS. The American journal of medicine, 1994, Volume: 97, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Myelitis; Polyradiculopathy	1994
[Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome]. Nippon Ganka Gakkai zasshi, 1994, Volume: 98, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Male	1994
Actinomyces infection of a cytomegalovirus esophageal ulcer in two patients with acquired immunodeficiency syndrome. The American journal of gastroenterology, 1994, Volume: 89, Issue:9 Topics: Actinomycosis; Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Esophageal Cyst; Esophagitis; Foscarnet; Ganciclovir; Humans; Male; Penicillin G	1994
Prevention of cytomegalovirus disease by a short course of preemptive ganciclovir or foscarnet. Blood, 1994, Sep-15, Volume: 84, Issue:6 Topics: Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans	1994
Central venous catheter infections in AIDS patients receiving treatment for cytomegalovirus disease. Journal of acquired immune deficiency syndromes, 1994, Volume: 7, Issue:3 Topics: AIDS-Related Opportunistic Infections; Bacterial Infections; Catheterization, Central Venous; Catheters, Indwelling; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Incidence; Leukocyte Count; Neutrophils	1994
Toxicologic and pharmacokinetic analysis of intravitreal injections of foscarnet, either alone or in combination with ganciclovir. Investigative ophthalmology & visual science, 1994, Volume: 35, Issue:3 Topics: Animals; Aqueous Humor; Drug Combinations; Electrophysiology; Electroretinography; Foscarnet; Ganciclovir; Half-Life; Injections; Ophthalmoscopy; Rabbits; Retina; Vitreous Body	1994
Drugs for non-HIV viral infections. The Medical letter on drugs and therapeutics, 1994, Apr-01, Volume: 36, Issue:919 Topics: Acyclovir; Amantadine; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Virus Diseases	1994
[Resistance to virostatic agents in Herpes viruses: mechanism, incidence and clinical significance]. Schweizerische medizinische Wochenschrift, 1994, Jan-29, Volume: 124, Issue:4 Topics: Acyclovir; Antiviral Agents; Drug Resistance; Foscarnet; Ganciclovir; Herpesviridae; Humans; Immunocompetence; Immunocompromised Host; Phosphorylation	1994
Retinal detachment in patients with acquired immunodeficiency syndrome. German journal of ophthalmology, 1994, Volume: 3, Issue:1 Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Incidence; Male; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Visual Acuity	1994
Rapid detection of cytomegalovirus strains resistant to ganciclovir through mutations within the gene UL97. Molecular and cellular probes, 1993, Volume: 7, Issue:6 Topics: Base Sequence; Bronchoalveolar Lavage Fluid; Cerebrospinal Fluid; Cytomegalovirus; Cytomegalovirus Infections; DNA Probes; Drug Resistance, Microbial; Fibroblasts; Foscarnet; Ganciclovir; Genes, Viral; Humans; Inactivation, Metabolic; Molecular Sequence Data; Mutation; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Urine; Viral Proteins; Viral Structural Proteins	1993
Predisposition to cytomegalovirus infection of the gastrointestinal tract. Annals of internal medicine, 1994, May-01, Volume: 120, Issue:9 Topics: Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans	1994
Treatment of gancyclovir resistant cytomegalovirus with foscarnet: a report of two cases occurring after bone marrow transplantation. Leukemia & lymphoma, 1994, Volume: 12, Issue:5-6 Topics: Adult; Bone Marrow Transplantation; Cytomegalovirus Infections; Drug Resistance; Foscarnet; Ganciclovir; Humans; Male; Middle Aged	1994
The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir. The American journal of medicine, 1994, Volume: 96, Issue:5 Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Cerebral Ventricles; Confusion; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Dementia; Encephalitis; Foscarnet; Ganciclovir; Humans; Male; Sleep Stages; Survival Rate	1994
Combined daily therapy with intravenous ganciclovir and foscarnet for patients with recurrent cytomegalovirus retinitis. American journal of ophthalmology, 1994, Jun-15, Volume: 117, Issue:6 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Injections, Intravenous; Male; Prognosis; Recurrence	1994
Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Infectious Disease Working Party of the European Group for Bone Marrow Transplantation. Bone marrow transplantation, 1994, Volume: 13, Issue:2 Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cytomegalovirus Infections; Europe; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Incidence; Lung Diseases, Interstitial; Middle Aged; Retrospective Studies; Surveys and Questionnaires; Survival Analysis	1994
Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Archives of ophthalmology (Chicago, Ill. : 1960), 1993, Volume: 111, Issue:10 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Male; Middle Aged	1993
Cytomegalovirus resistant to foscarnet: clinicovirologic correlation in a patient with human immunodeficiency virus. The Journal of infectious diseases, 1993, Volume: 168, Issue:5 Topics: Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Middle Aged; Recurrence	1993
Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology, 1993, Volume: 100, Issue:11 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Longitudinal Studies; Male; Middle Aged; Morbidity; Retrospective Studies; Vision Disorders; Visual Acuity	1993
Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. American journal of ophthalmology, 1993, Dec-15, Volume: 116, Issue:6 Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Infections; Humans; Incidence; Proportional Hazards Models; Prospective Studies; Retinal Detachment; Risk Factors; Time Factors	1993
Foscarnet-resistant herpes simplex virus infection in patients with AIDS. The Journal of infectious diseases, 1994, Volume: 169, Issue:1 Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpes Genitalis; Herpes Labialis; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Vidarabine	1994
Ganciclovir intraocular device and patient survival. Archives of ophthalmology (Chicago, Ill. : 1960), 1994, Volume: 112, Issue:1 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Delayed-Action Preparations; Drug Delivery Systems; Foscarnet; Ganciclovir; Humans; Survival Rate; Vitreous Body	1994
Ganciclovir intraocular device and patient survival. Archives of ophthalmology (Chicago, Ill. : 1960), 1994, Volume: 112, Issue:1 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Delayed-Action Preparations; Drug Delivery Systems; Foscarnet; Ganciclovir; Humans; Survival Rate; Vitreous Body	1994
Evaluation of AIDS-related diarrhea. Hospital practice (Office ed.), 1993, Jan-15, Volume: 28, Issue:1 Topics: Adult; Ampulla of Vater; Biopsy; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Chronic Disease; Common Bile Duct Diseases; Cytomegalovirus Infections; Decision Trees; Diarrhea; Enteritis; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Male; Medical History Taking	1993
Acute retinal necrosis in a renal allograft recipient--an unusual manifestation of cytomegalovirus infection. Transplantation, 1993, Volume: 55, Issue:1 Topics: Adult; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Male; Retinal Diseases; Retinal Necrosis Syndrome, Acute	1993
Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. The Journal of infectious diseases, 1993, Volume: 167, Issue:3 Topics: Adult; Base Sequence; Bone Marrow; Bone Marrow Transplantation; Cohort Studies; Colony-Forming Units Assay; Fever; Foscarnet; Ganciclovir; Hematopoiesis; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Restriction Mapping; Viremia	1993
Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients. The Journal of infectious diseases, 1993, Volume: 167, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Demography; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Middle Aged; Regression Analysis; Retrospective Studies	1993
Foscarnet treatment in various cytomegalovirus infections. International journal of clinical pharmacology, therapy, and toxicology, 1993, Volume: 31, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Colitis; Cytomegalovirus Infections; Eye Infections, Viral; Fissure in Ano; Foscarnet; Ganciclovir; Humans; Male; Retinitis; Stomatitis, Aphthous	1993
Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis. Ophthalmology, 1993, Volume: 100, Issue:7 Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Eye Infections, Viral; Female; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Microbial Sensitivity Tests; Prospective Studies; Retinitis; Survival Rate; Visual Acuity	1993
Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:7 Topics: Acyclovir; Antiviral Agents; Base Sequence; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 4, Human; Microbial Sensitivity Tests; Molecular Sequence Data; Oligodeoxyribonucleotides; Oligonucleotides, Antisense; Organophosphorus Compounds; Time Factors	1993
Therapy for cytomegalovirus retinitis: still no silver lining. JAMA, 1996, Jan-10, Volume: 275, Issue:2 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Recurrence	1996
In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate. Antiviral research, 1995, Volume: 27, Issue:4 Topics: Antigens, Viral; Antiviral Agents; Ascorbic Acid; Cells, Cultured; Cytomegalovirus; Endothelium; Fibroblasts; Foscarnet; Ganciclovir; Humans; Virus Replication	1995
Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients. Journal of medical virology, 1995, Volume: 47, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Foscarnet; Ganciclovir; Humans; Male; Reverse Transcriptase Inhibitors; Time Factors; Viral Plaque Assay	1995
[Clinical manifestations and course of cytomegalovirus colitis in AIDS patients]. Schweizerische medizinische Wochenschrift, 1995, Dec-16, Volume: 125, Issue:50 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cohort Studies; Colitis; Colonoscopy; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies	1995
Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogs. Antiviral research, 1995, Volume: 28, Issue:2 Topics: Antiviral Agents; Base Sequence; Cell Line; Cytomegalovirus; Drug Interactions; Foscarnet; Ganciclovir; HIV-1; Humans; Molecular Sequence Data; Nucleic Acid Synthesis Inhibitors; RNA, Viral; Thionucleotides; Virus Replication; Zalcitabine; Zidovudine	1995
Ganciclovir in cytomegalovirus retinitis. The Journal of infection, 1995, Volume: 31, Issue:3 Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Drug Therapy, Combination; Encephalitis, Viral; Foscarnet; Ganciclovir; Homosexuality, Male; Humans; Male	1995
Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS. Neurology, 1996, Volume: 46, Issue:2 Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Base Sequence; Cerebrospinal Fluid; Cytomegalovirus; Cytomegalovirus Infections; DNA Primers; Encephalitis; Foscarnet; Ganciclovir; Genes, Immediate-Early; HIV Seropositivity; Humans; Male; Meningitis; Molecular Sequence Data; Polymerase Chain Reaction; Prognosis; Sensitivity and Specificity; Spinal Cord Diseases	1996
Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered f Journal of virology, 1996, Volume: 70, Issue:3 Topics: AIDS-Related Opportunistic Infections; Amino Acid Sequence; Base Sequence; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Drug Resistance, Multiple; Foscarnet; Ganciclovir; Humans; Molecular Sequence Data; Mutation; Phenotype; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor)	1996
Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet. American journal of ophthalmology, 1996, Volume: 122, Issue:1 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Injections; Male; Recurrence; Vitreous Body	1996
Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group. Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:7 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Baltimore; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Humans; Incidence; Male; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Seroepidemiologic Studies; Urine; Viremia	1996
Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:7 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; HIV Infections; HIV-1; Humans; Immune Tolerance; Incidence; Male; Pneumonia, Pneumocystis; Prevalence; Survival Rate; Zidovudine	1996
Serous retinal detachments in a patient with clinically resistant cytomegalovirus retinitis. Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:7 Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Exudates and Transudates; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Infusions, Intravenous; Male; Recurrence; Retinal Detachment; Visual Acuity	1996
Four dually resistant human cytomegalovirus strains from AIDS patients: single mutations in UL97 and UL54 open reading frames are responsible for ganciclovir- and foscarnet-specific resistance, respectively. Scandinavian journal of infectious diseases. Supplementum, 1995, Volume: 99 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Drug Resistance, Multiple; Foscarnet; Ganciclovir; Genes, Viral; Humans; Mutation; Polymerase Chain Reaction; Viral Envelope Proteins	1995
Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral research, 1995, Volume: 28, Issue:4 Topics: Adenine; Antiviral Agents; Cell Line; Cidofovir; Cytopathogenic Effect, Viral; Cytosine; Flow Cytometry; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Nucleosides; Organophosphonates; Organophosphorus Compounds	1995
Treatment of cytomegalovirus retinitis in patients with AIDS. Annals of internal medicine, 1996, Jul-15, Volume: 125, Issue:2 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Routes; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Retinitis	1996
New developments in the treatment of CMV retinitis. Ophthalmology, 1996, Volume: 103, Issue:7 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Injections; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Vitreous Body	1996
[Current status of the management of cytomegalovirus retinitis in patients with AIDS]. Enfermedades infecciosas y microbiologia clinica, 1996, Volume: 14, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans	1996
Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs. Blood, 1996, Jul-01, Volume: 88, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Base Sequence; Blood Coagulation Disorders; Cohort Studies; DNA, Viral; Female; Foscarnet; Ganciclovir; Herpesviridae; Herpesviridae Infections; HIV Seronegativity; Homosexuality; Humans; Leukocytes, Mononuclear; Male; Molecular Sequence Data; Prevalence; Risk Factors; Sarcoma, Kaposi; Skin Neoplasms	1996
Interaction between ganciclovir and foscarnet as inhibitors of duck hepatitis B virus replication in vitro. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5 Topics: Animals; Antiviral Agents; Cells, Cultured; DNA Replication; DNA, Viral; Drug Combinations; Ducks; Foscarnet; Ganciclovir; Hepatitis B Virus, Duck; Immunoblotting; Liver; Viral Core Proteins; Virus Replication	1996
Current and experimental therapeutic options for cytomegalovirus disease. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996, Apr-15, Volume: 53, Issue:8 Suppl 2 Topics: Administration, Oral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Delayed-Action Preparations; Foscarnet; Ganciclovir; Guanine; Humans; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds	1996
Current management of cytomegalovirus infection: treatment and prophylaxis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996, Apr-15, Volume: 53, Issue:8 Suppl 2 Topics: Administration, Oral; Anti-Bacterial Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Injections, Intravenous; Recurrence	1996
Cytomegalovirus resistance to antiviral therapies. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996, Apr-15, Volume: 53, Issue:8 Suppl 2 Topics: Administration, Oral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Treatment Outcome	1996
European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone marrow transplantation, 1996, Volume: 17, Issue:5 Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Data Collection; Drug Resistance, Microbial; Europe; Foscarnet; Ganciclovir; Herpesviridae; Herpesviridae Infections; Herpesvirus 3, Human; Humans; Simplexvirus; Surveys and Questionnaires; Vidarabine	1996
Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation. Transplantation, 1996, Aug-15, Volume: 62, Issue:3 Topics: Adolescent; Adult; Antibodies, Viral; Cell Transplantation; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Feasibility Studies; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Pilot Projects; Transplantation, Homologous; Virus Activation	1996
A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs. Journal of virological methods, 1996, Apr-26, Volume: 58, Issue:1-2 Topics: Antigens, Viral; Antiviral Agents; Cidofovir; Cytosine; Drug Evaluation; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Organophosphonates; Organophosphorus Compounds; Reproducibility of Results	1996
Some antivirals may lower Kaposi's sarcoma risk. Lancet (London, England), 1996, Sep-21, Volume: 348, Issue:9030 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Sarcoma, Kaposi	1996
Nephrogenic diabetes insipidus associated with foscarnet--a case report. The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Diarrhea; Foscarnet; Ganciclovir; Humans; Male; Osmolar Concentration; Polyuria; Reverse Transcriptase Inhibitors; Urine	1996
Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet. Ophthalmology, 1996, Volume: 103, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Drug Therapy, Combination; Eye Infections, Viral; Female; Follow-Up Studies; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Infusions, Intravenous; Male; Middle Aged; Optic Disk; Optic Neuritis; Prognosis; Visual Acuity	1996
In vitro evaluation of polymeric matrix and porous biodegradable reservoir devices for slow-release drug delivery. Ophthalmic surgery and lasers, 1996, Volume: 27, Issue:5 Topics: Antiviral Agents; Biodegradation, Environmental; Delayed-Action Preparations; Drug Delivery Systems; Fluoresceins; Fluorouracil; Foscarnet; Ganciclovir; In Vitro Techniques; Microscopy, Electron, Scanning; Polyesters; Porosity	1996
Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment. Transplantation, 1996, Oct-27, Volume: 62, Issue:8 Topics: Antiviral Agents; Bone Marrow Transplantation; CD58 Antigens; Cytomegalovirus; Cytomegalovirus Infections; Fibroblasts; Foscarnet; Ganciclovir; Graft Rejection; Humans; Intercellular Adhesion Molecule-1; Organ Transplantation; Up-Regulation; Viral Proteins	1996
Combined ganciclovir and foscarnet in pediatric cytomegalovirus retinitis. Journal of the National Medical Association, 1996, Volume: 88, Issue:10 Topics: Child, Preschool; Cytomegalovirus Retinitis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Foscarnet; Ganciclovir; Humans	1996
Combined foscarnet -ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (Hsct). Bone marrow transplantation, 1996, Volume: 18 Suppl 2 Topics: Adolescent; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Transplantation, Homologous	1996
Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia. Clinical transplantation, 1996, Volume: 10, Issue:6 Pt 1 Topics: Adolescent; Adult; Antigens, Viral; Antiviral Agents; Chemoprevention; Child; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Microbial; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukocytes; Male; Middle Aged; Risk Factors; Survival Rate; Viremia	1996
[Early diagnosis and treatment of cytomegalovirus polyradiculoneuritis in a child infected by HIV]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1996, Volume: 3, Issue:8 Topics: AIDS-Related Opportunistic Infections; Child; Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Polyradiculoneuropathy	1996
Successful treatment of progressive outer retinal necrosis syndrome. Retina (Philadelphia, Pa.), 1996, Volume: 16, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Female; Foscarnet; Fundus Oculi; Ganciclovir; Herpes Zoster; Herpes Zoster Ophthalmicus; Humans; Infusions, Intravenous; Male; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Silicone Oils; Visual Acuity; Vitrectomy	1996
Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation. Transplantation, 1997, Feb-15, Volume: 63, Issue:3 Topics: Adolescent; Cytomegalovirus; Cytomegalovirus Infections; DNA Mutational Analysis; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Liver Transplantation; Male	1997
Repair of retinal detachments due to herpes varicella-zoster virus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology, 1997, Volume: 104, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Male; Retinal Detachment; Retinitis; Silicone Oils; Visual Acuity; Vitrectomy	1997
[Foscarnet therapy for ganciclovir-refractory cytomegalovirus hepatitis in a patient who underwent bone marrow transplantation from an unrelated donor]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1997, Volume: 38, Issue:2 Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cytomegalovirus Infections; Drug Resistance; Female; Foscarnet; Ganciclovir; Hepatitis, Viral, Human; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive	1997
Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis. Ophthalmology, 1995, Volume: 102, Issue:12 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus Retinitis; Drug Therapy, Combination; Female; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Infusions, Intravenous; Male; Recurrence; Retina	1995
Quantitative systemic and local evaluation of the antiviral effect of ganciclovir and foscarnet induction treatment on human cytomegalovirus gastrointestinal disease of patients with AIDS. Italian Foscarnet GID Study Group. Antiviral research, 1997, Volume: 34, Issue:1 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Gastrointestinal Diseases; HIV-1; Humans; Viral Load	1997
New therapies for cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. The Western journal of medicine, 1997, Volume: 166, Issue:2 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Prognosis; Retinitis	1997
Central venous line infections in AIDS. The Journal of infection, 1997, Volume: 34, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Catheterization, Central Venous; Catheters, Indwelling; Cytomegalovirus Retinitis; Equipment Contamination; Female; Foscarnet; Ganciclovir; Humans; Male; Sepsis; Survival Analysis; Wound Infection	1997
The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports. Recenti progressi in medicina, 1996, Volume: 87, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged	1996
Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. The Journal of infectious diseases, 1997, Volume: 175, Issue:5 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Base Sequence; Cytomegalovirus; Cytomegalovirus Infections; DNA Primers; DNA-Directed DNA Polymerase; Foscarnet; Ganciclovir; Genotype; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction	1997
Management of varicella zoster virus retinitis in AIDS. The British journal of ophthalmology, 1997, Volume: 81, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Antiviral Agents; Eye Infections, Viral; Female; Foscarnet; Ganciclovir; Herpes Zoster; Herpesvirus 3, Human; Humans; Male; Middle Aged; Retinal Detachment; Retinitis; Retrospective Studies; Treatment Outcome; Visual Acuity	1997
Cytomegalovirus retinitis: decreased risk of bilaterality with increased use of systemic treatment. Swiss HIV Cohort Study Group. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:4 Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Drug Therapy, Combination; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome	1997
Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir. AIDS (London, England), 1997, Volume: 11, Issue:3 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Foscarnet; Ganciclovir; Humans; Reverse Transcriptase Inhibitors; Salvage Therapy	1997
Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. The Journal of clinical investigation, 1997, May-01, Volume: 99, Issue:9 Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; DNA Probes; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 8, Human; HIV Protease Inhibitors; Humans; Methylurea Compounds; Nucleic Acid Hybridization; Organophosphonates; Organophosphorus Compounds; Phorbol Esters; Pyridines; Sarcoma, Kaposi; Tumor Cells, Cultured; Valine; Virus Replication	1997
Comparison of a new quantitative cytomegalovirus DNA assay with other detection methods. Transplantation, 1997, Jun-27, Volume: 63, Issue:12 Topics: Antibodies, Viral; Antiviral Agents; Biopsy; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulin M; Liver; Liver Transplantation; Nucleic Acid Hybridization	1997
Diagnosis of cytomegalovirus (CMV) polyradiculopathy and documentation of in vivo anti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays. The Journal of infectious diseases, 1997, Volume: 176, Issue:2 Topics: Antigens, Viral; Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Cytopathogenic Effect, Viral; DNA, Viral; Fibroblasts; Foscarnet; Ganciclovir; Genetic Techniques; Humans; Immunoenzyme Techniques; Polyradiculopathy; Sensitivity and Specificity	1997
Drugs for non-HIV viral infections. The Medical letter on drugs and therapeutics, 1997, Aug-01, Volume: 39, Issue:1006 Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases	1997
Concurrent ganciclovir and foscarnet treatment for cytomegalovirus encephalitis and retinitis in an infant with acquired immunodeficiency syndrome: case report and review. The Pediatric infectious disease journal, 1997, Volume: 16, Issue:8 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Encephalitis, Viral; Female; Foscarnet; Ganciclovir; Humans; Infant, Newborn; Retinitis	1997
Identification and treatment of cytomegalovirus retinitis in patients with AIDS. Journal of the American Academy of Nurse Practitioners, 1997, Volume: 9, Issue:7 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans	1997
Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. The Journal of infectious diseases, 1997, Volume: 176, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphotransferases (Alcohol Group Acceptor); Recombination, Genetic; RNA-Directed DNA Polymerase; Sequence Analysis, DNA	1997
Antiviral susceptibility testing-flow cytometric analysis (AST-FCA) for the detection of cytomegalovirus drug resistance. Diagnostic microbiology and infectious disease, 1997, Volume: 28, Issue:3 Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Dose-Response Relationship, Drug; Flow Cytometry; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity	1997
Quantitative cytomegalovirus (CMV) antigenaemia during antiviral treatment of AIDS-related CMV disease. The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Antigens, Viral; Antiviral Agents; Biomarkers; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Phosphoproteins; Viral Matrix Proteins	1997
In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS (London, England), 1997, Volume: 11, Issue:11 Topics: Acyclovir; Antiviral Agents; Carcinogens; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 8, Human; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Phorbol 12,13-Dibutyrate; Sarcoma, Kaposi; Thymidine; Tumor Cells, Cultured; Virus Latency	1997
Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation for non-A, non-B, non-C hepatitis. Transplantation, 1997, Oct-27, Volume: 64, Issue:8 Topics: Anemia, Aplastic; Antiviral Agents; Biopsy; Bone Marrow; Bone Marrow Transplantation; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Hepatitis, Viral, Human; Humans; Liver Failure, Acute; Liver Transplantation; Male; Polymerase Chain Reaction	1997
Successful treatment of severe cytomegalovirus retinitis with foscarnet and intraocular injection of ganciclovir in a myelosuppressed unrelated bone marrow transplant patient. Bone marrow transplantation, 1997, Volume: 20, Issue:9 Topics: Adult; Antiviral Agents; Aqueous Humor; Bone Marrow Transplantation; Cytomegalovirus Retinitis; Female; Foscarnet; Ganciclovir; Humans; Injections, Intralesional; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1997
Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:12 Topics: Acyclovir; Antiviral Agents; Fibroblasts; Flow Cytometry; Foscarnet; Ganciclovir; Herpes Simplex; Herpesvirus 1, Human; Humans; Kinetics; Microbial Sensitivity Tests; Phosphorylation; Viral Envelope Proteins	1997
Intravitreal ganciclovir treatment in progressive outer retinal necrosis. American journal of ophthalmology, 1997, Volume: 124, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Infusions, Intravenous; Laser Coagulation; Male; Retinal Necrosis Syndrome, Acute; Vitreous Body	1997
Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome. German journal of ophthalmology, 1996, Volume: 5, Issue:6 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Injections, Intravenous; Male; Middle Aged; Treatment Outcome; Vitreous Body	1996
Interpreting human cytomegalovirus antiviral drug susceptibility testing: the role of mixed virus populations. The Journal of infectious diseases, 1998, Volume: 177, Issue:3 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds	1998
New issues in the management of cytomegalovirus retinitis in AIDS patients. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Feb-15, Volume: 55, Issue:4 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds	1998
Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. American journal of ophthalmology, 1998, Volume: 125, Issue:3 Topics: Acetazolamide; Adult; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Carbonic Anhydrase Inhibitors; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cytomegalovirus Retinitis; Fluorescein Angiography; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Ketorolac Tromethamine; Macular Edema; Male; Retrospective Studies; Tolmetin; Tromethamine; Visual Acuity	1998
How to treat the cytomegalovirus troll. The American journal of gastroenterology, 1998, Volume: 93, Issue:3 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Recurrence; Treatment Outcome	1998
Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. The Journal of infectious diseases, 1998, Volume: 177, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Retinitis; DNA, Viral; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV; HIV Protease Inhibitors; Humans; Male; Polymerase Chain Reaction; Recurrence; RNA, Viral; Viral Load	1998
The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy. Ophthalmic surgery and lasers, 1998, Volume: 29, Issue:3 Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Male; Middle Aged; Recurrence; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Treatment Outcome; Visual Acuity	1998
Lack of efficacy of cidofovir in treating AIDS-related cytomegalovirus retinitis after long-term treatment with ganciclovir. AIDS (London, England), 1998, Apr-16, Volume: 12, Issue:6 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Recurrence	1998
[Favorable course of hepatitis B virus reactivation with hepatocellular insufficiency by a treatment combining corticoids, foscarnet and ganciclovir]. Gastroenterologie clinique et biologique, 1997, Volume: 21, Issue:12 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Glucocorticoids; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Failure; Methylprednisolone; Virus Activation	1997
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Archives of internal medicine, 1998, May-11, Volume: 158, Issue:9 Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Lung Diseases; Nervous System Diseases; Organophosphonates; Organophosphorus Compounds; Retinitis	1998
Prophylactic argon laser coagulation for rhegmatogenous retinal detachment in AIDS patients with cytomegalovirus retinitis. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1998, Volume: 236, Issue:5 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Laser Coagulation; Retina; Retinal Detachment; Retinal Perforations	1998
Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments. Journal of virology, 1998, Volume: 72, Issue:7 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genes, Viral; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Recombination, Genetic; Virus Replication	1998
Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantation. Transplantation, 1998, May-27, Volume: 65, Issue:10 Topics: Acute Disease; Adult; Antiviral Agents; Bone Marrow Transplantation; Female; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Leukemia, Myeloid; Postoperative Complications; Transplantation, Homologous	1998
Immunohistochemical localization of ganciclovir in the human retina. Current eye research, 1998, Volume: 17, Issue:6 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Delayed-Action Preparations; Fluorescent Antibody Technique, Indirect; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Male; Middle Aged; Retina; Vitreous Body	1998
Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1998, Volume: 212, Issue:4 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Body Fluids; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Retinitis; Disease Progression; Drug Therapy, Combination; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Retrospective Studies; Treatment Outcome	1998
Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy. The Journal of infectious diseases, 1998, Volume: 178, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Alanine; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Male; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Reverse Transcriptase Inhibitors; Valine; Viral Proteins	1998
Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients. The new microbiologica, 1998, Volume: 21, Issue:3 Topics: AIDS-Related Opportunistic Infections; Antibodies, Monoclonal; Antigens, Viral; Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Fibroblasts; Fluorescent Antibody Technique, Direct; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; In Situ Hybridization; Leukocytes; Polymerase Chain Reaction; Viral Load	1998
Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group. American journal of ophthalmology, 1998, Volume: 126, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Baltimore; Blood; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, Microbial; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Prognosis; Prospective Studies; Survival Rate; Urine; Viremia	1998
A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 1998, Jul-24, Volume: 11, Issue:1 Topics: Antiviral Agents; Coculture Techniques; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Viral Plaque Assay	1998
In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome. The Journal of infectious diseases, 1998, Volume: 178, Issue:6 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genotype; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Recurrence	1998
Risk of developing CMV retinitis following non-ocular CMV end organ disease in AIDS patients. The British journal of ophthalmology, 1998, Volume: 82, Issue:7 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Biopsy; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Middle Aged; Risk Factors	1998
Human herpesvirus 8 DNA load in leukocytes of human immunodeficiency virus-infected subjects: correlation with the presence of Kaposi's sarcoma and response to anticytomegalovirus therapy. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:2 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Herpesvirus 8, Human; HIV Infections; Humans; Leukocytes; Sarcoma, Kaposi; Viral Load	1999
Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1999, Jan-01, Volume: 20, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Middle Aged; Retrospective Studies; Sarcoma, Kaposi; Time Factors	1999
[Cytomegalovirus (CMV) retinitis in AIDS. Gancilovir implantation in comparison with systemic therapy]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1999, Volume: 96, Issue:1 Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cytomegalovirus Retinitis; Drug Implants; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Quality of Life; Retrospective Studies	1999
Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma. The Journal of infectious diseases, 1999, Volume: 179, Issue:5 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Gene Expression; Humans; Leukocytes, Mononuclear; Phosphoproteins; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Viral; Sensitivity and Specificity; Viral Load; Viral Matrix Proteins; Viremia	1999
Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 28, Issue:3 Topics: Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pneumonia, Viral; Transplantation, Homologous; Treatment Outcome	1999
Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:6 Topics: Antiviral Agents; Codon; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genotype; Humans; Sequence Homology, Amino Acid	1999
Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants. Journal of acquired immune deficiency syndromes (1999), 1999, Aug-01, Volume: 21 Suppl 1 Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; HIV Infections; Humans; Incidence; Indinavir; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Retrospective Studies; Sarcoma, Kaposi	1999
Ganciclovir resistance in a heart transplant recipient infected by cytomegalovirus. International journal of cardiology, 1999, Sep-30, Volume: 71, Issue:1 Topics: Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Heart Transplantation; Humans; Male; Microbial Sensitivity Tests	1999
HHV-6-related secondary graft failure following allogeneic bone marrow transplantation. British journal of haematology, 1999, Volume: 105, Issue:4 Topics: Antiviral Agents; Bone Marrow Diseases; Bone Marrow Transplantation; Child; Diagnosis, Differential; Fatal Outcome; Foscarnet; Ganciclovir; Graft Rejection; Herpesviridae Infections; Herpesvirus 6, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous	1999
Fatal herpesvirus-6 encephalitis in a recipient of a T-cell-depleted peripheral blood stem cell transplant from a 3-loci mismatched related donor. Haematologica, 2000, Volume: 85, Issue:1 Topics: Cytomegalovirus Infections; DNA, Viral; Encephalitis, Viral; Fatal Outcome; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesviridae Infections; Herpesvirus 6, Human; Histocompatibility; Humans; Immunosuppressive Agents; Lymphocyte Depletion; Male; Middle Aged; Polymerase Chain Reaction; Tissue Donors; Transplantation Conditioning; Virus Activation	2000
The antisense oligonucleotide ISIS 2922 prevents cytomegalovirus-induced upregulation of IL-8 and ICAM-1 in cultured human fibroblasts. Journal of medical virology, 2000, Volume: 60, Issue:3 Topics: Antiviral Agents; Cells, Cultured; Chemotaxis, Leukocyte; Cidofovir; Cytomegalovirus Infections; Cytosine; Fibroblasts; Foscarnet; Ganciclovir; Humans; Immunohistochemistry; Intercellular Adhesion Molecule-1; Interleukin-8; Neutrophils; Oligonucleotides, Antisense; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; Thionucleotides; Up-Regulation	2000
A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:3 Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Fibroblasts; Foscarnet; Ganciclovir; Humans; Laboratories; Microbial Sensitivity Tests; Reproducibility of Results; Viral Plaque Assay	2000
Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1999, Jul-01, Volume: 56, Issue:13 Topics: Adult; Age Factors; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Male; Maryland; Retrospective Studies; Risk Factors; Sex Factors; Zidovudine	1999
Antiviral activity of ganciclovir elaidic acid ester against herpesviruses. Antiviral research, 2000, Volume: 45, Issue:3 Topics: Acyclovir; Administration, Oral; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Cytomegalovirus; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesvirus 3, Human; HIV-1; HIV-2; Humans; Mice; Simplexvirus	2000
[Severe cytomegalovirus enteritis in AIDS. Favorable outcome of medical treatment]. Presse medicale (Paris, France : 1983), 2000, Mar-25, Volume: 29, Issue:11 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Celiac Disease; Cytomegalovirus Infections; Foscarnet; Ganciclovir; HIV Protease Inhibitors; Humans; Lamivudine; Male; Nelfinavir; Parenteral Nutrition; Pentamidine; Protein-Losing Enteropathies; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Treatment Outcome	2000
Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis. Cytometry, 2000, Jun-01, Volume: 40, Issue:2 Topics: Antibodies, Monoclonal; Antigens, Surface; Antigens, Viral; Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Flow Cytometry; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Organophosphonates; Organophosphorus Compounds; Reproducibility of Results	2000
Value of long-term administration of acyclovir and similar agents for protecting against AIDS-related lymphoma: case-control and historical cohort studies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 30, Issue:5 Topics: Acyclovir; Adult; Antiviral Agents; Case-Control Studies; Cohort Studies; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Foscarnet; Ganciclovir; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Time Factors	2000
Outcome of AIDS-associated cytomegalovirus colitis in the era of potent antiretroviral therapy. Journal of clinical gastroenterology, 2000, Volume: 30, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cohort Studies; Colitis; Cytomegalovirus Infections; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Protease Inhibitors; Humans; Male; Proportional Hazards Models; Recurrence; Survival Rate; Time Factors; Treatment Outcome	2000
Cidofovir: new preparation. Of help in CMV retinitis. Prescrire international, 1998, Volume: 7, Issue:37 Topics: Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Treatment Outcome	1998
Ganciclovir resistance: a matter of time and titre. Lancet (London, England), 2000, Aug-19, Volume: 356, Issue:9230 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Disease Management; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Immunocompromised Host; Organ Transplantation; Simplexvirus	2000
Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet (London, England), 2000, Aug-19, Volume: 356, Issue:9230 Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Humans; Immunosuppression Therapy; Inhibitory Concentration 50; Kidney Transplantation; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Opportunistic Infections; Organ Transplantation; Pancreas Transplantation; Phosphotransferases (Alcohol Group Acceptor); Retrospective Studies	2000
Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. Journal of acquired immune deficiency syndromes (1999), 2000, Jul-01, Volume: 24, Issue:3 Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Infections; Homosexuality, Male; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Retrospective Studies; Risk Factors; Sarcoma, Kaposi; Skin Neoplasms	2000
[Stopping secondary prevention in AIDS patients with inactive CMV retinitis treated with HAART (highly active antiretroviral therapy)]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2000, Volume: 97, Issue:8 Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds	2000
Growth phenotypes of cytomegalovirus isolates do not correlate with glycoprotein B, major immediate early genotypes or antiviral sensitivity. Journal of medical virology, 2000, Volume: 62, Issue:2 Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Cytopathogenic Effect, Viral; Fibroblasts; Foscarnet; Ganciclovir; Humans; Immediate-Early Proteins; Phenotype; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Viral Envelope Proteins; Viral Proteins; Virus Replication	2000
Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes. Blood, 2000, Nov-01, Volume: 96, Issue:9 Topics: Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Follow-Up Studies; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Mutation; Phosphotransferases (Alcohol Group Acceptor); Time Factors; Treatment Outcome; Viral Proteins	2000
A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance. The Journal of infectious diseases, 2000, Volume: 182, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Drug Resistance, Multiple; Foscarnet; Ganciclovir; Gene Deletion; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphotransferases; Transfection	2000
Fatal cytomegalovirus pneumonia after preemptive antiviral therapy in a renal transplant recipient. Clinical nephrology, 2000, Volume: 54, Issue:5 Topics: Antigens, Viral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Fatal Outcome; Female; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pneumonia, Viral; Polymerase Chain Reaction; Postoperative Complications	2000
Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes. Blood, 2001, Feb-15, Volume: 97, Issue:4 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antigens, Viral; Antiviral Agents; Cause of Death; Child; Child, Preschool; Cytomegalovirus Infections; DNA, Viral; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Phosphoproteins; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Viral Load; Viral Matrix Proteins; Viremia; Virus Activation	2001
Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma. British journal of haematology, 2001, Volume: 112, Issue:1 Topics: Adult; Aged; Antigens, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Fever; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Multiple Myeloma; Postoperative Complications; Retrospective Studies; Transplantation, Autologous; Virus Activation	2001
Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Jan-15, Volume: 32, Issue:2 Topics: Adult; Antiviral Agents; Chronic Disease; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Risk Factors; Treatment Outcome; Virus Activation	2001
Failure of cidofovir to reduce CMV-antigenemia in a child transplanted from a matched unrelated donor. Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:1 Topics: Adenoviridae; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Evaluation; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Male; Organophosphonates; Organophosphorus Compounds; Treatment Outcome	2001
Frosted branch angiitis in a child with HIV infection. American journal of ophthalmology, 2001, Volume: 131, Issue:3 Topics: Antiviral Agents; Child; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Glucocorticoids; HIV Infections; Humans; Male; Retinal Diseases; Retinal Vessels; Vasculitis	2001
High-dose intravitreal ganciclovir and foscarnet for cytomegalovirus retinitis. American journal of ophthalmology, 2001, Volume: 131, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Treatment Outcome; Visual Acuity; Vitreous Body	2001
Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits. Investigative ophthalmology & visual science, 2001, Volume: 42, Issue:5 Topics: Animals; Antiviral Agents; Biological Availability; Chromatography, High Pressure Liquid; Foscarnet; Ganciclovir; Injections; Rabbits; Retina; Vitreous Body	2001
Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality. Blood, 2001, Apr-01, Volume: 97, Issue:7 Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lymphocyte Count; Male; Middle Aged; Polymerase Chain Reaction; Risk; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Virus Activation	2001
Flow cytometric evaluation of antiviral agents against human herpesvirus 6. Microbiology and immunology, 2001, Volume: 45, Issue:3 Topics: Acyclovir; Animals; Antigens, Viral; Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Flow Cytometry; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Viral Proteins	2001
CMV retinitis: a clinical management update. AIDS patient care and STDs, 1996, Volume: 10, Issue:2 Topics: AIDS-Related Opportunistic Infections; Algorithms; Antiviral Agents; Cidofovir; Clinical Protocols; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Injections; Organophosphonates; Organophosphorus Compounds; Patient Participation; Vitreous Body	1996
Support for new foscarnet indication for AIDS-related CMV retinitis is mixed. AIDS patient care and STDs, 1997, Volume: 11, Issue:5 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Combinations; Foscarnet; Ganciclovir; Humans	1997
Advances in the treatment of CMV. PI perspective, 1995, Issue:no 16 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Therapy, Combination; Eye; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Quality of Life	1995
New developments in the delivery of ganciclovir for cytomegalovirus (CMV retinitis). STEP perspective, 1995,Summer, Volume: 7, Issue:2 Topics: Administration, Oral; Cytomegalovirus Retinitis; Drug Costs; Drug Implants; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous	1995
New drug applications sought. AIDS alert, 1995, Volume: 10, Issue:9 Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Cytomegalovirus Retinitis; Drug Approval; Drug Implants; Drug Labeling; Foscarnet; Ganciclovir; Herpes Simplex; HIV Infections; Infusions, Intravenous; Mycobacterium avium-intracellulare Infection; Stavudine; United States; United States Food and Drug Administration	1995
Medicare may not reimburse for certain AIDS and cancer drugs. BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1995 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Insurance, Pharmaceutical Services; Medicare; Neoplasms; Vancomycin	1995
Advances in treatment for cytomegalovirus retinitis. BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1995 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Antiviral Agents; Cytomegalovirus Retinitis; Drug Implants; Drug Interactions; Foscarnet; Ganciclovir; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Kidney; Neutropenia	1995
Combination therapy improves CMV treatment. AIDS alert, 1996, Volume: 11, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Quality of Life	1996
Detecting CMV retinitis: know what to look for. Treatment is effective but not pleasant. AIDS alert, 1996, Volume: 11, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Antiviral Agents; Cytomegalovirus Retinitis; Drug Implants; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans	1996
CMV: the other virus. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1996, Volume: 10, Issue:3 Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Implants; Foscarnet; Ganciclovir; Humans	1996
Guide to CMV management. PI perspective, 1996, Issue:no 18 Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Drug Implants; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Quality of Life; Thionucleotides	1996
Intraocular therapy for cytomegalovirus retinitis. Journal of the International Association of Physicians in AIDS Care, 1996, Volume: 2, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Implants; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Visual Acuity	1996
CMV resistance: "more complicated than we thought". Journal of the International Association of Physicians in AIDS Care, 1996, Volume: 2, Issue:5 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans	1996
Spectrum and treatment of cytomegalovirus disease in persons with AIDS. Journal of the International Association of Physicians in AIDS Care, 1996, Volume: 2, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Central Nervous System Diseases; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Digestive System Diseases; Foscarnet; Ganciclovir; Humans; Valacyclovir; Valine	1996
Two-drug treatment effective against recurrent CMV retinitis. NIAID AIDS agenda, 1996 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Recurrence	1996
Responding to CMV neurologic infections. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1996, Volume: 10, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Central Nervous System Diseases; Cytomegalovirus Infections; Diagnosis, Differential; Foscarnet; Ganciclovir; Humans; Polymerase Chain Reaction	1996
Foscavir receives new indication. AIDS alert, 1997, Volume: 12, Issue:6 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpes Simplex; Humans; United States; United States Food and Drug Administration	1997
Fomivirsen. BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1998 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Foscarnet; Ganciclovir; Health Services Accessibility; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides	1998
Progressive outer retinal necrosis syndrome in a lymphoma patient with good visual outcome. American journal of ophthalmology, 2001, Volume: 132, Issue:1 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Immunoglobulins, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Retinal Necrosis Syndrome, Acute; Treatment Outcome; Visual Acuity	2001
Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients. The Journal of infectious diseases, 2001, Aug-01, Volume: 184, Issue:3 Topics: Antigens, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA Primers; DNA Probes; Drug Therapy, Combination; Foscarnet; Ganciclovir; Gene Expression Regulation, Viral; Glycoproteins; Graft Rejection; Humans; Immediate-Early Proteins; Immunosuppressive Agents; Kinetics; Lung Transplantation; Membrane Proteins; Phosphoproteins; Postoperative Complications; RNA-Binding Proteins; RNA, Messenger; Time Factors; Trans-Activators; Transcription, Genetic; Viral Matrix Proteins; Viral Proteins	2001
Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment approaches. Blood, 2001, Sep-01, Volume: 98, Issue:5 Topics: Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Phosphoproteins; Recurrence; Salvage Therapy; Time Factors; Transplantation, Homologous; Viral Matrix Proteins; Viremia	2001
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA. Bone marrow transplantation, 2001, Volume: 27, Issue:11 Topics: Adolescent; Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Infant; Nucleic Acid Amplification Techniques; RNA, Viral	2001
Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Nov-01, Volume: 33, Issue:9 Topics: Antiviral Agents; Bone Marrow Transplantation; Cerebral Ventricles; Child; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Combinations; Drug Resistance, Viral; Encephalitis, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds	2001
Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2001, Volume: 23, Issue:1-2 Topics: Antiviral Agents; Codon; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Foscarnet; Ganciclovir; Genes, Viral; Genetic Variation; Humans; Microbial Sensitivity Tests; Phosphotransferases; Virus Replication	2001
[In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:2 Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Drug Resistance, Viral; Fibroblasts; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Reference Values; Viral Plaque Assay; Virus Replication	2001
T-cell activation response to allogeneic CMV-infected endothelial cells is not prevented by ganciclovir or foscarnet: implications for transplant vascular sclerosis. Transplantation, 2002, Jan-27, Volume: 73, Issue:2 Topics: Antiviral Agents; Blood Vessels; Cytomegalovirus; Endothelium, Vascular; Foscarnet; Ganciclovir; Graft Rejection; Humans; Lymphocyte Activation; Sclerosis; T-Lymphocytes	2002
Sequence analysis of UL54 and UL97 genes and evaluation of antiviral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment. Transplant infectious disease : an official journal of the Transplantation Society, 2001, Volume: 3, Issue:4 Topics: Adult; Aged; Amino Acid Sequence; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mutation; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins	2001
[Cytomegalovirus sensitivity to anti-retroviral agents in patients infected with the human immunodeficiency virus with chorioretinitis in Spain]. Enfermedades infecciosas y microbiologia clinica, 2001, Volume: 19, Issue:10 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Chorioretinitis; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Spain	2001
Herpesvirus-6 encephalitis complicated by Wernicke-Korsakoff syndrome in a pediatric recipient of unrelated cord blood transplantation. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Child; Combined Modality Therapy; Cytarabine; Daunorubicin; Encephalitis, Viral; Etoposide; Fatal Outcome; Female; Fetal Blood; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; Immunocompromised Host; Korsakoff Syndrome; Leukemia, Myeloid, Acute; Recurrence; Roseolovirus Infections; Transplantation Conditioning; Transplantation, Homologous; Virus Activation	2001
Clinicopathologic reports, case reports, and small case series: cytomegalovirus retinitis in patients with Good syndrome. Archives of ophthalmology (Chicago, Ill. : 1960), 2002, Volume: 120, Issue:4 Topics: Agammaglobulinemia; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; DNA, Viral; Female; Foscarnet; Ganciclovir; Humans; Middle Aged; Retinal Detachment; Syndrome; Thymoma; Thymus Neoplasms; Vitreous Body	2002
Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, May-15, Volume: 34, Issue:10 Topics: Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Transplants; Treatment Outcome	2002
Necrotizing herpetic retinopathy associated with Ramsay Hunt syndrome. Archives of ophthalmology (Chicago, Ill. : 1960), 2002, Volume: 120, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Hearing Loss, Bilateral; Hearing Tests; Herpes Zoster Ophthalmicus; Herpes Zoster Oticus; Humans; Retinal Necrosis Syndrome, Acute; Syndrome; Visual Acuity	2002
Antiviral therapy for cytomegalovirus infections in pediatric patients. Seminars in pediatric infectious diseases, 2002, Volume: 13, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Infant; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Time Factors	2002
The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation. British journal of haematology, 2002, Volume: 118, Issue:4 Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; Infant; Lymphocyte Depletion; Male; Middle Aged; Platelet Transfusion; Postoperative Complications; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous	2002
Intravitreal antivirals in the management of patients with acquired immunodeficiency syndrome with progressive outer retinal necrosis. Archives of ophthalmology (Chicago, Ill. : 1960), 2002, Volume: 120, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Injections; Male; Retinal Necrosis Syndrome, Acute; Vitreous Body	2002
Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) are active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants. Antiviral research, 2002, Volume: 56, Issue:3 Topics: Adenine; Antiviral Agents; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Foscarnet; Ganciclovir; Guanine; Humans; Immunocompromised Host; Phosphotransferases (Alcohol Group Acceptor)	2002
Successful treatment of varicella zoster virus retinitis with aggressive intravitreal and systemic antiviral therapy. Ocular immunology and inflammation, 2002, Volume: 10, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Injections, Intravenous; Male; Organophosphonates; Organophosphorus Compounds; Retinitis; Vitreous Body	2002
Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection. Transplant infectious disease : an official journal of the Transplantation Society, 2002, Volume: 4, Issue:4 Topics: Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Organ Transplantation	2002
Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2002, Volume: 4, Issue:4 Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Encephalitis, Viral; Foscarnet; Ganciclovir; Humans; Leukodystrophy, Metachromatic; Male	2002
Point mutations induced by foscarnet (PFA) in the human cytomegalovirus DNA polymerase. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2003, Volume: 26, Issue:3 Topics: Amino Acid Substitution; Cells, Cultured; Codon; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Fibroblasts; Foscarnet; Ganciclovir; Genes, Viral; Humans; Lung; Mutation, Missense; Phenotype; Point Mutation; Sequence Analysis, Protein; Viral Proteins; Viral Structural Proteins	2003
Progressive outer retinal necrosis in immunocompetent patients treated initially for optic neuropathy with systemic corticosteroids. American journal of ophthalmology, 2003, Volume: 135, Issue:4 Topics: Acyclovir; Aged; Antiviral Agents; Aqueous Humor; Blindness; DNA, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Glucocorticoids; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Immunocompromised Host; Middle Aged; Multiple Sclerosis; Optic Neuritis; Polymerase Chain Reaction; Prednisone; Pupil Disorders; Retinal Necrosis Syndrome, Acute; Retrospective Studies	2003
Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry. Antiviral research, 2003, Volume: 58, Issue:2 Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Cells, Cultured; Cidofovir; Cytosine; Flow Cytometry; Foscarnet; Ganciclovir; Herpesvirus 4, Human; Herpesvirus 6, Human; Herpesvirus 8, Human; Humans; Organophosphonates; Organophosphorus Compounds	2003
Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro. Antiviral research, 2003, Volume: 58, Issue:2 Topics: Acyclovir; Animals; Antiviral Agents; Cattle; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Drug Synergism; Foscarnet; Ganciclovir; Inhibitory Concentration 50; Lactoferrin; Organophosphonates; Organophosphorus Compounds	2003
Cytomegalovirus infection resistant to ganciclovir in a renal transplant patient. Transplantation proceedings, 2003, Volume: 35, Issue:3 Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Cadaver; Candidiasis; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Male; Postoperative Complications; Streptococcal Infections; Streptococcus pneumoniae; Tissue Donors; Treatment Outcome	2003
Successful treatment with combination of systemic antiviral drugs and intravitreal ganciclovir injections in the management of severe necrotizing herpetic retinitis. Ocular immunology and inflammation, 2003, Volume: 11, Issue:2 Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Injections; Male; Necrosis; Retinitis; Severity of Illness Index; Visual Acuity; Vitreous Body	2003
Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423. Biochemical pharmacology, 2004, Jan-15, Volume: 67, Issue:2 Topics: Antiviral Agents; Carrier Proteins; Cell Cycle; DNA-Directed DNA Polymerase; Foscarnet; Ganciclovir; Gene Expression; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Indolizines; Intracellular Signaling Peptides and Proteins; Microbial Sensitivity Tests; Phosphotransferases (Alcohol Group Acceptor); Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines; Transcription, Genetic; Tumor Cells, Cultured; Virus Replication	2004
Recurrent cytomegalovirus disease, visceral leishmaniosis, and Legionella pneumonia after liver transplantation: a case report. Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2004, Volume: 51, Issue:1 Topics: Anti-Bacterial Agents; Antimony Sodium Gluconate; Antiviral Agents; Bone and Bones; Clarithromycin; Cross Infection; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Legionnaires' Disease; Leishmaniasis, Visceral; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Schistosomicides; Viral Load	2004
Comparison of sequential cytomegalovirus isolates in a patient with lymphoma and failing antiviral therapy. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 29, Issue:4 Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Resistance, Viral; Evolution, Molecular; Female; Foscarnet; Ganciclovir; Humans; Lymphoma, T-Cell; Molecular Epidemiology; Mutation, Missense; Organophosphonates; Organophosphorus Compounds; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA	2004
In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. American journal of veterinary research, 2004, Volume: 65, Issue:4 Topics: Acyclovir; Animals; Antiviral Agents; Cats; Cells, Cultured; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Foscarnet; Ganciclovir; Guanine; Idoxuridine; In Vitro Techniques; Inhibitory Concentration 50; Organophosphonates; Organophosphorus Compounds; Varicellovirus; Virus Replication	2004
Susceptibility of porcine cytomegalovirus to antiviral drugs. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:6 Topics: Animals; Antiviral Agents; Cell Survival; Cidofovir; Cytomegalovirus; Cytosine; DNA, Viral; Fluorescent Antibody Technique, Indirect; Foscarnet; Ganciclovir; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; Swine; Virus Replication	2004
How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients. Journal of clinical microbiology, 2005, Volume: 43, Issue:1 Topics: Adolescent; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Evolution, Molecular; Fatal Outcome; Female; Foscarnet; Ganciclovir; Gene Products, pol; Hematopoietic Stem Cell Transplantation; Humans; Male; Mutation; Treatment Outcome	2005
The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production. Blood, 2005, May-15, Volume: 105, Issue:10 Topics: Antiviral Agents; Apoptosis; Cell Line; DNA-Directed DNA Polymerase; Foscarnet; Ganciclovir; Herpesvirus 8, Human; Humans; Lymphoma; Nucleic Acid Synthesis Inhibitors; RNA, Messenger; Valproic Acid; Viral Proteins; Virus Assembly; Virus Replication	2005
Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2005, Volume: 34, Issue:2 Topics: Adolescent; Antigens, Viral; Antiviral Agents; Child; Cidofovir; Creatinine; Cytomegalovirus Infections; Cytosine; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Organophosphonates; Premedication; Virus Activation	2005
Early onset of ganciclovir-resistant cytomegalovirus infection in a lung-transplant recipient. The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi, 2005, Volume: 53, Issue:10 Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Lung Transplantation; Postoperative Complications	2005
An in vitro study of the design and development of a novel doughnut-shaped minitablet for intraocular implantation. International journal of pharmaceutics, 2006, Mar-09, Volume: 310, Issue:1-2 Topics: Anti-Retroviral Agents; Aqueous Humor; Drug Carriers; Drug Implants; Eye; Foscarnet; Ganciclovir; Hardness; Humans; In Vitro Techniques; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Tablets; Viscosity	2006
Cytomegalovirus colitis in children with inflammatory bowel disease. Gut, 2006, Volume: 55, Issue:4 Topics: Antiviral Agents; Child; Colitis; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Inflammatory Bowel Diseases; Treatment Outcome	2006
Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. The British journal of ophthalmology, 2006, Volume: 90, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Chronic Disease; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Eye Infections, Viral; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Glaucoma, Open-Angle; Gonioscopy; Humans; Iridocyclitis; Male; Middle Aged; Recurrence; Retrospective Studies; Uveitis, Anterior; Valganciclovir; Vitreous Body	2006
Fatal haemolytic uraemic syndrome in an AIDS patient with disseminated adenovirus and cytomegalovirus co-infection. Le infezioni in medicina, 2006, Volume: 14, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenovirus Infections, Human; Colitis; Cytomegalovirus Infections; Enteritis; Fatal Outcome; Female; Foscarnet; Ganciclovir; Hemolytic-Uremic Syndrome; Humans; Respiratory Distress Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination	2006
Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2006, Volume: 37, Issue:2 Topics: Antiviral Agents; Benzimidazoles; Cidofovir; Cytomegalovirus; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Ribonucleosides; Viral Proteins	2006
Pancreatic hyperamylasemia and hyperlipasemia in association with cytomegalovirus infection following unrelated cord blood transplantation for acute myelogenous leukemia. International journal of hematology, 2006, Volume: 84, Issue:5 Topics: Adult; Amylases; Antiviral Agents; Cord Blood Stem Cell Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Hyperamylasemia; Leukemia, Myeloid, Acute; Male; Pancreatitis; Transplantation, Homologous	2006
Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant. American journal of ophthalmology, 2007, Volume: 143, Issue:2 Topics: Aged; Antiviral Agents; Behcet Syndrome; Cytomegalovirus Retinitis; Drug Implants; Fluocinolone Acetonide; Foscarnet; Ganciclovir; Glucocorticoids; Humans; Immunocompromised Host; Macular Edema; Male; Retrospective Studies; Uveitis	2007
In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet. Veterinary microbiology, 2007, May-16, Volume: 122, Issue:1-2 Topics: Acyclovir; Adenine; Animals; Antiviral Agents; Cell Survival; Cells, Cultured; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Epithelial Cells; Foscarnet; Ganciclovir; Herpesvirus 1, Equid; Horses; Lung; Organophosphonates	2007
Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Antigens, Viral; Antiviral Agents; Cord Blood Stem Cell Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Enterocolitis; Exanthema; Female; Foscarnet; Ganciclovir; Humans; Japan; Male; Middle Aged; Neoplasms; Postoperative Complications; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Water-Electrolyte Imbalance	2007
Persistent erythema multiforme and CMV infection. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:3 Topics: Antiviral Agents; Bone Marrow Diseases; Cytomegalovirus Infections; Erythema Multiforme; Fatal Outcome; Female; Foscarnet; Ganciclovir; Hepatitis C; Humans; Liver Transplantation; Middle Aged; Pancytopenia; Skin	2007
Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2007, Volume: 13, Issue:5 Topics: Adolescent; Adult; Aged; Cord Blood Stem Cell Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Transplantation Conditioning	2007
Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:1 Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus Retinitis; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Male; Middle Aged; Organ Transplantation; Prognosis; Severity of Illness Index	2008
Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests. Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:3 Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Disease Progression; DNA, Viral; Female; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Immunohistochemistry; Male; Middle Aged; Phosphoproteins; Polymerase Chain Reaction; Transplantation; Viral Matrix Proteins	2007
Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2007, Volume: 40, Issue:2 Topics: Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Multiple, Viral; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Retrospective Studies; X-Linked Combined Immunodeficiency Diseases	2007
Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:10 Topics: Antibodies, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Fatal Outcome; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Liver Failure; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction	2007
Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant. Journal of virology, 2008, Volume: 82, Issue:1 Topics: Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; Benzimidazoles; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Models, Molecular; Molecular Sequence Data; Mutant Proteins; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Protein Structure, Tertiary; Ribonucleosides; Sequence Alignment; Viral Proteins	2008
A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2007, Volume: 26, Issue:12 Topics: Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Genetic Predisposition to Disease; Humans; Lung Transplantation; Male; Middle Aged; Mutation; Opportunistic Infections; Phosphotransferases (Alcohol Group Acceptor); Postoperative Complications; Retrospective Studies; Treatment Outcome	2007
Studies on a novel doughnut-shaped minitablet for intraocular drug delivery. AAPS PharmSciTech, 2007, Dec-28, Volume: 8, Issue:4 Topics: Administration, Topical; Antiviral Agents; Aqueous Humor; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Implants; Foscarnet; Ganciclovir; Hydrogen-Ion Concentration; Kinetics; Models, Chemical; Models, Statistical; Polyglactin 910; Research Design; Solubility; Tablets; Technology, Pharmaceutical; Viscosity	2007
Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology, 2008, Feb-05, Volume: 70, Issue:6 Topics: Antiviral Agents; Brain; Confusion; Diagnosis, Differential; DNA, Viral; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Herpesvirus 6, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Limbic Encephalitis; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Predictive Value of Tests; Roseolovirus Infections; Stem Cell Transplantation; Treatment Outcome	2008
Contrasting drug resistance phenotypes resulting from cytomegalovirus DNA polymerase mutations at the same exonuclease locus. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2008, Volume: 43, Issue:1 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phenotype; Protein Structure, Tertiary; Viral Proteins	2008
Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis. The Journal of infectious diseases, 2008, Sep-01, Volume: 198, Issue:5 Topics: Acyclovir; Adult; Aged; Antiviral Agents; Cohort Studies; Cornea; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Herpesvirus 1, Human; Humans; Keratitis, Herpetic; Male; Middle Aged; Prevalence; Thymidine Kinase	2008
Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes. Journal of medical virology, 2008, Volume: 80, Issue:10 Topics: Alemtuzumab; Anemia, Refractory, with Excess of Blasts; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antiviral Agents; Base Sequence; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Viral Proteins; Virus Activation	2008
Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Dec-15, Volume: 47, Issue:12 Topics: Adult; Antiviral Agents; Cerebrospinal Fluid; Encephalomyelitis; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Male; Proviruses; Roseolovirus Infections; Serum; Treatment Outcome	2008
Successful treatment of cytomegalovirus polyradiculopathy in a 9-year-old child with congenital human immunodeficiency virus infection. Journal of child neurology, 2009, Volume: 24, Issue:2 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Brain; Child; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Infections; Humans; Magnetic Resonance Imaging; Polyradiculopathy; Spine; Treatment Outcome	2009
Cytomegalovirus retinitis. Ophthalmology, 2009, Volume: 116, Issue:4 Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antibodies, Viral; Aqueous Humor; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell; Male; Middle Aged; Opportunistic Infections; Polymerase Chain Reaction; Transplantation Conditioning; Transplantation, Homologous; Visual Acuity; Vitreous Body	2009
[Disease by CMV resistant to Ganciclovir. Should plasma valganciclovir levels be monitored in high risk patients?]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2009, Volume: 29, Issue:2 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Gastric Mucosa; Humans; Immunoglobulins, Intravenous; Kidney Transplantation; Mutation, Missense; Phosphotransferases (Alcohol Group Acceptor); Postoperative Complications; Risk; Valganciclovir; Viral Load	2009
Donor CMV serostatus not predictive of relapse in D-/R- pediatric HCT. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:6 Topics: Acyclovir; Adolescent; Adult; Antibodies, Viral; Antigens, Viral; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; Ethnicity; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Living Donors; Male; Middle Aged; Myeloablative Agonists; Postoperative Complications; Premedication; Proportional Hazards Models; Recurrence; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Virus Activation; Young Adult	2009
Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS. Ophthalmology, 2010, Volume: 117, Issue:1 Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Male; Proportional Hazards Models; Prospective Studies; Survival Rate; Time Factors; Viral Load	2010
Sustained release of ganciclovir and foscarnet from biodegradable scleral plugs for the treatment of cytomegalovirus retinitis. Biomaterials, 2010, Volume: 31, Issue:7 Topics: Animals; Biocompatible Materials; Chromatography, High Pressure Liquid; Conjunctiva; Cytomegalovirus Retinitis; Dark Adaptation; Delayed-Action Preparations; Electroretinography; Foscarnet; Ganciclovir; Prosthesis Implantation; Rabbits; Sclera; Sclerostomy	2010
Fundus autofluorescence changes in cytomegalovirus retinitis. Retina (Philadelphia, Pa.), 2010, Volume: 30, Issue:1 Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Cytomegalovirus Retinitis; Drug Implants; Female; Fluorescein Angiography; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Retinal Pigment Epithelium; Retrospective Studies; Valganciclovir	2010
Long-term follow-up of acute retinal necrosis. Retina (Philadelphia, Pa.), 2010, Volume: 30, Issue:5 Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Eye Infections, Viral; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster; Herpesvirus 3, Human; Humans; Injections; Male; Middle Aged; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Simplexvirus; Visual Acuity; Vitreous Body	2010
[Cytomegalovirus infection--diagnostic and therapeutic difficulties in neonatal intensive care unit]. Przeglad lekarski, 2010, Volume: 67, Issue:1 Topics: Antiviral Agents; Cross-Sectional Studies; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunoglobulin G; Immunoglobulin M; Incidence; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Poland; Retrospective Studies; Sensitivity and Specificity; Serologic Tests; Urine	2010
Opposite effect of two cytomegalovirus DNA polymerase mutations on replicative capacity and polymerase activity. Antiviral therapy, 2010, Volume: 15, Issue:4 Topics: Animals; Antiviral Agents; Cells, Cultured; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Fibroblasts; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Mutation; Rabbits; Recombination, Genetic; Reticulocytes; Virus Replication	2010
Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor. International journal of hematology, 2010, Volume: 92, Issue:2 Topics: Adolescent; Adult; Aged; Cytomegalovirus Infections; Drug Evaluation; Family; Female; Foscarnet; Ganciclovir; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Young Adult	2010
Analysis of human cytomegalovirus glycoprotein N genotypes in Chinese hematopoietic stem cell transplant recipients. Archives of virology, 2011, Volume: 156, Issue:1 Topics: Antiviral Agents; China; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Foscarnet; Ganciclovir; Genetic Variation; Genotype; Hematopoietic Stem Cell Transplantation; Humans; Male; Polymerase Chain Reaction; Viral Envelope Proteins; Viral Load	2011
De novo thrombotic microangiopathy induced by cytomegalovirus infection leading to renal allograft loss. American journal of nephrology, 2010, Volume: 32, Issue:5 Topics: Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Thrombotic Microangiopathies; Time Factors	2010
Ganciclovir-resistant human herpesvirus-6 encephalitis in a liver transplant patient: a case report. Journal of neurovirology, 2011, Volume: 17, Issue:2 Topics: Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Liver Transplantation; Male; Polymerase Chain Reaction	2011
Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 50, Issue:4 Topics: Antiviral Agents; Chromosomes, Artificial, Bacterial; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genomic Structural Variation; Humans; Mutation; Phenotype; Viral Proteins	2011
Progressive outer retinal necrosis in a patient with acquired immune deficiency syndrome. Clinical & experimental optometry, 2011, Volume: 94, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Injections, Intravenous; Intravitreal Injections; Middle Aged; Retina; Retinal Necrosis Syndrome, Acute; Visual Acuity	2011
Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Transplantation, 2011, Jul-27, Volume: 92, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Incidence; Infant; Kidney; Kidney Transplantation; Male; Middle Aged; Mutation; Norway; Phosphotransferases (Alcohol Group Acceptor); Retrospective Studies; Transplantation; Treatment Outcome; Young Adult	2011
Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9 Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; DNA-Directed DNA Polymerase; Foscarnet; Ganciclovir; Genotype; Humans; Mutation; Phenotype; Recombination, Genetic; Viral Proteins	2011
Longitudinal analysis of human herpesvirus-8 DNA and antibodies in an Italian allogeneic stem cell transplant recipient. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 52, Issue:3 Topics: Antibodies, Viral; Cidofovir; Cytosine; DNA, Viral; Encephalitis; Fatal Outcome; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Italy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Organophosphonates; Stem Cell Transplantation; Transplantation, Homologous	2011
Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Alkaline Phosphatase; Antiviral Agents; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exonucleases; Foscarnet; Ganciclovir; Genes, Reporter; Genotype; Guanine; Humans; Inhibitory Concentration 50; Mutation; Organophosphonates; Phenotype; Viral Proteins; Virus Replication	2012
Polymerase chain reaction-based ganciclovir resistance testing of ocular fluids for cytomegalovirus retinitis. Archives of ophthalmology (Chicago, Ill. : 1960), 2012, Volume: 130, Issue:1 Topics: Adult; Aged; Antiviral Agents; Aqueous Humor; Cytomegalovirus; Cytomegalovirus Retinitis; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Genome, Viral; Genotype; Humans; Infant; Male; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Polymerase Chain Reaction; Retrospective Studies; Valganciclovir; Viral Proteins; Vitreous Body	2012
Polymorphic ventricular tachycardia in a patient with herpes encephalitis. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2012, Volume: 19, Issue:3 Topics: Acute Disease; Acyclovir; Antiviral Agents; Defibrillators, Implantable; Electrocardiography; Encephalitis, Herpes Simplex; Female; Foscarnet; Ganciclovir; Headache; Heart Arrest; Herpesvirus 2, Human; Humans; Long QT Syndrome; Magnetic Resonance Imaging; Meningitis, Viral; Middle Aged; Seizures; Tachycardia, Ventricular; Torsades de Pointes	2012
Ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasma. Journal of clinical microbiology, 2012, Volume: 50, Issue:5 Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA, Viral; Drug Resistance, Viral; Eye; Female; Foscarnet; Ganciclovir; Humans; Organophosphonates; Plasma; Sequence Analysis, DNA	2012
Case report: Multidrug-resistant cytomegalovirus in a modified multivisceral transplant recipient. Transplantation, 2012, Apr-15, Volume: 93, Issue:7 Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Isoxazoles; Kidney Transplantation; Leflunomide; Organophosphonates; Pancreas Transplantation; Recurrence; Stomach; Treatment Outcome	2012
[Clinical analysis of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation]. Zhongguo shi yan xue ye xue za zhi, 2012, Volume: 20, Issue:4 Topics: Adolescent; Adult; Child; Child, Preschool; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Transplantation, Homologous; Young Adult	2012
[Q & A. Enteritis found in a young man]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2011, Volume: 108, Issue:11 Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Enteritis; Foscarnet; Ganciclovir; Humans; Male	2011
Fever and pancytopenia in a patient with Crohn's disease. Gut, 2013, Volume: 62, Issue:9 Topics: Angiography; Antiviral Agents; Azathioprine; Cecum; Crohn Disease; Digestive System Surgical Procedures; Disease Progression; Female; Fever; Foscarnet; Ganciclovir; Gastrointestinal Hemorrhage; Humans; Ileitis; Ileum; Immunosuppression Therapy; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Male; Pancytopenia; Rectum; Treatment Outcome; Valganciclovir; Young Adult	2013
The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013, Volume: 13, Issue:2 Topics: Adult; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Inhibitory Concentration 50; Male; Middle Aged; Mutation; Odds Ratio; Organ Transplantation; Phosphotransferases (Alcohol Group Acceptor); Prevalence; Recurrence; Risk Factors; Time Factors; Treatment Outcome; Young Adult	2013
A possible coincidence of cytomegalovirus retinitis and intraocular lymphoma in a patient with systemic non-Hodgkin's lymphoma. Virology journal, 2013, Jan-07, Volume: 10 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Eye Neoplasms; Female; Foscarnet; Ganciclovir; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Polymerase Chain Reaction; Rituximab; Valganciclovir; Vitrectomy	2013
Cytomegalovirus retinitis in the absence of AIDS. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2013, Volume: 48, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; DNA, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Seronegativity; Humans; Immunocompetence; Intravitreal Injections; Male; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Valganciclovir	2013
Chronic retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients. Retina (Philadelphia, Pa.), 2013, Volume: 33, Issue:9 Topics: Aged; Aged, 80 and over; Antiviral Agents; Aqueous Humor; CD4 Lymphocyte Count; Chronic Disease; Cytomegalovirus; Cytomegalovirus Retinitis; DNA, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Seronegativity; Humans; Male; Middle Aged; Necrosis; Polymerase Chain Reaction; Retinal Neovascularization; Retinal Vasculitis; Retinal Vessels; Retrospective Studies; Uveitis, Posterior; Valganciclovir; Vitreous Body	2013
Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; Cells, Cultured; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phenotype; Sequence Analysis, DNA	2013
Cytomegalovirus polyradiculopathy of late onset in a young renal transplant recipient. Clinical nephrology, 2013, Volume: 80, Issue:1 Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Magnetic Resonance Imaging; Polyradiculopathy; Time Factors; Valganciclovir	2013
Persistent human herpesvirus-6 infection in patients with an inherited form of the virus. Journal of medical virology, 2013, Volume: 85, Issue:11 Topics: Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Infectious Disease Transmission, Vertical; Prevalence; RNA, Viral; Roseolovirus Infections; Sequence Analysis, DNA; Treatment Outcome; United States; Valganciclovir; Virus Replication	2013
Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides. PloS one, 2013, Volume: 8, Issue:9 Topics: Adolescent; Adult; Antigens, Viral; Antiviral Agents; Blood Donors; Combined Modality Therapy; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Host-Pathogen Interactions; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Reproducibility of Results; Retrospective Studies; Transplantation, Homologous; Young Adult	2013
Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation. Antiviral research, 2013, Volume: 100, Issue:3 Topics: Antiviral Agents; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Foscarnet; Ganciclovir; Genes, Viral; Humans; Mutagenesis; Mutation, Missense; Organophosphonates; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Viral Proteins	2013
Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:1 Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Viremia; Young Adult	2014
In vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of Action. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Antiviral Agents; Artemisinins; Butadienes; Cell Line; Cytomegalovirus; Digitoxin; Digoxin; Drug Combinations; Drug Interactions; Fibroblasts; Foscarnet; Ganciclovir; Humans; Indoles; Nitriles; Ouabain; Pyrroles; Sunitinib; Virus Replication	2014
Cytomegalovirus mutants resistant to ganciclovir and cidofovir differ in susceptibilities to synguanol and its 6-ether and 6-thioether derivatives. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3 Topics: Antiviral Agents; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytosine; Drug Resistance, Multiple, Viral; Foscarnet; Ganciclovir; Genotype; Guanine; Mutation; Organophosphonates	2014
Intravitreal foscarnet for recurring CMV retinitis in a congenitally infected premature infant. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2014, Volume: 18, Issue:1 Topics: Antiviral Agents; Cytomegalovirus Retinitis; Female; Foscarnet; Ganciclovir; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Infusions, Intravenous; Intravitreal Injections; Recurrence; Retinopathy of Prematurity	2014
UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:2 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mutation; Organophosphonates; Viral Proteins	2014
Human herpesvirus 6 encephalitis simulating brain metastases in a patient with advanced small-cell lung cancer. Chemotherapy, 2013, Volume: 59, Issue:5 Topics: Antiviral Agents; Brain Neoplasms; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Immunocompromised Host; Lung Neoplasms; Male; Middle Aged; Roseolovirus Infections; Small Cell Lung Carcinoma	2013
Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; High-Throughput Nucleotide Sequencing; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Organophosphonates; Pneumonia, Viral; Time Factors; Viral Proteins; Virus Replication	2014
Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 28 Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Leflunomide; Lung Transplantation; Monitoring, Immunologic; Transplant Recipients	2014
Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12 Topics: Acyclovir; Amino Acid Sequence; Animals; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cytarabine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Guanine; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; Molecular Sequence Data; Protein Kinases; Rhadinovirus; Sequence Alignment; Structure-Activity Relationship; Thymidine Kinase; Viral Proteins	2014
Cytomegalovirus retinitis in HIV-negative patients: a practical management approach. Ophthalmology, 2015, Volume: 122, Issue:4 Topics: Adult; Aged; Antigens, Viral; Antiviral Agents; Child, Preschool; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Seronegativity; Humans; Immediate-Early Proteins; Infant; Injections, Intravenous; Intravitreal Injections; Male; Polymerase Chain Reaction; Retrospective Studies; Viral Load; Visual Acuity	2015
Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility. Journal of virology, 2015, Volume: 89, Issue:8 Topics: Acyclovir; Analysis of Variance; Animals; Antiviral Agents; Chlorocebus aethiops; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Gene Transfer Techniques; Herpesvirus 1, Human; Humans; Kinetics; Models, Molecular; Mutation, Missense; Protein Structure, Secondary; Vero Cells	2015
Perivascular hypofluorescence in frosted branch angiitis. Ophthalmic surgery, lasers & imaging retina, 2015, Volume: 46, Issue:3 Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cytomegalovirus Retinitis; Female; Fluorescein Angiography; Foscarnet; Ganciclovir; Humans; Intravitreal Injections; Middle Aged; Retinal Vasculitis; Valganciclovir	2015
Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis. Antiviral research, 2016, Volume: 129 Topics: Antiviral Agents; Chromosomes, Artificial, Bacterial; Cytomegalovirus; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Models, Molecular; Mutagenesis; Organophosphonates; Phenotype; Point Mutation; Protein Domains; Viral Proteins	2016
Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report. Nephrology (Carlton, Vic.), 2016, Volume: 21 Suppl 1 Topics: Adult; Allografts; Antiviral Agents; Biopsy; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Immunohistochemistry; Immunosuppressive Agents; Kidney Transplantation; Time Factors; Treatment Outcome	2016
Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:3 Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antiviral Agents; Cohort Studies; Communicable Diseases; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Organ Transplantation; Retrospective Studies; Risk Factors; Valganciclovir; Young Adult	2016
Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Gene Expression; Humans; Microbial Sensitivity Tests; Mutation; Organophosphonates; Protein Domains; Viral Proteins	2016
Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance. Antiviral research, 2016, Volume: 131 Topics: Adolescent; Adult; Antiviral Agents; Child; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genotype; Humans; Immunocompromised Host; Infant; Middle Aged; Mutation; Organophosphonates; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Polymorphism, Genetic; Viral Proteins	2016
Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation. Transplantation proceedings, 2016, Volume: 48, Issue:2 Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Immunosuppressive Agents; Intestines; Isoxazoles; Leflunomide; Male; Middle Aged; Retrospective Studies; Viremia	2016
Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2016, Volume: 80 Topics: Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; High-Throughput Nucleotide Sequencing; Humans; Kidney Transplantation; Male; Middle Aged; Mutation; Phylogeny; Retrospective Studies; Sequence Analysis, DNA; Viral Load	2016
Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report. Transplantation proceedings, 2016, Volume: 48, Issue:4 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Liver Transplantation; Meningoencephalitis; Middle Aged; Polymerase Chain Reaction; Renal Dialysis	2016
Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2016, Volume: 82 Topics: Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Lung Transplantation; Transplant Recipients; Viral Load	2016
Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection. Transplantation, 2016, Volume: 100, Issue:10 Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Transplant Recipients	2016
Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series. Antiviral research, 2016, Volume: 135 Topics: Aged; Antiviral Agents; Chemotherapy, Adjuvant; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Salvage Therapy; Transplant Recipients; Virus Activation	2016
Dual Intravitreal Injections With Foscarnet and Ganciclovir for Ganciclovir-Resistant Recurrent Cytomegalovirus Retinitis in a Congenitally Infected Infant. Journal of pediatric ophthalmology and strabismus, 2016, Oct-22, Volume: 53 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Infant; Intravitreal Injections; Pregnancy; Pregnancy Complications, Infectious; Recurrence; Viral Load; Vitreous Body	2016
Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene. Antiviral research, 2017, Volume: 138 Topics: Amino Acid Substitution; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genotype; Humans; Mutation; Phenotype; Viral Proteins	2017
Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand. Transplantation proceedings, 2017, Volume: 49, Issue:5 Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Mutation; Organ Transplantation; Organophosphonates; Postoperative Complications; Real-Time Polymerase Chain Reaction; Retrospective Studies; Thailand; Young Adult	2017
Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation, 2017, Volume: 52, Issue:11 Topics: Adolescent; Antiviral Agents; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Registries; Retrospective Studies; Risk Factors; Roseolovirus Infections; Stem Cell Transplantation; Survival Analysis; Tissue Donors; Transplantation, Homologous	2017
Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report. Transplantation proceedings, 2017, Volume: 49, Issue:7 Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Male; Organophosphonates; Postoperative Complications; Tissue Donors	2017
Analysis of five cases of human herpesvirus-6 myelitis among 121 cord blood transplantations. International journal of hematology, 2018, Volume: 107, Issue:3 Topics: Adolescent; Adult; Aged; Allografts; Antiviral Agents; Autonomic Nervous System Diseases; Cord Blood Stem Cell Transplantation; Female; Fever; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myelitis; Pain; Pruritus; Spinal Cord; Treatment Outcome; Young Adult	2018
Safety and efficacy of foscarnet for the management of ganciclovir-resistant or refractory cytomegalovirus infections: A single-center study. Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:2 Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Glomerular Filtration Rate; Humans; Male; Middle Aged; Retrospective Studies	2018
Molecular detection of human herpesvirus 7 DNA in cerebrospinal fluid from adult patients with neurological disorders. Journal of neurovirology, 2018, Volume: 24, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Encephalitis, Viral; Female; Foscarnet; Ganciclovir; Herpesvirus 7, Human; Humans; Male; Meningitis, Viral; Middle Aged; Myelitis; Retrospective Studies; Roseolovirus Infections; Spinal Puncture	2018
Antiviral combination therapy for cytomegalovirus infection in high-risk infants. Antiviral therapy, 2018, Volume: 23, Issue:6 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Infant, Newborn; Male; Retrospective Studies; Risk Factors; Severe Combined Immunodeficiency; Survival Analysis; Viral Load; Viremia	2018
Antiviral therapy for the treatment of HHV-6-associated syndromes after transplant. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019, Volume: 19, Issue:1 Topics: Antiviral Agents; Control Groups; Cord Blood Stem Cell Transplantation; Encephalitis; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Prospective Studies; Syndrome	2019
In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus. Antiviral research, 2018, Volume: 158 Topics: Antiviral Agents; Benzimidazoles; Cell Line; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Antagonism; Drug Combinations; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Endodeoxyribonucleases; Fibroblasts; Foscarnet; Ganciclovir; Guanine; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Ribonucleosides; Viral Proteins; Virus Replication	2018
Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report. Transplantation proceedings, 2018, Volume: 50, Issue:10 Topics: Adolescent; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Kidney Transplantation; Mutation	2018
Acute Retinal Necrosis: Virological Features Using Quantitative Polymerase Chain Reaction, Therapeutic Management, and Clinical Outcomes. American journal of ophthalmology, 2019, Volume: 208 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Aqueous Humor; Cytomegalovirus Retinitis; DNA, Viral; Eye Infections, Viral; Female; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster Ophthalmicus; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 3, Human; Humans; Intravitreal Injections; Male; Middle Aged; Real-Time Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Viral Load; Visual Acuity; Young Adult	2019
Cost analysis of ganciclovir and foscarnet in recipients of allogeneic hematopoietic cell transplant with cytomegalovirus viremia. Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:2 Topics: Adolescent; Adult; Aged; Antiviral Agents; Chemoprevention; Child; Costs and Cost Analysis; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Health Care Costs; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Transplant Recipients; Viremia; Young Adult	2020
Comparison of Transplantation Outcomes after Foscarnet and Ganciclovir Administration as First-Line Anti-Cytomegalovirus Preemptive Therapy. Transplantation and cellular therapy, 2021, Volume: 27, Issue:4 Topics: Antiviral Agents; Cytomegalovirus; Foscarnet; Ganciclovir; Humans; Neoplasm Recurrence, Local; Retrospective Studies	2021
Continuous-Infusion Foscarnet Facilitates Administration in Hematopoietic Stem Cell Transplantation Patients. Transplantation and cellular therapy, 2021, Volume: 27, Issue:7 Topics: Cytomegalovirus Infections; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Retrospective Studies	2021
Use of letermovir-valganciclovir combination as a step-down treatment after foscarnet for ganciclovir-resistant CMV infection in kidney transplant recipients. Clinical transplantation, 2021, Volume: 35, Issue:11 Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Quinazolines; Transplant Recipients; Valganciclovir	2021
Cutaneous presentation of disseminated cytomegalovirus infection in a non-transplant patient with hematological malignancy: A case report. Medicine, 2022, Feb-04, Volume: 101, Issue:5 Topics: Antiviral Agents; Cytomegalovirus Infections; Fatal Outcome; Foscarnet; Ganciclovir; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Skin Diseases	2022
Intra-host diversity of drug-resistant cytomegalovirus: A case report of cytomegalovirus infection after allogeneic hematopoietic cell transplantation. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:10 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Mutation; Phosphotransferases (Alcohol Group Acceptor)	2022
Artificial stem cells mediated inflammation-tropic delivery of antiviral drugs for pneumonia treatment. Journal of nanobiotechnology, 2022, Jul-16, Volume: 20, Issue:1 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Fatty Acids, Monounsaturated; Foscarnet; Ganciclovir; Humans; Inflammation; Nanoparticle Drug Delivery System; Pneumonia; Polylactic Acid-Polyglycolic Acid Copolymer; Quaternary Ammonium Compounds; Stem Cells	2022
Efficacy of ganciclovir versus foscarnet in ganciclovir-resistant cytomegalovirus retinitis: A case report. European journal of ophthalmology, 2023, Volume: 33, Issue:5 Topics: Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Treatment Outcome	2023
[Resistance to antiviral drugs in human viruses from the subfamily Voprosy virusologii, 2022, 11-19, Volume: 67, Issue:5 Topics: Antiviral Agents; Betaherpesvirinae; Cytomegalovirus; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans	2022
Prevalence of cytomegalovirus antiviral drug resistance in transplant recipients. Antiviral research, 2023, Volume: 215 Topics: Antiviral Agents; Benzimidazoles; Cidofovir; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Prevalence; Transplant Recipients; Viral Proteins	2023